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Introduction 
 
1 Introduction 
 
The demand for chiral molecules has increased considerably in recent years and 
intensive research has been carried out in order to develop improved methods for 
synthesizing such compounds. For many decades enantiomerically enriched 
molecules were generated either via classical resolution or by chemical 
transformation of an enantiomerically enriched precursor obtained with the help of 
chiral auxiliaries. It was as early as 1848 when the first resolution, that of tartaric acid, 
was carried out by Louis Pasteur.1 With microscope and tweezers, he carefully 
separated the two mirror-image crystal forms of the sodium ammonium salt of 
optically inactive tartaric acid. The technique is laborious and requires the two crystal 
forms to be distinguishable. Unfortunately this does not happen very often and 
therefore new approaches for resolving the enantiomers have been developed. The 
most widely used method is based on converting the enantiomers of a racemic 
mixture into a pair of diastereomers which can be easily separated by crystallization 
or chromatographic methods, followed by an appropriate chemical transformation to 
liberate the enantiomers and recover the resolving agent. An emerging technology is 
the separation of the racemic mixture by chiral high-performance liquid 
chromatography by using a chiral stationary phase. One drawback of all resolution 
techniques is that the desired enantiomer can only be isolated in up to 50% yield. 
Enantioselective synthesis using auxiliaries requires stoichiometric amounts of chiral 
substances which are not incorporated in the target molecules and have to be 
removed after the establishment of the stereogenic centers. Asymmetric 
transformations, where achiral starting materials are converted into enantiomerically 
enriched products with the help of a chiral catalyst or mediator have, therefore, 
significant potential advantages over the afore mentioned approaches. Effective 
catalysts for several processes are readily available in nature (biocatalysis) or they 
have been designed and synthesized in laboratories (chemical catalysis). Enzymes 
are the catalysts which evolved in nature and one of their features is their high 
selectivity while conducting the reactions.2 One limitation of the enzymatic processes 
is that most of the time only one enantiomer of the product can be obtained directly. 
Over the last few years, considerable efforts have been made in the field of 
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organometallic catalysis and a wide variety of catalytic transformations are leading to 
products with >99% ee. A major advance was achieved in the 1970’s by Knowles 
and his colleagues,3 who performed the first enantioselective hydrogenation of a 
prochiral olefin, with up to 96% ee in the presence of a rhodium based catalyst. The 
process was immediately commercialized and applied on a large scale in the 
synthesis of the anti-Parkinson drug L-DOPA (95% ee).4 In recognition of his 
achievements, Knowles5 shared the 2001 Nobel Prize in chemistry with Noyori for 
enantioselective hydrogenation6 and Sharpless for enantioselective oxidation 
catalysis.7 All these processes have found industrial applications in the synthesis of 
chiral drugs and building blocks for asymmetric synthesis. Thus, often the concept of 
asymmetric catalysis is connected with that of metal-complex catalyzed syntheses 
and much work in this area has been focused on the design and synthesis of such 
organometallic complexes which are able to induce asymmetry during the 
transformations. Recently, scientists have also become more interested in the 
possibility of using simple organic molecules to induce chirality in the products. 
Actually, several popular organocatalysts are well known ligands in the field of 
organometallic chemistry. Their rediscovery and use as catalysts themselves had a 
considerable impact on the modern organic chemistry and the field of asymmetric 
organocatalysis is a rapidly growing one. So far, the common catalysts involved in 
these processes are nitrogen-containing molecules such as amino acids and 
derivatives, small peptide chains, cinchona alkaloids as well as chiral diamines and 
heterazolium based compounds.8 The scope of organocatalysis has been extended 
considerably and a large range of reactions are now performed efficiently in the 
presence of these small chiral molecules. Their great potential was demonstrated in 
the last two years when typical transition-metal-mediated coupling reactions were 
performed under metal-free conditions.9 Organocatalysis now offers complementary 
approaches to the well-established chemical and biochemical transformations and 
some of their practical advantages are notable. The catalysts are inexpensive, easily 
available and usually more stable than the metal-based complexes. The reactions 
generally tolerate aerobic conditions and do not require absolute solvents. In 
comparison with enzymes, organocatalysts possess a wider substrate scope 
because, often, both enantiomeric forms of the chiral catalyst are readily accessible 
from nature or easily synthesized and modified by simple chemical reactions. 
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Furthermore, they can be anchored to a solid support, easily recovered after the 
transformations, and repeatedly reused without loss of selectivity. 
If in the case of metal-mediated enantioselective catalytic reactions, the metal is the 
one responsible for the transmission of chiral information through the formation of a 
favorable transition state, in its absence, the transition state necessary for 
enantioselective transformation is achieved either through passive or dynamic 
interactions. Dynamic bindings involve activation of the substrate through 
nucleophilic addition of the chiral amine catalyst to the prochiral substrate. Such 
bindings also rely on the formation of hydrogen bonding between substrate and 
catalysts to aid stereoselectivity. Organocatalysts, which function using passive 
(hydrophobic, van der Waals, electrostatic interactions) or dynamic interactions, 
display characteristic features and mechanistic similarities to known bioorganic 
catalysts and are often referred to as enzyme mimetics. Generally, the 
organocatalysts proved to be highly effective with a wide range of substrates in 
different reactions and therefore deserve their recognition as a privileged class of 
ligands. For example proline10 and its derivatives are known to effectively catalyze 
different types of reactions such as the intra- and intermolecular aldol reaction, 
Michael addition, Mannich reaction, [4+2] cycloaddition, Baylis-Hillman reaction, as 
well as α-alkylation and α-amination of aldehydes.11 Cinchona alkaloids further 
enlarge the field of organocatalysis and remarkable results have been achieved in 
the field of anhydride desymmetrization, conjugate addition, ketene chemistry and 
kinetic resolution.12 
 
 
1.1 Proline 
 
Even if the first attempts to use pure organic molecules as chiral catalysts date back 
from the beginning of the twentieth-century, the first successful results were not 
obtained until the early 1970s by Hajos and Parrish,13 as well as Eder, Sauer and 
Wiechert14 independently. The two groups have discovered that asymmetry could be 
induced in a Robinson type annulation of an achiral triketone 1 by simply adding a 
catalytic amount of D- or L-proline to the reaction mixture (Scheme 1). 
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O
O
O O
O
OH
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O
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1 2 3
 
Scheme 1: Hajos-Parrish-Eder-Sauer-Wiechert Reaction. 
 
The first mechanistic hypotheses were suggested also by Hajos in 1974. Upon 
observation that no O-18 was incorporated into the product when the reaction was 
carried out in the presence of O-18 enriched water, Hajos and Parrish proposed that 
proline activates one of the two enantiotopic carbonyl acceptor groups by forming a 
carbinol amine 4 in the transition state (TS). Thirteen years later, Agami and co-
workers published strong evidence (second order in proline, small negative nonlinear 
effect) for an enamine type intermediate and propose a TS 5 which involves two 
proline molecules.15 Recently, after taking a deeper look on the possible products of 
this reaction, Houk16 proposed a set of four TS’s, (two chair and two boat 
conformations), and with the help of density functional theory calculations they 
concluded that the chair TS’s are lower in energy than the boat TS’s. Of the two chair 
TS’s, the energy barrier of the one responsible for the formation of the (S,S) bicyclic 
ketol is lower than the barrier for the formation of the (R,R) product, a result which is 
in agreement with the experimental data. Swaminathan invoked a heterogeneous 
aldolization process which takes place on the surface of crystalline proline (TS 7).17 
 
O
OH
O
H
N
H
CO2−
+
Hajos Model
O
O
N
N CO2−
H
−O2C H
+
Agami Model Houk Model
O
O
N O
O
H
H
4 5 6
H
O
O
NO
−O
H
H +
O
7
Swaminathan Model  
Scheme 2: Selected TS Models for the Proline-Catalyzed Aldol Reaction. 
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Recently, List, Lerner and Barbas have developed the first intermolecular version of a 
cross-aldol reaction between aldehydes as acceptors and ketones as donors using 
catalytic amounts of proline.18 While aromatic aldehydes gave products with 
moderate selectivity (~70% ee),18a a large variety of α-mono- and α-disubstituted 
aliphatic aldehydes provided aldols with excellent enantioselectivities (up to 99% ee, 
Scheme 3).18b Under optimized conditions, it can also be applied to α-unbranched 
aliphatic aldehydes to give products with up to 99% ee. Previously, the use of α-
unbranched aldehydes in the cross-aldolization process was hindered by their self-
condensation, fact which can be avoided now by carrying out the reactions under 
optimal conditions. List’s kinetic and theoretical studies on intra- and intermolecular 
versions of the reaction contradict Hajos and Agami’s findings and point to a unified 
enamine catalysis mechanism.19 List’s observations are consistent with Houk’s 
theoretical calculations, and the proposed metal-free Zimmerman-Traxler-type 
transition state 1120 invokes one single proline molecule which catalyses the reaction 
in the same manner as type I-aldolases and catalytic antibodies (type I-aldolase 
mimics) do.21 
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Scheme 3: Proline Mediated Intermolecular Aldol Reaction. 
 
MacMillan further enlarged the substrate scope by demonstrating that α-unbranched 
aldehydes can be used as donors in the reaction with aldehyde acceptors to give 
products in high yields with up to 24:1 dr and >99% ee.22 Cordova reported the 
proline catalyzed direct asymmetric cross-aldol reaction of aldehydes in an ionic 
liquid medium, leading to optically pure 3-hydroxy aldehydes (99->99% ee) in high 
yields (68-78%) and good diastereoselectivities (3:1 to >19:1 dr).23 
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An asymmetric intramolecular version of the Hajos-Parrish-Eder-Sauer-Wiechert 
reaction has also been developed, and the enolexo aldolization was successfully 
applied to various pentane-1,5-dialdehydes to give products in high yields and 
diastereoselectivities, with up to 99% ee.24 
 
Fascinated by these results, the scientific community became increasingly attracted 
to these small molecules and the potential behind them. Soon after, it was found that 
proline is capable of performing other types of reaction in a highly selective manner. 
For example, the proline catalyzed Mannich reaction offers practical access to a 
large number of enantiomerically enriched β-amino carbonyl compounds.25 Under 
optimized conditions, it can be carried out either directly, as a three-component one-
pot reaction, or indirectly, using preformed imines and enolates. Various structurally 
diverse ketones and aldehydes have been tested in the reaction with different aniline 
derivatives to give products in high yields and excellent selectivities. The reaction is 
supposed to follow an enamine mechanism26 and occurs with diastereo- and 
enantioselectivity opposite to that of related aldol reaction (Scheme 4). 
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Scheme 4: Proposed TS for Proline Catalyzed Aldol and Mannich Reactions. 
 
Surprisingly, only modest levels of enantioselection were achieved when L-proline 
was used as a catalyst in the asymmetric Michael addition of ketones to nitro 
olefins27 and α-alkylation of aldehydes.28 In contrast, excellent yields and selectivities 
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were achieved when L-α-methyl proline (10 mol%) was employed in the 
intramolecular alkylation reaction.28 No detectable racemization, self condensation or 
catalyst alkylation occurs during this process which provides access to 
enantiomerically enriched cyclopropane, cyclopentane and pyrrolidine derivatives. 
Also worthy of note is the α-amination of ketones and aldehydes which furnishes 
useful precursors for the synthesis of 2-oxazolidinones and other natural and 
unnatural α-amino acids derivatives (Scheme 5).29 A similar enamine mechanism is 
suggested to rationalize the stereochemical outcome of the reaction. 
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Scheme 5: Proline Catalyzed Asymmetric α-Amination of Aldehydes. 
 
Recently, MacMillan, Hayashi, Zhong, and soon after Córdova, independently 
reported on the proline catalyzed enantioselective α-oxyamination of aldehydes.30 
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Scheme 6: Proline Catalyzed Asymmetric α-Oxyamination of Aldehydes. 
 
MacMillan found that the use of chloroform as solvent and the superior reactivity of 
nitrosobenzene are suppressing the self-aldolization and α-amination pathways.30a 
Lowering the temperature to 4 °C also had a positive effect on the reaction selectivity 
and various aldehydes were enantioselectively oxidized in good yields under these 
mild conditions. In addition, lowering the catalyst loading from 10 to 0.5 mol% had no 
significant detrimental influence on the enantioselectivity. Accordingly, the 
oxyamination of propanal in chloroform at 4 °C in the presence of 2 mol% L-proline 
 7
Introduction 
afforded the α-aminooxy aldehyde in 88% yield and 97% ee. Zhong reported the in 
situ reduction of the carbonyl group of 19 to give the 1,2-protected diol (secondary 
alcohol protected as an O-amino group) with high enantioselectivity.30b,c Subsequent 
hydrogenation over Adams catalyst furnished the corresponding 1,2-diol without any 
loss in the optical purity. Accordingly, various aliphatic aldehydes were converted into 
the corresponding 1,2-protected diols with excellent selectivities (94-99% ee). 
Hayashi reported that the same reaction can be performed in acetonitrile at −20 °C to 
give the protected diol in quantitative yield (two steps) and 98% ee.30d 
 
Excellent chemo-, regio-, and enantioselectivities were reported by Córdova in the α-
oxyamination of cyclic, as well as acyclic ketones (Scheme 7).30e,31 
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Scheme 7: Proline Catalyzed Asymmetric α-Oxyamination of Cyclic Ketones. 
 
The double oxyamination of the ketones with two available enol forms could be 
circumvented by slow addition of the nitrozo electrophile, via syringe pump, to the 
reaction mixture. The oxyamination of the acyclic ketones afforded, along with the O-
addition adducts (>99% ee), small amounts of the aminated ketones with the same 
regioselectivity as the major products. At the same time, Hayashi applied the same 
methodology to different cyclohexanone derivatives to give products in good yields 
and excellent selectivity (mainly >99% ee).32 
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1.2 Amino acid derivatives 
 
 
1.2.1 Imidazolidinone derivatives 
 
Several attempts towards the development of an organocatalytic asymmetric Diels-
Alder reaction are described in the literature and chiral amines such as cinchona 
alkaloids, ephedrine, and prolinol derivatives are known to catalyze the reaction with 
a moderate level of enantioselectivity.33 The first highly selective Diels-Alder reaction 
between α,β-unsaturated aldehydes and various dienes was reported by MacMillan34 
and employs the use of secondary amines (as their hydrochloric salts) as chiral 
catalysts. The strategy was based on the possibility of activating the dienophile by 
lowering its LUMO energy upon reversible formation of an iminium ion. This process 
is analogous to the Lewis acid catalyzed Diels-Alder reaction where an unsaturated 
carbonyl system is activated upon chelation. The general reaction mechanism is 
outlined in Scheme 8. The first step employs the formation of iminium ion 25 between 
catalyst and aldehyde. Next, Diels-Alder cycloaddition leads to the iminium ion 26 
and subsequent hydrolysis provides the enantiomerically enriched product and 
liberates the catalyst 24. 
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R'R
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Scheme 8: Proposed Mechanism for the Organocatalyzed Diels-Alder Reaction. 
 
Several catalysts were evaluated in the reaction between cinnamaldehyde (27) and 
cyclopentadiene and the best results were obtained with the phenylalanine derivative 
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28 (Scheme 9). Molecular modeling calculations explain the asymmetric induction of 
the reaction in terms of selective formation of the (E)-iminium isomer 29, and by 
substantial shielding of the re face of the dienophile by the catalyst’s benzyl group, 
leaving the si face exposed for cycloaddition. 
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Scheme 9: Organocatalytic Diels-Alder Reaction. 
 
The reaction proved to be general with respect to the structure of the diene and the 
dienophile, and the products were obtained in good yields and excellent 
enantioselectivities (83-96% ee), with exo:endo selectivities ranging from 1:14 to 
35:1. The reaction could also be extended to α,β-unsaturated ketones by using a 
modified catalyst.35 A large variety of simple cyclic and acyclic enones have been 
tested in reactions with different dienes, affording products with superior diastereo- 
and enantiocontrol compared to the metal catalysis pathway. The preparative utility 
of the method was demonstrated in the reaction between ethyl-vinyl ketone and 
different dienes, where endo products were isolated as single diastereomers (GLS- 
and HPLC-analysis) with up to 98% ee. 
 
The same imidazolidinone 28·HCl proved to be highly effective in the 1,3-dipolar 
cycloaddition between nitrones and α,β-unsaturated aldehydes.36 Reaction at −10 °C 
between crotonaldehyde 32 (R” = Me) and nitrone 31 (R = Bn, R’ = Ph) provided the 
isoxazolidine 33 in 70% yield with a 88:12 endo:exo ratio and 95% ee (endo). 
Variation of the Brønsted acid cocatalyst from HCl to HClO4 led to an increase in the 
diastereoselectivity (94:6) and a slight decrease in the enantioselectivity (90% ee). 
However, the enantioselectivity decrease could be avoided by performing the 
reaction at lower temperature (−20 °C, 94% ee). 
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Scheme 10 gives an overview of a field where organocatalysis succeeded, while 
traditional Lewis-acid catalysis failed. Coordination of the Lewis-acid on the nitrone 
oxide in the presence of monodenate dipolarophiles inhibits the reaction, while the 
organocatalyst selectively activates the α,β-unsaturated aldehydes, enabling the 
reaction to take place. 
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Scheme 10: Organocatalyzed 1,3 -Dipolar Cycloaddition. 
 
Recent studies have shown that the concept of iminium ion activation is a general 
strategy for the asymmetric organocatalysis and remarkable results were also 
achieved in the Friedel-Crafts alkylation,37 conjugate addition of electron-rich 
benzenes to α,β-unsaturated aldehydes38, aldol reaction,39 4+3 cycloaddition 
reactions,40 as well as Mukaiyama-Michael reaction41 and α-chlorination of 
aldehydes.42 A more reactive and selective chiral imidazolidinone catalyst, in which 
the two geminal methyl groups were replaced by a tert-butyl group, was developed in 
order to ensure a high level of asymmetric induction for the conjugate additions and 
Mukaiyama-Michael reactions. Catalyst 28·HCl was also found to selectively catalyze 
the intramolecular Michael reaction of aldehydes.43 The reaction requires very mild 
conditions (THF, r.t., 15-24 h) and it is supposed to proceed through an enamine 
mechanism. This process affords cyclic ketoaldehydes in excellent yields and with 
high diastereo- and enantiomeric excesses. 
 
One of the most useful chemical transformations developed in laboratories and 
employed on large scale in the synthesis of various chiral drugs, agrochemicals and 
natural products is the asymmetric hydrogenation. Statistically, hydrogenation of 
carbon-carbon double bonds and carbonyl compounds are predominant 
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transformations applied in industry.44 Up to now, almost all chemical reductions 
require metal catalysts or stoichiometric amounts of metal hydrides. Only few metal 
free asymmetric reductions of olefins have been reported in the literature and they 
are based on biological transformations.45 In late 2004 List reported on the first metal 
free non-asymmetric transfer hydrogenation of olefins.46 Diverse α,β-unsaturated 
aldehydes, including substituted aromatic and aliphatic ones, were chemoselectively 
reduced in the presence of Hantzsch ester as hydride donor and dibenzylammonium 
trifluoroacetate (5 mol%) as catalyst. The reaction was performed in THF at r.t. and 
required 5-6 h for complete conversion. No aldolization or carbonyl reduction could 
be detected and various functional groups, which are sensitive to standard 
hydrogenation conditions, were tolerated under these conditions. As expected, the 
first asymmetric version did not hesitate to appear. Independently, List47 and 
MacMillan48 have developed similar systems for the metal-free asymmetric reduction 
of olefins. Treatment of trisubstituted enals 34 with a slight excess of dihydropyridine 
37 and a catalytic amount of MacMillan’s catalyst 36 (dioxane, 13 °C) affords, after 
48 h, the corresponding saturated aldehydes 35 in high yields and selectivities 
(Scheme 11). 
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Scheme 11: Organocatalytic Conjugate Reduction of α,β-unsaturated Aldehydes according to List. 
 
In order to study the influence of the double bond geometry on the stereochemical 
outcome of the reaction, pure (E)- and (Z)-3-(4-nitrophenyl)but-2-enal were subjected 
to the same reaction conditions and in both cases the same (R)-3-(4-
nitrophenyl)butanal was isolated in good yield and 94% ee. Similarly, different (E)/(Z) 
substrate mixtures always afforded the same (R)-isomer with 94% ee. The reaction is 
supposed to follow an iminium mechanism and to proceed in all cases (pure and 
mixture of isomers, respectively) via an iminium ion (E)-38. During the reaction, the 
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(Z)-38 intermediate easily isomerizes to (E)-38 and the proton transfer from the 
dihydropyridine 37 to (E)-38 occurs much faster than that to (Z)-38 (Scheme 12). 
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Scheme 12: Proposed Mechanism for the Organocatalytic Asymmetric Transfer Hydrogenation. 
 
Various α,β-unsaturated aldehydes were selectively reduced under these conditions 
to give products in high yields and enantioselectivities (77-90% y, 90-96% ee). 
High levels of enantiocontrol (91-97% ee) were also attained by MacMillan, for the 
same olefin reduction. After screening different reaction conditions, MacMillan 
concluded that the reduction of enal 40 with Hantzsch ester (43) is highly efficient 
when the reaction is catalyzed by imidazolidinone 42·Cl3CCOOH at low temperature 
in chloroform. 
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Scheme 13: Organocatalytic Olefin Reduction According to MacMillan. 
 
Remarkable, the two systems complement each other in terms of product 
stereochemistry. Comparison of Scheme 11 with 13 shows that either enantiomer of 
the saturated aldehydes is readily available from the same starting material by 
appropriate selection of the catalyst. Notable is also the fact that both processes are 
enantioconvergent in that the same enantiomer is obtained independent of the olefin 
geometry. 
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1.2.2 Peptide-based catalysts 
 
The hydrocyanation of aldehydes49 is one of the first reactions which involves the use 
of an oligopeptide as catalyst.50 Oxynitrilase (hydroxynitrile lipase) is known to 
catalyze the stereospecific addition of HCN to aldehydes and to alkyl methyl ketones, 
as well as the transhydrocyanation of aromatic and aliphatic aldehydes with acetone 
cyanohydrin.51 Enantiomerically enriched cyanohydrins are easily prepared on kg 
scale just by using small quantities of the corresponding enzyme. Inoue52 has 
designed alternative synthetic catalysts for the anhydride hydroxycyanation and the 
best results were obtained with the cyclic diketopiperazine 46. Electron rich aromatic 
aldehydes proved to be the best substrates for this reaction. In contrast, electron 
deficient aromatic aldehydes gave products with lower enantioselectivities. The 
reaction of aliphatic and heteroaromatic aldehydes also proceeded with moderate to 
high levels of asymmetric induction. Solvent and catalyst preparation were crucial 
factors in obtaining high yields and selectivities. Use of an amorphous catalyst and 
toluene, which produces a gel-like reaction mixture, resulted in higher selectivity than 
that obtained with a crystalline catalyst structure and protic solvents or additives.52,53 
Accordingly, cyclic peptide 46 catalyzes the stereospecific addition of HCN to the si-
face of benzaldehyde (44) to give (R)-2-hydroxy-2-phenylacetonitrile (45) with 97% 
conversion and 97% ee. Under optimal conditions, cyanohydrin 45 was next 
converted, without loss of enantiomeric excess, into (R)-mandelic acid, (R)-methyl 
mandelate and (R)-2-amino-1-phenylethanol,52 known useful reagents in organic 
chemistry. 
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H H
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Scheme 14: Hydrocyanation of Aldehydes According to Inoue. 
 
Since several mechanistic similarities between the hydrocyanation of aldehydes and 
imines are known, the next step was to test catalyst 46 in the asymmetric Strecker 
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synthesis.54 Surprisingly, no asymmetric induction could be achieved with 
diketopiperazine 46.55 A slight modification of the catalyst, involving replacement of 
the imidazole side chain with a more basic guanidine group, afforded a new catalyst 
50, which promoted an enantioselective reaction. This slight modification of the 
Inoue’s catalyst resulted in opposite facial selectivity for HCN addition and the (S)-
isomer was isolated as major product in all cases. Addition of HCN to preformed N-
benzhydryl protected imines, subsequent hydrolysis of the nitrile and N-deprotection 
yields optically active α-amino acids. While aromatic aldimines (R = Ar, R’ = H) 
afforded products with up to 99% ee, aliphatic (R = Alkyl, R’ = H) and electron 
deficient (R = 3-nitrophenyl, R’ = H), as well as heteroaromatic derivatives afforded 
almost racemic products. In order to circumvent this problem, new peptide-based 
catalysts were synthesized and optimized by means of combinatorial chemistry.56 
Two ligand libraries (48 + 132 members) were screened in the asymmetric Strecker 
reaction (addition of a silyl ketene acetal to N-Boc benzaldimine)56a and the best 
results were achieved with 52-urea and thiourea derivatives. Remarkable, with 52b 
as catalysts, the reaction was successful for a broad range of aryl and alkyl aldimine-
substrates, as well as for various ketimines. 
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Scheme 15: Novel Organocatalysts for the Asymmetric Strecker Reaction. 
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The efficiency of the process was demonstrated by the synthesis of two optically 
active α-amino acids (Scheme 16). Unnatural (R)-tert-leucine56b and (R)-α-methyl 
phenylglycine56c were isolated in good overall yields with >99% ee. 
 
N
HtBu
Bn
COOHtBu
NH3Cl
5 steps: 84% y
 >99% ee
N
CH3Ph
Bn
COOHPh
NH3ClH3C
4 steps: 70% y
 >99.9% ee
;
 
Scheme 16: Applications of the Organocatalytic Strecker Reaction in the Synthesis of  
Optically Pure α-Amino Acids. 
 
Chiral C2-symmetric guanidine 51, derived from (R)-phenylglycine, promoted the 
addition of HCN to N-protected aldimines, yielding the corresponding α-amino nitriles 
in high yields (80-99%) and with moderate to high selectivities (50-80% ee).57 
Hydrogen bonding and van der Waals interactions between the catalyst and the 
imine are taken in consideration in order to explain the reaction selectivity. 
Overall, the reactions described above offer attractive alternatives for the synthesis of 
optically active amino acids. 
 
In 1980, Juliá reported on the asymmetric epoxidation of chalcone 53 (R’ = R” = Ph) 
in a triphasic system consisting of an aqueous solution of NaOH and H2O2, a solution 
of chalcone in an organic solvent and an insoluble poly-α-amino acid as catalyst.58 
Toluene, excess NaOH-H2O2 and polypeptides with more than 10 amino acids in the 
chain were found to have a positive effect on the yield and enantioselectivity.59 The 
process has been optimized and several oxidant systems and catalysts have been 
developed in order to ensure shorter reaction time, a larger substrate spectrum and 
to prevent the catalyst degradation.59,60,61 Epoxides generated by using Juliá-Colonna 
reaction are useful intermediates in the synthesis of optically active compounds such 
as: δ-lactones,62 2,3-trans-disubstituted tetrahydroquinolones63 and 2-arylpropanoic 
acids including the non-steroidal anti-inflammatory agent (S)-fenoprofen.64 
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Scheme 17: Juliá-Colonna Epoxidation of Enones. 
 
Recently, the Juliá-Colonna epoxidation was further optimized to make it applicable 
for large-scale industrial applications.60e 
 
 
1.3 Cinchona alkaloids 
 
Naturally occurring cinchona alkaloids constitute our next privileged class of catalysts 
and ligands for asymmetric synthesis. Among all known alkaloids, they are the most 
widely used compounds in the pharmaceutical, chemical and food industry. Several 
hundred tons of cinchona alkaloids are produced annually by extraction from the bark 
of the cinchona tree. Their family consists of four pairs of pseudoenantiomers: 
quinine (QN) – quinidine (QD), cinchonidine (CD) − cinchonine (CN) as well as the 
corresponding hydrogenated analogs. 
 
Although known to treat malaria since the beginning of the 17th century,65 the alkaloid 
quinine was isolated for the first time from the cinchona bark in 1820.66 Since then, 
several studies have been done in order to elucidate the structure of quinine and its 
correct stereochemistry and several attempts toward an asymmetric total synthesis 
have been reported.67 Nevertheless, the first stereoselective total synthesis of 
quinine was accomplished only five years ago.68 More recently two other successful 
approaches, including a catalytic version, and leading to both pseudoenantiomers 
(QN, QD), have been reported.69 Due to their ready availability, stability and low 
production cost, cinchona alkaloids have been used frequently as resolving agents. 
Within the last few years they impose also as efficient catalysts for a large range of 
reactions. Their main advantages are that they posses a naturally occurring 
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(pseudo)enantiomeric counterpart, and that their structure can be easily modified in 
order to obtain a more effective catalyst. 
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Scheme 18: Schematic Representation of the Common Cinchona Alkaloids. 
 
 
1.3.1 Carbon-carbon bond formation 
 
 
1.3.1.1 Alkylation reactions 
 
Phase-transfer catalysis (PTC) is an attractive alternative for the reactions taking 
place in two- or three-phase systems and involving anionic intermediates. Crown 
ethers, cryptands, open chain polyethers and quaternary onium salts (phosphonium 
and ammonium salts) promote these types of reaction by facilitating the transfer of 
species from one reaction phase to another and so, making the reaction between 
reagents in two/three non-miscible phases possible. The most popular catalysts 
applied in the asymmetric PTC are chiral, quaternary ammonium salts. Among them, 
cinchona alkaloid derivatives have proved to be efficient over a large range of 
reactions. In this respect, cinchonine and cinchonidine derivatives have been used 
extensively in enantioselective alkylation reactions. After several studies it turned out 
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that O-alkylation and the bulkiness of the substituent at the quaternary quinuclidine 
nitrogen play crucial roles in the reaction stereoselectivity. This observation was 
immediately fructified and new N-benzyl-O-alkylated derivatives were subsequently 
synthesized (second generation of catalysts). A significant improvement in the 
selectivity was achieved by replacing the benzyl group of the quaternary ammonium 
ion with the bulkier anthracen-9-ylmethyl group (third generation of catalysts). The 
three generations of these catalysts are illustrated in the Scheme 19. 
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Scheme 19: Selected Cinchonidinium Quaternary Ammonium Salts Used in the PTC. 
 
A breakthrough in the field was the enantioselective synthesis of the uricosuric agent 
62. The establishment of the stereogenic center in the methylindanone derivative via 
chiral PTC is the key step of the synthesis developed by the group of Dolling at Merk 
in 1984.70 Enantiomeric excesses of up to 94% were achieved using p-
trifluoromethylbenzylcinchoninium bromide 63 as catalyst. 
 
In the TS, the enolate substrate approaches the top face of the catalyst where it is 
positioned by hydrogen bonding effects and π-π stacking interactions between the 
aromatic rings of the catalyst and enolate. Subsequent methylation from the exposed 
face of the enolate yields the observed isomer (Scheme 20). 
 19
Introduction 
N
OH
N
CF3
H
MeO
Cl
Cl O
CH3
Ph O
Cl
Cl O
CH3
Ph
COOH
N
MeO
Cl
Cl O
N
CF3
O
H
Br−
MeO
Cl
Cl O
Ph
+
−
60 61
63
10 mol% 63
MeCl, Toluene
r.t., 18 h
95% y, 92% ee
50% aq. NaOH
62, S-(+)-Indacrinone
+
 
Scheme 20: Enantioselective Alkylation of Indanone under PTC. 
 
A series of significant achievements in the field of alkylation followed the reaction 
described above. Both, racemic and optically active natural and unnatural α-amino 
acids have been synthesized by means of PTC. Achiral quaternary ammonium salts 
were employed in the synthesis of racemic mixtures. Enantioselective alkylation of 
glycine and alanine Schiff bases under PTC conditions, subsequent recrystallization 
(if required) and deprotection yields the corresponding free α-amino acids in optically 
pure form.71 Benzophenone imines of glycine esters are suitable for small as well as 
for large scale preparation of the amino acids. The monoalkylation process can be 
easily controlled by using mild basic systems (NaOH, KOH, K2CO3). Only moderate 
levels of enantiocontrol (up to 66% ee) were achieved in this process using the first 
generation of N-benzyl cinchona salts developed by Dolling. The first improvement in 
the enantioselectivity was reported by O’Donnell.72 In consideration of the fact that 
the active catalytic species in the alkylation process are formed in situ by O-alkylation 
of the cinchona quaternary ammonium salt, O’Donnell introduced pre-formed N,O-
dialkylated cinchona salts 66.72c Additional optimization of the reaction conditions led 
to significantly higher enantioselectivities (up to 81% ee). The next major 
improvement in the reaction selectivity was reported in 1997 by Lygo73 and Corey74 
independently. Enantioselectivities of up to 99.5% were obtained by using a new 
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generation of catalysts bearing an anthracen-9-ylmethyl group with either a free OH 
or an O-alkyl group (Scheme 21). 
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Scheme 21: Enantioselective Alkylation of Glycine Imine. 
 
More recently, Lygo has developed a new procedure, suitable for automated catalyst 
screening, involving in situ generation of the quaternary ammonium salt catalysts (in 
situ N and O-alkylation) during the liquid-liquid phase transfer alkylation process.75 
Application of this new protocol resulted in enantioselectivities comparable with those 
obtained by using pre-formed N,O-dialkylated catalysts. With the third generation of 
catalysts in hand, and by replacing the inorganic hydroxides with the non ionic, 
organic soluble bases 69 and 70, O’Donnell and Schwesinger have developed a 
homogeneous version of the alkylation process which gives comparable results and 
considerably shorten the reaction time (Scheme 21).76 In addition, a convenient 
procedure for the multigram synthesis of 68 has been developed by Corey.77 
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In search of better catalysts and taking into account the development of Sharpless’ 
bis-cinchona alkaloids for the asymmetric dihydroxylation, new di- and trimeric 
cinchona alkaloid ammonium salts have next evolved. Two groups, Park78 and 
Nájera,79 have worked intensively on the design and synthesis of such types of 
cinchona derivatives. Several dimeric species with a spacer group between the 
cinchona units have been synthesized and evaluated in the enantioselective 
alkylation reaction. Among them, 71 and 72 led to a considerable increase in both 
enantioselectivity (90->99% ee) and scope of the substrate (active & nonactive alkyl 
halides performed excellently in the reaction). In addition the catalyst loading could 
be reduced even to 1 mol% in the case of naphthalene-based catalyst 72 without any 
decrease in the selectivity. Also the first total synthesis of (−)-antofine, a potent 
cancer cell growth inhibitor, could be now achieved by means of PTC.80 The chirality 
was introduced into the molecule in an alkylation step which employs dimeric 
derivative 72 as catalyst. Similar dimeric-type catalysts have also been reported by 
Nájera. Unfortunately, the new dimeric species, with a bulkier 9,10-dimethylanthryl 
group between the cinchona moieties, could not compete with the catalysts 
developed by the group of Jew and Park. 
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Scheme 22: Selected di- and trimeric Cinchona Alkaloid Derivatives. 
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1.3.1.2 Aldol condensation 
 
Since the PTC alkylation of glycine Schiff bases gave promising results, some 
cinchonine and cinchonidine derivatives were subsequently tested in the aldol and 
Michael reactions. The direct aldol reaction between glycine donors and aldehyde 
acceptors constitutes a convenient route to β-hydroxy-α-amino acids. Catalysts from 
the first generation exhibited modest levels of diastereo- and enantiocontrol in the 
aldol reaction between glycine derivative 64 and different aliphatic and aromatic 
aldehyde acceptors. A significant improvement in the enantioselectivity could be 
achieved by switching from the Schiff base 64 to the corresponding trimethylsilyl enol 
ether and from the first to the third catalyst generation.81 
 
 
1.3.1.3 Michael addition 
 
Recent reports from Corey have demonstrated that the third generation of catalysts is 
also highly efficient in the conjugate addition reactions.82 Enantioselective Michael 
addition with glycine anion equivalents provides a convenient route to various 
functionalized α-alkylamino acids. Accordingly, naturally occurring (S)-glutamic acid 
(95% ee)82a and (S)-ornithine (91% ee)82b are readily available by means of chiral 
PTC when the Michael acceptors involved are methyl acrylate and acrylonitrile 
respectively. It is also worthy of note that if the same catalyst is used to promote both 
PTC enantioselective alkylation and addition reaction, the same major isomer (S or 
R) will be isolated. In both cases, the same enolate-catalyst combination is 
responsible for the high selectivity and the sense of asymmetric induction. The tight, 
structured ion pair between the ammonium cation and the enolate blocks one face 
(re) of the nucleophilic carbon center in the enolate and leaves only the other (si 
face) free for attack by the alkylating or electrophilic agent. The same methodology 
was recently applied in the synthesis of therapeutically useful GABAB receptor 
agonist (R)-baclofen.83 The enantioselective Michael addition of nitromethane to the 
chalcone-derived enone 74 in the presence of cinchoninium salt 77 and powdered 
cesium fluoride afforded the product 75 in 89% yield and 70% ee. A single 
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recrystallization allowed the ee to be increased to 95%. Subsequent Baeyer-Villiger 
oxidation, reduction and acidic hydrolysis afforded the desired product (R)-baclofen 
as its hydrochloric salt. The opposite enantiomer has been synthesized 
enantioselectively (95% ee) starting from the same precursor just by appropriate 
selection of the catalyst. 
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Scheme 23: Enantioselective Synthesis of (R)-Baclofen. 
 
Plaquevent applied the PTC asymmetric Michael addition, as a key step, in the 
synthesis of both enantiomers of methyl dihydrojasmonate, important perfumery 
ingredients (jasmine-like odor).84 Solvent free, solid-liquid phase transfer asymmetric 
addition of dimethylmalonate to enone 78, catalyzed by cinchonidinium salt 81, 
afforded 79 in 91% yield and 90% ee. Subsequent demethoxycarboxylation under 
Krapcho conditions yielded the desired product in good overall yield (Scheme 24). 
 
A general protocol for the synthesis of optically active 1,5-diketones was next 
developed. Michael addition of trimethylsilyl enol ethers to α,β-unsaturated ketones 
under PTC conditions afforded the corresponding adducts in high yields (79-94%) 
and excellent enantioselectivities (91-95% ee).85 Further advantages of the enol 
ethers over ketones as reactants are shorter reaction time and minimalization of the 
aldol side reaction. 
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Scheme 24: Synthesis of (+)-Methyl Dihydroiasmonate. 
 
Recent contributions from Deng have shown that slight modification of the natural 
cinchona alkaloids provides remarkable catalysts for the asymmetric conjugate 
addition reaction. For example, quinidine and quinine derivatives 84 and 85, in which 
the methoxy group has been replaced by a hydroxyl group, are highly effective in the 
addition of dimethylmalonate to nitroalkenes.86 Moreover, the reaction proved to be 
quite general with respect to β-substitution on the nitroalkene electrophile. A large 
range of substituents including alkyl, heteroaryl, electron rich as well as electron 
deficient aromatic groups were tolerated during this process. Treatment of 
nitroalkenes 82 with dimethylmalonate in the presence of 85a in THF at –20 °C 
afforded the corresponding 1,4-addition products in very high yields (71-99%) and 
with excellent enantioselectivities (94-98% ee). The opposite enantiomer was 
produced with slightly lower enantiomeric excess (91-96% ee) when the reaction was 
promoted by 84a. In both cases, lowering the temperature to −55 °C had a positive 
effect on the asymmetric induction but required a three times longer reaction time. 
 
 25
Introduction 
N
OH
N
RO
S R
N
N
OH
OR
H
R
S
R
NO2
NO2
CO2MeMeO2C
R
activate
electrophile
activate
nucleophile
10 mol% 85a
3 eq. CH2(CO2Me)2
−20 °C, THF
R = alkyl, aryl,
       heteroaryl 71-99% y, 94-98% ee
a: R = H b: R = Bn
c: R = PHN
82
83
84 85  
Scheme 25: 1,4-Addition of Dimethyl Malonate to Nitroalkenes. 
 
The conjugate addition of a prochiral, trisubstituted carbon nucleophile to a prochiral 
β-substituted Michael acceptor is an efficient synthetic strategy because it allows the 
simultaneous formation of two vicinal stereogenic centers in a molecule. If the 
formation of the chiral centers could be diastereo- and enantioselectively controlled, 
this process would provide access to multifunctional compounds, useful building 
blocks in organic synthesis. Exceptional levels of asymmetric induction have been 
attained for various substrates with the cinchona alkaloid derived catalysts 84 and 
85.87 As in the previously described example, a wide range of nitroalkene-
electrophiles bearing alkyl, aryl or heteroaryl groups were found to be effective 
reaction partners in the conjugate addition. Diastereoselectivities ranging from 91:9 
to (≥98):(≤2) and excellent enantioselectivities (99->99% ee) were obtained with 
various cyclic and acyclic β-ketoesters. Aprotic solvents (THF, ether, toluene) and 
lower temperature led to increased stereoselectivity. The methodology could also be 
applied to 1,3-diketones, cyanoacetate and nitro ester derivatives as Michael donors, 
yielding products with high diastereo- and enantiomeric excesses. 
 
Jørgensen has developed a useful protocol for the organocatalytic enantioselective 
conjugate addition of β-dicarbonyl compounds to alkynones.88 From a class of eight 
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selected catalysts, only Sharpless biscinchona alkaloid [DHQ]2PHAL gave promising 
results in the addition of acetyl cyclopentanone with butyn-2-one, affording the 
product as a 2:1 mixture of (E) and (Z) isomers with 70 and 40% ee respectively. The 
products are stable and may be separated by chromatography. A considerable 
increase in the enantioselectivity (up to 95% ee) was observed when aromatic 
alkynones were employed as substrates (Scheme 26). In addition, the isomerization 
of the (Z)-isomer to the more stable (E)-isomer could be accomplished in the same 
step, using a catalytic amount of Bu3P, without affecting the yield or the 
enantioselectivity. Moreover, the newly developed protocol is of synthetic utility 
because the presence of a carbon-carbon double bond next to the carbonyl groups 
allows further functionalization. 
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Scheme 26: Organocatalytic Enantioselective Conjugate Addition to Alkynones. 
 
 
1.3.1.4 Baylis-Hillman reactions 
 
The base catalyzed reaction of aldehydes with activated alkenes, such as acrylates, 
provides a convenient route to α-methylene-β-hydroxycarbonyl compounds, which 
are useful precursors in the synthesis of natural products and biologically active 
substances. Within the last few years, several research groups have focused their 
attention on the development of an efficient, asymmetric version. In principle, this 
could be achieved either by using chiral substrates (chiral activated alkenes or chiral 
electrophiles) or by employing chiral catalysts. Despite all efforts, only unsatisfactory 
results (low conversion and low asymmetric induction) were obtained when brucin, N-
methylprolinol, N-methylephedrine, quinidine and nicotine were employed as chiral 
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base catalysts.89 The first significant improvement was reported by Leahy in 1997 
and employs the use of Oppolzer sultame as chiral auxiliary in DABCO-catalyzed 
Baylis-Hillman reactions.90 Soon after, the first highly enantioselective catalytic 
version was described by Hatakeyama.91 
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Scheme 27: Asymmetric Baylis-Hillman Reaction. 
 
A large variety of aromatic and aliphatic aldehydes were reacted with 
hexafluoroisopropyl acrylate (HFIPA) (89) in the presence of 10 mol% β-
isocupreidine (β-ICD) (93) as chiral amine catalyst, to give products in 31-51% yield 
and 91-99% ee (Scheme 27). The rigid tricyclic quinidine-derived chiral amine β-ICD 
(93), DMF and low temperature were found to be optimal for an enantioselective 
reaction. The increased nucleophilicity of the β-ICD compared to quinidine, the anti-
open alkaloid conformation and the presence of the free hydroxyl group on the 
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quinoline moiety seems to be responsible for the asymmetric induction. Conjugate 
addition of the amine to the acrylate yields the enolate A. Attack on the aldehyde 90 
by the enolate A generates two diastereomeric intermediates B and C, stabilized 
through intramolecular hydrogen bonding. While betaine B possesses the required 
conformation for the elimination reaction (yielding the product), betaine C suffers 
from severe steric interactions and therefore undergoes reaction with a second 
aldehyde molecule, affording the dioxanone 92. Formation of the dioxanone 
byproducts, which considerably decreases the yield of the desired product, 
constitutes one drawback of Hatakeyama’s protocol. 
 
Despite low yield, the synthetic utility of this methodology has been demonstrated in 
the synthesis of (−)-mycestericin E,92 a potent immunosupressor, and epopromycine 
B,93 an inhibitor of cell wall synthesis in plants. The synthesis of the key precursor of 
epopromycin B is illustrated in Scheme 28. 
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Scheme 28: Application of the Asymmetric Baylis-Hillman Reaction in the  
Synthesis of Epopromycin B. 
 
Nowadays, intensive research is also being carried out for the improvement of the 
related aza-Baylis-Hillman reaction. Reported for over twenty years ago, the reaction 
between methyl acrylate and preformed imines offers an attractive alternative route 
to α-methylene-β-amino acid derivatives.94 The achiral version of the reaction has 
been well documented by the group of Shi.95 Making use of their vast experience in 
the field, and the findings of Hatakeyama, Shi investigated and developed a metal-
free catalytic asymmetric version.96 
Several aromatic N-tosylated imines were evaluated in the reaction with methyl-vinyl 
ketone (MVK) (98) in the presence of 10 mol% β-ICD (93). In the preliminary 
investigations, the best ee values were observed at −30 °C in DMF, and the best 
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yields were obtained at −30 °C in MeCN. Thus, different DMF/MeCN solvent 
combinations were tested, and the best results were obtained in a 1:1 mixture. With 
one exception (Ar = C6H5CHCH-), various aromatic N-tosylated imines 97 were 
reacted with MVK (98) to give (R) configured products 99 in good yields (55-80%) 
and with high ee’s (73-99%) (Scheme 29).96 Methyl acrylate, as donor, required a 
longer reaction time and gave products with opposite absolute configuration in 
comparable yields (58-87%) although slightly lower ee values ((S), 70-83%).96b Any 
attempts toward extending the reaction scope to aliphatic N-tosylated imines failed 
due to their high instability, even when stored at low temperature. 
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Scheme 29: Asymmetric aza-Baylis-Hillman Reaction According to Shi. 
 
A one-pot three-component aza-Baylis-Hillman reaction between acrylates, 
aldehydes and tosylamines has been reported by Adolfsson.97 A combination of an 
achiral Lewis acid with a chiral Lewis base and 4Å molecular sieves additives are 
responsible for the increased yield and selectivity. Accordingly, various aromatic 
aldehydes were reacted at r.t. in THF with tosylamines and methyl acrylate, in the 
presence of 15 mol% β-ICD (93) and 2 mol% titanium isopropoxide, to give aza 
adducts in high yields (78-95%) and moderate enantioselectivities ((R), 49-74% ee). 
 
In his recent studies on the aza-Baylis-Hillman reaction, Hatakeyama98 showed that 
β-ICD (93) promoted reaction between various N-protected aromatic imines and 
HFIPA proceeds with (S)-selectivity. Due to the ease of their deprotection, N-
diphenylphosphinoyl aromatic imines 100 were chosen for further investigations 
(Scheme 30). Since the products were crystalline, the moderate enantioselectivities 
(54-73% ee) observed in the reaction could be increased by simple recrystallization 
((S), 93-100% ee). 
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Scheme 30: Asymmetric aza-Baylis-Hillman Reaction According to Hatakeyama. 
 
Although great progress has been made in view of asymmetric induction, the Baylis-
Hillman reaction still suffers from slow rate, low yield and limited substrate scope. 
Concerning the reaction rate, additional information was furnished by Aggarwal who 
found a direct correlation between the catalyst basicity and its reactivity: the higher 
the pKa value, the faster the reaction.99 
 
 
1.3.1.5 Asymmetric cyanation of ketones 
 
As already mentioned, the enantioselective hydrocyanation of aldehydes and imines 
is a versatile synthetic transformation, providing important synthons for organic 
synthesis. Conversely, the asymmetric cyanation of ketones is still considered as 
problematic.49 The first reports in this area employed chiral metal-based Lewis acids 
as catalysts and were dominated by low yields and selectivities. The first general 
protocol was reported by Shibasaki.100 Titanium and gadolinium based complexes 
were found to effectively catalyze the addition of TMSCN to prochiral ketones. 
In 2001, Deng reported the first Lewis base catalyzed cyanation of ketones.101 
Addition of ethyl cyanoformate to structurally diverse ketones proceeded with high 
selectivity when modified cinchona alkaloids were employed as catalysts. With one 
exception, 2-heptanone, the 1,2-addition was highly selective (81-97% ee) for a large 
range of cyclic and acyclic sterically hindered dialkylketones. The reaction is claimed 
to proceed cleanly, although, for several substrates a strong discrepancy exists 
between the reported yield, conversion into the product and conversion from ketone. 
As an extension of this field, cyanosilylation of ketones with modified cinchona 
alkaloids was next investigated.102 While simple ketones afforded products with low 
to moderate enantioselectivity, acetal ketones proved to be effective substrates. A 
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broad range of acetal ketones, bearing aryl, alkenyl, alkynyl and alkyl substituents 
were reacted with TMSCN to give products in good to excellent yields (81-99%) and 
with high selectivities (90-98% ee). The reaction has found synthetic applications in 
the synthesis of enantiomerically enriched amino alcohols, hydroxy amino acids and 
their derivatives (Scheme 31). 
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Scheme 31: Catalytic Asymmetric Cyanosilylation of Acetal Ketones. 
 
Caron has developed a highly specialized cinchonine derived catalyst for the 
enantioselective addition of a trifluoromethyl anion to aryl ketone 104.103 Activation of 
Ruppert’s reagent CF3TMS by the fluoride counterion of the catalyst enabled the 
trifluoromethyl anion formation. Under optimized conditions (4 mol% cat, −78 °C, 
CH2Cl2), the product could be isolated with 92% ee. Unfortunately the catalyst is not 
generally applicable to other ketone and aldehyde substrates. Attempts to extend the 
substrate scope resulted in high conversion but disappointing enantioselectivities. 
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Scheme 32: Enantioselective Nucleophilic Addition of CF3TMS to Ketones. 
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1.3.1.6 Cyclopropanation 
 
The cyclopropane unit is a key structural element in a wide range of synthetic as well 
as naturally occurring biologically active substances. Therefore, much effort has been 
made toward their diastereo- and enantioselective synthesis. Significant advances 
have been registered in the field of both Simmons-Smith type cyclopropanation and 
metallocarbenoid chemistry.104 As an alternative, cinchona alkaloid mediated 
asymmetric cyclopropanation105 via ammonium ylides has recently gained 
considerable attention. The initial studies dealt with the elaboration of a general 
diastereoselective reaction protocol amenable to the [2+1] inter- and intramolecular 
versions. While catalytic amounts of the achiral tertiary amine were employed in the 
intramolecular version, stoichiometric amounts were required for the intermolecular 
reaction. 
 
Use of cinchona alkaloids resulted in a highly diastereo- and enantioselective 
reaction applicable to a large range of substrates. For example, the trans product 
was isolated as a single diastereomer in high yield (60-96%) and enantioselectivity 
(80-97% ee) by the intermolecular reaction of different α-bromo carbonyl compounds 
with various enones and acrylates (Scheme 33). It is notable that this strategy avoids 
the use of highly sensitive diazo compounds and the reaction therefore constitutes 
another great achievement in the field of organocatalysis. 
 
N
N
OMe
OMe
H
R
S
O
Et2N
Br
O
O
Ph
Et2N
O
94% y, 97% ee
1.3 eq. Cs2CO3, MeCN,
20 mol% 110, 80 °C, 24 h
1 eq. 107 1.1 eq. 108
109
110
+
 
Scheme 33: Enantioselective Organocatalytic Cyclopropanation. 
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Concerning the reaction mechanism, it is assumed that the bromo carbonyl 
compound 112 reacts with the tertiary amine 111 yielding a quaternary ammonium 
salt 113. Deprotonation by cesium carbonate forms the ylide 114 which undergoes 
conjugate addition to enone 115 to form 116. Subsequent 3-exo-tet cyclization 
affords the cyclopropane 117 and regenerates the catalyst 111. 
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Scheme 34: Proposed Catalytic Cycle for the Cyclopropanation Reaction. 
 
 
1.3.1.7 [2+2] Cycloaddition reactions 
 
In the early 1980’s, Wynberg106 reported excellent asymmetric induction in the 
cinchona alkaloid catalyzed [2+2] cycloaddition between highly activated carbonyl 
compounds, such as chloral 119 (R = H), and ketene 118 (Scheme 35).107 
Nucleophilic addition of the alkaloid to the ketene yields an acylammonium enolate 
which undergoes addition to aldehyde, generating a new zwitterionic intermediate. 
Subsequent cyclization affords the β-lactone and regenerates the chiral amine 
catalyst. Both enantiomers of the lactone are readily available with up to 98% ee by 
employing 1-2 mol% of the pseudoenantiomeric QD-QN alkaloids as catalyst. 
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Scheme 35: β-Lactone Synthesis According to Wynberg. 
 
Although the method is efficient and has been commercialized for the large-scale 
production of optically pure malic and citramalic acids, there are some limitations 
concerning the nature of the electrophile and the ketene generator. Recent reports by 
Romo108 and Nelson109 describe solutions to these problems. In situ generation of the 
ketene107 by dehydrohalogenation of acid chlorides with Hünig’s base resulted in high 
yields (40-85%) and selectivities (93-98% ee) which are comparable with those 
obtained by using preformed ketenes. As in the previous case, the reaction only 
proceeded with highly electrophilic carbonyl compounds (α-di- and trichlorinated 
ones).108 It has been hypothesized that Lewis acid activation of the electrophile 
substrate would offer an alternative method for the use of non-activated aldehydes. 
For this purpose, a bifunctional catalytic system consisting of a chiral Lewis 
base/achiral Lewis acid cocatalyst was investigated. Diisopropylethyl amine (2.5 eq.) 
was employed for the in situ ketene generation. A combination of O-trimethylsilyl 
quinidine and lithium perchlorate emerged as an effective catalyst/cocatalyst system. 
For the first time, structurally diverse aldehydes were reacted with methylketene to 
give β-lactones in high yields (70-85%) and with excellent enantioselectivities (84-
96% ee). An exceptional level of asymmetric induction was also observed when 
propionyl chloride-derived methylketene was employed in the reaction. In all cases 
cis-substituted β-lactones were isolated as major diastereomers (mostly >90% de) 
with up to >99% ee.109 
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Scheme 36: β-Lactone Synthesis According to Nelson. 
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Calter reported the cinchona alkaloid catalyzed dimerization of methylketene, 
generated in situ either from α-bromopropionyl bromide110 or by thermolysis of 
propionic anhydride.111 Trapping of the ketene dimer with a secondary amine and 
subsequent aldol reaction provides convenient access to complex polypropionate 
systems.112 In this manner, ketene dimerization served as a synthetic tool in the 
asymmetric synthesis of C1’-C10’ segment of the macrocyclic antibiotic pamamycin 
621A.113 
 
Although the reaction between ketene and imines proceeds at low temperature 
without catalyst, and usually chiral auxiliaries are required in order to effectively 
control the stereochemistry of β-lactam formation, Lectka’s recent studies have 
shown that nucleophilic catalysis can also provide excellent levels of asymmetric 
induction.114 It has been demonstrated that benzoylquinine in combination with a 
non-nucleophilic amine base, such as proton sponge, catalyzes the addition of 
various ketenes (R = Et, vinyl, Ph, OAc, OPh, OBn) to tosyl imine, yielding the cis β-
lactams (99:1 dr) in moderate yield (45-65%) and with high enantiomeric excesses 
(95-99% ee).115 A significant decrease in the diastereoselectivity (98:2 to 10:1 dr) 
was registered when the substituent on the acid chloride was R = F, Br, N3, CH2OPh 
or 2-Np, but the reaction was still highly enantioselective (95-97.5% ee).116 
Regarding the mechanism, it is assumed that free ketenes are not involved in the 
reaction, and that the acid chloride reacts with benzoylquinine to form, in a first step, 
an acylammonium salt intermediate. Subsequent deprotonation by the proton sponge 
yields a zwitterionic enolate which then reacts with the imine to give the β-lactam. 
The enolate formation is accomplished by the formation of 1 eq. of proton sponge 
hydrochloride which precipitates from the reaction solution. 
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Scheme 37: β-Lactam Synthesis According to Lectka. 
 
On the basis that Lewis acid activation of the imine would favor the desired 
cycloaddition pathway, suppressing the possible side reactions and thus increasing 
the yield, a combination of Lewis acid and Lewis base was next investigated.117 It 
was found that addition of 10 mol% In(OTf)3 to the reaction mixture increased the 
yield considerably (95-99%) without lowering the enantioselectivity (92-98% ee); the 
diastereoselectivity, however, was affected (Scheme 37). 
 
Next, a general multistage, one-pot procedure for the synthesis of β-substituted 
amino acids was elaborated (Scheme 38).118 Due to its easy removal, the tosyl group 
was replaced by a benzoyl protecting group. It is notable that the cinchona alkaloid 
catalyst plays four distinct roles during the synthesis: (1) catalytic 
dehydrohalogenation of the acid chloride to generate the enol 129; (2) 
dehydrohalogenation of the N-acyl-α-chloroamine to form the corresponding imine 
131; (3) catalysis of the [2+2] cycloaddition to afford the β-lactam 132 and (4) 
catalysis of the nucleophilic ring opening of the lactam to yield optically enriched β-
substituted amino acid derivatives 133. 
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Scheme 38: One-pot Multicomponent β-Substituted Amino Acids Synthesis. 
 
The in situ ketene generation was successfully extended to the catalytic, asymmetric 
α-halogenation of acid chlorides.119 Once formed, the zwitterionic enolate 
intermediate is attacked at the α-position by the electrophilic halogenating reagent 
yielding an acylammonium salt. Transacylation with the leaving group of the 
electrophile leads to the α-halogenated products, liberating also the catalyst. 
Accordingly, α-chloro119a,b and α-bromo esters119c are easily available with up to 81% 
yield and 99% ee. 
 
 
1.3.2 Carbon-oxygen bond formation 
 
 
1.3.2.1 Epoxidation 
 
As already mentioned in chapter 1.2.2, Juliá-Colonna epoxidation impose on as an 
efficient synthetic method for the enantioselective functionalization of α,β-unsaturated 
enones. More recently, the asymmetric epoxidation of electron deficient olefins by 
means of PTC emerged as an alternative method. Wynberg reported for the first time 
in 1976, the use of a chiral phase catalyst in a biphasic Weinz-Scheffer asymmetric 
epoxidation.120 Modest levels of asymmetric induction (up to 54% ee) were attained 
when catalytic amounts of simple N-benzyl salts of cinchona alkaloids were 
employed in the reaction.121 Twenty years later, Taylor achieved an enhancement in 
the enantioselectivity (89% ee, 99.5% ee after two recrystallizations) by using a 
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stoichiometric amount of cinchona alkaloid derivative, TBHP in toluene and a 
catalytic amount of sodium hydroxide.122 In light of the excellent results obtained with 
the third generation of catalysts in the asymmetric alkylation reaction, Lygo123 and 
Corey124 independently examined their utility in the PTC oxidation of enones. Lygo’s 
detailed studies led to the development of an improved protocol for the epoxidation 
reaction. A wide range of substituted chalcones and alkyl substituted enones were 
selectively oxidized (≥95% de, 69-90% ee) in the presence of sodium hypochloride 
as stoichiometric oxidant and 10 mol% catalyst. In addition, a more efficient protocol 
for the chalcone epoxidation has been disclosed. A decrease to 1 mol% in the 
catalyst loading did not alter the reaction selectivity and the trans epoxides were 
isolated with up to 92% ee (≥98% ee after recrystallization) (Scheme 39). 
Interestingly, the direct conversion of secondary allylic alcohols into enantiomerically 
enriched α,β-epoxyketones could be achieved under the same reaction conditions 
(Scheme 39).125 
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Scheme 39: Asymmetric Epoxidation via Phase-Transfer Catalysis. 
 
Corey developed a similar protocol for the epoxidation of enones which gives slightly 
higher enantiomeric excesses (91-99% ee).124 Shioiri designed new phase transfer 
catalysts126 but they were less effective in the epoxidation reaction. 
 
 
1.3.2.2 Asymmetric dihydroxylation 
 
Asymmetric dihydroxylation is one of the most powerful catalytic asymmetric 
reactions which has been developed in the last twenty years. An enormous 
contribution to this field came from Sharpless who was awarded with the Nobel Prize 
in 2001. The initial asymmetric dihydroxylation process was stoichiometric in both 
chiral ligand and expensive OsO4 as oxidizing reagent.127 Moderate to good 
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enantiomeric excesses were obtained when stoichiometric amounts of acetate esters 
of cinchona alkaloids were employed as chiral ligands in the osmylation reaction. 
The first catalytic version was based on the Upjohn process and made use of N-
methylmorpholine-N-oxide as stoichiometric reoxidant.128 Unfortunately, the enantio-
selectivities obtained in the catalytic version were slightly lower compared to those 
obtained under stoichiometric conditions. Mechanistic studies revealed that the origin 
of this discrepancy lies in the presence of a second, non-selective catalytic cycle 
(Scheme 40).129 
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Scheme 40: Proposed Catalytic Cycle for the AD using NMO as Cooxidant. 
 
As depicted in Scheme 40, the primary catalytic cycle proceeds with high facial 
selectivity since it involves a chiral ligand in its selectivity-determining step, which is 
the formation of the osmium (VI) glycolate 137. Subsequent oxidation by the NMO 
cooxidant results in the formation of osmium (VIII) glycolate 138 with concomitant 
loss of the chiral ligand. At this point the desired reaction pathway involves the 
hydrolysis of 138 to the enantiomerically enriched 1,2-diol with the formation of OsO4. 
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The undesired pathway appears when, instead of hydrolysis, 138 undergoes addition 
with a second olefin molecule, yielding the osmium (VI) bisglycolate 139 which upon 
hydrolysis liberates the product with low enantiomeric excess. However the problem 
could be circumvented by slow addition of the olefin.129 
 
Several improvements followed, and now almost all classes of olefins can be 
dihydroxylated with excellent enantioselectivity.130 The first considerable 
improvement in the catalytic version was the development of a two phase reaction 
system with K3Fe(CN)6 as stoichiometric inorganic cooxidant and a tert-butanol/water 
mixture as heterogeneous solvent system.131 Under these conditions the osmylation 
takes place in the organic phase yielding the osmium (VI) glycolate 137 which upon 
hydrolysis liberates the diol and the ligand into the organic layer and the Os(VI) 
species into the aqueous layer where it is reoxidized to OsO4 (Scheme 41). In this 
way, the occurrence of the secondary cycle is completely avoided and the 
enantioselectivities are comparable with those obtained under stoichiometric 
conditions. Furthermore, it was found that addition of methyl sulfonamide to the 
reaction mixture considerably accelerates the hydrolysis of osmium (VI) glycolate 137 
so that the reaction time is up to 50 times shorter.132 
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Scheme 41: Proposed Catalytic Cycle for the Heterogeneous AD Reaction. 
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The next major improvement involved the development of new ligands with two 
independent cinchona alkaloid units bridged by an aromatic or heteroaromatic 
moiety.133 The two alkaloid moieties play different roles, one being responsible for the 
catalytic process while the other one provides the binding surface for the substrate 
(“chiral binding pocket for the olefin”). Over 400 different alkaloid derivatives from the 
first and second generation of ligands have been screened in the AD reaction and it 
was found that the latest ones are superior in terms of selectivity. Among them, the 
bis-cinchona alkaloids bearing a pyridazine (PYDZ), phtalazine (PHAL), 
diphenylpyrimidine (PYR) and more recently an antraquinone (AQN) core are the 
most effective ones (Scheme 42). 
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Scheme 42: Selected Dimeric Cinchona Alkaloid Derivatives. 
 
Moreover, the absolute stereochemistry of the products can be predicted from an 
empirical ‘mnemonic’ device (Scheme 43).134 All these developments have 
converged to allow the formulation of a reagent mixture called AD-mix, which 
contains all necessary reagents for performing the AD reaction under heterogeneous 
conditions. 
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Scheme 43: Face Selection Rule for Prediction of AD Selectivity. 
 
Concerning the reaction mechanism, two possible pathways have been proposed to 
rationalize the characteristic features of the reaction and are currently under 
investigation: a concerted [3+2]135 (the CCN model for Criegee-Corey-Noe) and a 
stepwise [2+2]136 pathway (Sharpless). However, recent evidence from Sharpless 
supports a [3+2] cycloaddition as the rate determining step.137 
 
Taking into account the high cost of the chiral ligands and osmium tetroxide, 
extensive work is being carried out in order to replace them with reusable derivatives 
such as (soluble or insoluble) polymer supported ligands138 and more recently 
immobilized osmium tetroxide which has been produced by microencapsulation,139 
ion-exchange techniques140 or osmylation of resins.141 All these approaches 
succeeded in recovering either the ligand or the osmium species, but failed in 
recycling the two components at the same time. 
 
Zhang has developed a recyclable catalytic system based on a mono-quaternized 
bis-cinchona alkaloid ligand 142 and OsO4 in combination with PEG or an ionic 
liquid.142 Both catalytic components have been recycled in five consecutive AD’s of 
trans-stilbene without significant loss in the selectivity and without the use of 
additional OsO4 or ligand. Furthermore it was found that addition of 
tetraethylammonium acetate to the reaction mixture had a positive effect on the 
enantioselectivity. 
 
 43
Introduction 
Ph
Ph
Ph
HO
H
OH
Ph H
N
N
O
NN
N
O
N
MeO OMe
+ Br
−
140 141
142
1.5 mol% OsO4, 2 mol% Ligand 142
1.3 eq. NMO, [bmim][PF6] or PEG
acetone/H2O 10:1, 0 °C, 10 h
 
Scheme 44: Asymmetric Dihydroxylation According to Zhang. 
 
Recently, systems based on RuO4/NaIO4,143 iron complexes/H2O2144 as well as chiral 
phase transfer reagents/KMnO4145 emerged as alternatives for the well known 
osmylation reaction.130 
Recent advances in the field of transition metal catalyzed olefin oxidation led to the 
development of the second fundamental osmium-based oxidative olefin 
functionalization: asymmetric aminohydroxylation.146 Within the last years both 
systems have found wide applications in the synthesis of chiral drugs, natural 
products as well as in the production of fine chemicals on a large scale.147 
 
 
1.3.3 C-N bond formation 
 
There is only a limited number of reports on the asymmetric construction of nitrogen 
substituted quaternary stereogenic centers employing cinchona alkaloids as 
catalysts.148 Some are dedicated to the enantioselective synthesis of aziridines and 
2H-azirines, compounds which have attracted attention due to the regio- and 
stereoselective ring opening reaction which they may undergo. Asymmetric 
aziridination of electron deficient olefins with aryl hydroxamic acids, by means of 
phase transfer catalysis, afforded N-aryl aziridines with moderate enantioselectivity 
(up to 62% ee). An enhancement in the optical purity could be achieved by 
recrystallization. 
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Another simple approach toward the synthesis of optically active nitrogen-containing 
compounds, via C-N bond formation, is the direct α-amination of carbonyl 
compounds. For example, the proline catalyzed α-amination of unmodified aliphatic 
ketones and aldehydes,29 yielding useful synthons for the synthesis of amino acid 
derivatives was described in chapter 1.1. Bifunctional Lewis acid catalysts for the α-
amination of β-ketoesters and α-substituted β-ketoesters are also known.149 Recent 
reports enlarged the number of applications in this area by showing that cinchona 
alkaloid derivatives serve as organocatalysts in the enantioselective amination of α-
substituted α-cyanoacetates. 
 
In late 2004 Jørgensen reported the first general protocol for the direct asymmetric 
catalytic α-amination of cyanoacetates using commercially available 
azodicarboxylates as the nitrogen source and β-ICD (93) as catalyst.150 Both, the rate 
and the asymmetric induction were highly dependent on the azodicarboxylate 
structure. The reaction required only a few seconds for completion when diethyl- or 
dibenzyl-azodicarboxylate were employed as electrophile, affording products with 
84% and 64% ee respectively. Excellent enantioselectivity (>98% ee) was obtained 
in the amination of 143 with di-tert-butyl azodicarboxylate (144) catalyzed by 5 mol% 
β-ICD (93) in toluene at −78 °C. It is worthy of note that lowering the catalyst loading 
to 0.5 mol% had no influence on the yield or selectivity. 
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Scheme 45: Cinchona Alkaloid Catalyzed Asymmetric α-Amination of Cyanoacetates. 
 
Accordingly, a large range of α-aryl α-cyanoacetate were found to undergo a clean 
reaction, affording the corresponding products in excellent yields (95-99%) and high 
enantiomeric excesses (89->98% ee). Moreover, the reaction versatility has also 
been demonstrated in the reaction of various β-dicarbonyl compounds (β-ketoesters, 
β-diketones) with di-tert-butyl azodicarboxylate, providing easy access to useful chiral 
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building blocks. Unfortunately, any attempts to promote a highly selective amination 
of α-alkyl α-cyanoacetates failed, and the products were obtained in high yields but 
nearly racemic form. 
 
Due to the fact that the conformationally rigid cinchona alkaloid catalyst is available in 
only one form (as quinidine derivative) the amination reaction provides access to only 
one of the two possible enantiomeric adducts. Subsequently, Deng optimized the 
system, and now both enantiomers are readily available by employing either the 
quinidine derivative 84b or the quinine derivative 85b as catalyst.151 
 
 
1.3.4 C-S bond formation 
 
Catalytic asymmetric conjugate addition to activated olefins has attracted 
considerable attention because of its synthetic utility. While different strategies have 
been devised for the enantioselective conjugate addition of carbon nucleophiles to 
α,β-unsaturated ketones and aldehydes,152 addition of heteroatom containing 
nucleophiles, such as nitrogen, oxygen or sulfur based nucleophiles, remains still an 
elusive goal. Although much effort has been made toward the development of a 
general and highly enantioselective 1,4-addition of thiols to activated olefins, the 
results still leave space for further improvement. In 1981, Wynberg reported on the 
stereoselective addition of aromatic thiols to cyclic enones promoted by catalytic 
amounts of non-modified cinchona alkaloids.153 It is assumed that the thiol and the 
chiral amine base are forming an ion pair which then reacts with the enone in the rate 
determining step. It was found that the presence of the free hydroxyl group in the 
catalyst has a positive effect on the enantioselectivity. However, despite intensive 
optimization of the reaction parameters and careful investigation of the catalyst 
structure, the addition resulted in only low to moderate enantioselectivity. 
 
Nowadays, various ethers of mono- and bis-cinchona alkaloids are commercialized 
since they proved to be effective over a wide range of reactions. Taking advantage of 
the catalyst availability, Deng developed a general protocol for the addition of 2-
thionaphthol to various cyclic enones.154 Sharpless bis-cinchona alkaloids are 
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responsible for the success of this reaction. Interestingly, the sense of asymmetric 
induction obtained with the natural cinchona alkaloid is opposite to that obtained 
when the corresponding bis-derivative was used in the reaction. This fact inevitably 
leads to the conclusion that the mechanism of this reaction differs from the one 
described by Wynberg. 
 
 
1.3.5 C-F bond formation 
 
Considerable attention has been paid in recent years to fluorinated molecules, and 
the field of organofluorine chemistry is growing rapidly. Fluorinated compounds are of 
great interest not only in chemistry, but also medicinal and material science.155 
Hence, the development of efficient methodologies for their stereoselective synthesis 
is now demanded. Although several successful approaches are known for their 
diastereoselective synthesis,156 the enantioselective fluorination is still a challenging 
field. The first direct enantioselective fluorination was reported in 1988, and various 
N-fluorocamphorsultams157 were employed as source of chirality. Despite only 
moderate results being obtained, this was the first report on the reagent-controlled 
asymmetric fluorination reaction involving an electrophilic fluorine atom. In order to 
improve the enantioselectivity, new chiral electrophilic fluorinating agents have been 
designed (Scheme 46).158 Generally, the new reagents were more efficient and 
enantioselectivities with up to 88% ee have been attained with Takeuchi’s saccharin-
based fluorinating agent 147. However, these protocols seem not attractive in view of 
preparative aspects due to the tedious catalyst synthesis ending with the N-F bond 
formation by means of either toxic molecular fluorine or explosive gaseous perchloryl 
fluoride. 
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Scheme 46: First Generation of Chiral Fluorinating Reagents. 
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Independently, Shibata159 and Cahard160 reported on the development of an efficient 
direct fluorination method based on the use of stoichiometric amounts of cinchona 
alkaloid N-fluoro ammonium salts. These chiral reagents, capable of selective 
fluorine cation delivery, were synthesized according to Bank’s fluorine-transfer 
procedure.161 Complete fluorine transfer from the commercially available achiral 
reagent Selectfluor (1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis 
tetrafluoro-borate)155d to the cinchona alkaloid was achieved within 30 min in 
acetonitrile, as determined by 19F-NMR analysis of the reaction mixture. Ketones and 
ketoesters were typical substrates evaluated in the reaction. 
 
Two equivalents of base were necessary in order to avoid protonation of the in situ 
generated enolate by the free OH group of the alkaloid. Furthermore, protection of 
the hydroxyl group was found to be crucial for achieving high enantioselectivities. 
Regarding the influence of the O-substituent, reagents bearing a bulkier protecting 
group were found to be superior in terms of selectivity. Moreover, the degree of 
asymmetric induction exhibited by these preformed reagents was strongly dependent 
on the reaction conditions. A considerable increase in enantioselectivity has been 
observed when silyl enol ethers were used as substrates (61-84% ee vs 33-50% ee). 
This new approach involving silyl enol ethers is more convenient than the fluorination 
of metal enolates since no base is required for the in situ enol formation. 
 
Next, the usefulness of this new protocol was demonstrated by the enantioselective 
synthesis of MaxiPost, a potent potassium channel opener.162 Reaction of oxindole 
151 with the N-fluoroammonium salt 150, in the presence of DABCO as base, 
yielded the desired product 152 in excellent yield and with high enantiomeric excess 
(96% y, 88% ee). A single recrystallization afforded optically pure material (>99% 
ee). Previously, the two enantiomers have been separated by chiral HPLC resolution 
of the racemic mixture. 
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Scheme 47: Enantioselective Synthesis of MaxiPost According to Cahard. 
 
While Cahard’s protocol makes use of preformed cinchona alkaloid ammonium salts, 
Shibata prefers the in situ generation of the active fluorinating species.159 The order 
of addition was found to be crucial in order to achieve enantioselective fluorination. 
Addition of Selectfluor to a mixture of alkaloid and enolate resulted in racemic 
product. This means that an alkaloid/enolate complex cannot be responsible for an 
enantioselective process. On the other hand, satisfactory results were obtained when 
Selectfluor and the alkaloid were combined before the addition of the substrate. 19F-
NMR and X-ray crystal structure analysis are in agreement with Cahard’s studies and 
supports the formation of a new active species by fluorination of the cinchona 
alkaloid. This also explains why only stoichiometric amounts of alkaloid assure a 
successful reaction and why any attempts toward a catalytic version failed. 
 
It was Park who first reported a catalytic enantioselective electrophilic fluorination of 
indanone and tetralone, by means of phase transfer catalysis.163 Slow addition of the 
(PhSO2)2NF to the preformed enolates in the presence of 10 mol% chiral phase 
transfer catalyst afforded the α-fluoro-β-keto esters in high yields (74-94%) and with 
moderate enantiomeric excesses (41-69% ee). 
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1.4 Asymmetric anhydride opening 
 
Desymmetrization of meso-dicarbonyl compounds to yield chiral products proved to 
be a powerful synthetic tool in asymmetric synthesis since it allows the formation of 
multiple stereogenic centers in one symmetry breaking operation.164 For this 
purpose, both enzymatic and chemical approaches have been extensively 
investigated (Scheme 48). For example, starting from symmetrically substituted 
diesters, desymmetrization with the help of enzymes provides optically active 
hemiesters which are valuable building blocks for the synthesis of natural products or 
biologically active substances.165 PLE is known to selectively catalyze the 
enantiotopos-differentiating hydrolysis of over 400 prochiral dicarboxylic acid diesters 
and diol diacetates.165d Unfortunately, the enzymatic approach is generally limited to 
the synthesis of only one enantiomer. In contrast, the desymmetrization of meso-
anhydrides is not limited by this restriction since often the chiral reagent or mediator 
involved in the reaction is available in both enantiomeric forms.166 
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Scheme 48: Desymmetrization of meso-Dicarbonyl Compounds. 
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1.4.1 Chiral nucleophiles 
 
Several reports have been made on the addition of chiral alcohol or amine 
nucleophiles to meso-anhydrides. One of the most successful systems was reported 
by Heathcock and involves the addition of (S)-1-naphthylethanol to 3-substituted 
glutaric anhydrides.167 A de of 88% was observed in the case of 3-methylglutaric 
anhydride and the product has found application in the synthesis of a new powerful 
oxamacrolide musk odorant (Scheme 49).168 
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Scheme 49: Diastereoselective Ring Opening of 3-Methyl Glutaric Anhydride According to Heathcock. 
 
Mukaiyama reported on the desymmetrization of bicyclic meso-anhydrides with (R)-2-
methoxy-1-phenylethanol diphenylborate, affording the corresponding hemiesters in 
good yields (75-95%) and moderate to excellent diastereoselectivities (40-99% 
de).169 
 
Kunieda has attained high diastereoselectivity in the ring opening of a variety of bi- 
and tricyclic anhydrides by using lithium complexes generated in situ from various 
sterically hindered chiral N-sulfonylamino alcohols.170 A significant increase in the 
diastereoselectivity was observed when hexamethylphosphoric triamide (HMPA) was 
employed as additive. For example, the cyclohexane hemiester 157 was obtained in 
93% yield and 99% de by using the lithium salt of the corresponding bulky 2,4,6-
triisopropylbenzenesulfonyl amino alcohol and 5 eq. of HMPA at −78 °C in THF. 
Interestingly, the use of the zinc salt as nucleophile resulted in the opposite sense of 
asymmetric induction. Accordingly, either diastereomer could be selectively 
synthesized by using different metal salts of the same chiral amino alcohol. 
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Scheme 50: Representative Diastereoselective Anhydride Desymmetrizations. 
 
North reported on the desymmetrization of endo-bicyclo[2.2.1]hept-5-ene-2,3-
dicarboxylic anhydride using proline esters as chiral nucleophiles.171 The process has 
been successfully applied to the synthesis of peptides and pseudopeptides 
incorporating an endo-(2S,3R)-norborn-5-ene residue. Unfortunately, proline cannot 
be cleaved and replaced by other amino acids so that this synthetic approach is 
limited to molecules containing proline at the first position of one peptide strand. In 
addition, the protocol suffers from strong substrate limitations in that any attempts to 
extend the methodology to bicyclic anhydrides resulted in poor or no asymmetric 
induction. 
Despite several attempts toward a highly diastereoselective process, no general 
protocol, with respect to anhydride structure, could be elaborated. Consequently, the 
enantioselective alcoholysis emerged as an attractive alternative. 
 
 
1.4.2 Enantioselective desymmetrization using chiral Lewis acids 
 
Seebach investigated the Lewis acid-mediated transfer of an isopropoxy group from 
the chiral ligand sphere of Ti-TADDOLate to cyclic meso-anhydrides to afford the 
corresponding hemiesters.172 Unlike the previously described protocols, which give 
products with covalently linked chiral auxiliaries, Seebach’s system delivers directly 
enantiomerically enriched hemiesters. The system was optimized for the norbornene 
anhydride and the best results (88% y, 98% ee) were obtained at −30 °C in THF, 
using β-naphthyl-titanium TADDOLate derivative 161 as mediator. A large variety of 
tricyclic anhydrides have been functionalized under these conditions, affording 
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products in high yields (82-92%) and with excellent enantiomeric excesses (94-98% 
ee). Slightly higher temperatures were required in the case of less reactive bicyclic 
anhydrides, leading to products in good yields (59-87%) and with high enantiomeric 
excesses (88-96% ee). Unfortunately, only unsatisfactory results were obtained when 
mono- and disubstituted glutaric anhydrides were subjected to the alcoholysis 
reaction. 
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Scheme 51: Enantioselective Anhydride Opening According to Seebach. 
 
In addition, a catalytic protocol which permits the substoichiometric use of Ti-
TADDOLate in the presence of stoichiometric amounts of Al(OiPr)3 was 
developed.172b The proposed catalytic cycle is outlined in Scheme 52. It was 
assumed that if the rate of the Ti-TADDOLate catalyzed enantioselective alcoholysis 
is much greater than the rate of the Al(OiPr)3 catalyzed racemic alcoholysis, then the 
ee of the hemiester can be retained, while Al(OiPr)3 regenerates the chiral catalyst 
via metal-ligand exchange. Accordingly, hemiester 162 was obtained in 74% yield 
and 96% ee by using a catalytic amount of Ti-TADDOLate (20 mol%) and a 
stoichiometric amount of aluminum isopropoxide. Unfortunately, the catalytic process 
now required an extremely long reaction time (24 days) and was less successful 
when applied to other substrates. 
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Scheme 52: Proposed Mechanism for the Substoichiometric use of Ti-TADDOLate. 
 
Subsequently, the methodology was extended to the ring opening of meso-
sulfonylimides to give the corresponding sulfonylamido isopropyl esters with up to 
98% ee.173 The Ti-TADDOLate mediated kinetic resolution of racemic dioxolanones, 
azlactones, and biaryllactones leading to highly enantioenriched products was also 
described.174 
 
Recently, the interest in the development of general and selective desymmetrization 
methods has increased considerably and along with the well-known concepts 
described above, new approaches for the ring opening reaction, involving carbon-
based nucleophiles, have been reported. Detailed studies on the alkylation of cyclic 
meso-anhydrides catalyzed by a nickel complex have been described by Rovis.175 
Several phosphine ligands were initially tested in combination with Ni(COD)2 in the 
addition of diethylzinc to cyclohexanedicarboxylic anhydride. The mechanistic 
pathway involves firstly an oxidative addition of the low-valent nickel complex to the 
electron deficient C-O bond of the anhydride. The resulting organometallic species 
then undergoes transmetalation with the zinc reagent to provide the key intermediate, 
which upon reductive elimination affords the product and regenerates the catalyst. 
The use of electron-deficient olefins as promoters for the reductive elimination 
increased the yield and the reaction rate considerably. For example the addition of 
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ZnEt2 to anhydride 163 is 250 times faster in the presence of 10 mol% p-
trifluoromethylstyrene and affords the product in 80% yield in less than five minutes. 
Concerning the influence of the ligand structure on the reaction efficiency, it was 
found that bidentate phosphine ligands are superior to trialkyl- and triarylmonodenate 
ones. Moreover, the reaction is highly general with respect to the substrate, and a 
large variety of mono-, di-, and tricyclic anhydrides have been reacted with ZnEt2 to 
give the corresponding γ- and δ-keto acids in moderate to excellent yields (61-96%). 
In addition, the use of Pfaltz N,P-ligand 165 afforded an active catalyst for the 
enantioselective alkylation of cyclohexane dicarboxylic anhydride 163 and provided 
the γ-keto acid 164 in 85% yield and 79% ee. 
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Scheme 53: Enantioselective Ring Opening with C-based Nucleophile According to Rovis. 
 
An improved protocol for the asymmetric anhydride desymmetrization has also been 
developed. Room temperature palladium-catalyzed diphenylzinc addition to 
structurally diverse cyclic anhydrides provided the corresponding keto acids in good 
yields (61-89%) and high enantioselectivities (89-97% ee).176 
 
A second useful transformation involving carbon-based nucleophiles was reported by 
Fu.177 It was found that commercially available (−)-sparteine promotes an 
enantioselective ring opening reaction of 3-phenyl glutaric anhydride (166) by phenyl 
magnesium chloride (PhMgCl), leading to the corresponding δ-keto acid 167 in 63% 
yield and 88% ee. A significant improvement in the yield (91%) and selectivity (92% 
ee) was observed when a slight excess of Grignard reagent/(−)-sparteine was 
employed as source of chirality (Scheme 54). The reaction proved to be general with 
respect to the substrate, and various 3-substituted glutaric anhydrides were 
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converted into the corresponding keto acids in good yields (51-91%) and high 
enantioselectivities (87-92% ee). 
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Scheme 54: Enantioselective Ring Opening with C-based Nucleophile According to Fu. 
 
 
1.4.3 Enantioselective desymmetrization with chiral Lewis bases 
 
Much progress has also been made on the metal free anhydride desymmetrization, 
the first results being reported in the late 80’s by Oda178 and Aitken179 independently. 
A large variety of cyclic meso-anhydrides were functionalized and the corresponding 
half-esters were obtained in high yield and with moderate enantioselectivities by 
using a catalytic amount of cinchona alkaloids. While Oda’s studies dealt with the 
desymmetrization of mono- and bicyclic anhydrides, Aitken extended the substrate 
scope to more complex tri- and tetracyclic anhydrides. 
 
Oda investigated the influence of the catalyst structure on the reaction selectivity and 
the sense of asymmetric induction. Glutaric and succinic anhydrides were examined 
in the reaction with methanol, as nucleophile, in the presence of 10 mol% cinchona 
alkaloid. The products were obtained in high yields but with low to moderate 
enantiomeric excesses. The enantioselectivity was found to be strongly dependent 
on specific substrate/catalyst combinations. Generally, the naturally occurring 
cinchona alkaloids (erythro bases) were more active and selective than their C9-
epimers (threo bases) in the desymmetrization of glutaric anhydrides, affording the 
products with up to 70% ee. On the other hand, the erythro bases exhibited lower 
asymmetric induction compared to the threo bases for the five-membered ring 
anhydrides (Scheme 55). Furthermore, it was found that the reaction stereochemistry 
is entirely controlled by the configurations at C8 and C9 in the catalyst and it was 
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demonstrated that quinuclidine catalyzes the reaction to the same extent as 
cinchonine, whereas quinoline showed almost no activity. The involvement of a 
catalyst/substrate ion-pair complex in the determination of the stereochemical 
outcome of the reaction was excluded and a general-base catalysis mechanism (with 
the quinuclidine nitrogen being responsible for the catalytic activity) was rationalized. 
The first order dependence of the reaction rate on the alcohol nucleophile, the 
deuterium isotope effect and the fact that the more acidic 2,2,2-trifluoroethanol was 
more reactive than ethanol all pointed toward a general-base catalysis mechanism. 
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Scheme 55: Cinchona Alkaloid Mediated Ring Opening According to Oda. 
 
A similar reaction protocol was developed by Aitken.179a Room temperature 
methanolysis of meso-epoxyanhydride 174 in the presence of 10 mol% quinine in 
toluene, followed by intramolecular epoxide opening led to the lactone 175 in 80% 
yield and 38% ee. An increase in the catalyst loading to 50 mol% afforded the 
lactone with 76% ee (Scheme 56). In addition, a single recrystallization furnished 
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enantiomerically pure product (>99% ee). Since lactone 175 is acid sensitive, in order 
to avoid possible difficulties which could occur during the acidic workup, polymer 
supported cinchona alkaloids, prepared by copolymerization with acrylonitrile, were 
next examined. The reaction was found to be efficient, but always occurred with 
lower selectivity compared to the non-polymeric catalysts. 
 
Under the same reaction conditions (10-50 mol% catalyst, 3 eq. MeOH, r.t., toluene, 
24 h), several norbornane type anhydrides afforded the corresponding methyl 
hemiesters in good yields (69-97%) with moderate enantiomeric excesses (35-67% 
ee).179b 
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Scheme 56: Cinchona Alkaloid Mediated Ring Opening of Epoxyanhydride 174 According to Aitken. 
 
Based on Oda’s and Aitken’s pioneering studies, an improved protocol was 
developed by Bolm which allowed a wide range of structurally diverse methyl 
hemiesters to be prepared with up to 99% yield and 99% ee (Scheme 57).180 Low 
temperature, an excess of methanol and a stoichiometric amount of the inexpensive 
and readily available cinchona alkaloid constituted the key for a highly efficient ring 
opening reaction. Compared to the existing methods, this new protocol proved to be 
very simple and more convenient to perform. After reaction, the alkaloids can be 
recovered quantitatively and reused without loss of enantioselectivity. In addition, a 
catalytic protocol which gives comparable results and involves the use of 0.1 eq. 
quinidine and 1 eq. of an achiral sterically hindered tertiary amine base such as 
pempidine, was described.180b 
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Scheme 57: Anhydride Desymmetrization According to Bolm. 
 
It is remarkable that the process has found immediate application in the synthesis of 
β-amino acids,181 γ-amino alcohols182 and 1,2-diamines.182,183 The methodology was 
also successfully applied in other groups, as for example: by Carreira in the synthesis 
of the cyclopentyl core of the axinellamines,184 by Bernardi in the synthesis of both 
enantiomers of trans-cyclohex-4-ene-1,2-dicarboxilyc acid on a multigram scale,185 
by Tanyeli in the synthesis of a chiral norbornane-type 1,4 diamine,186 and more 
recently by Keen in the synthesis of an αvβ3 antagonist.187 
 
Comparable results were subsequently obtained by Deng, who found that 
commercially available mono and bis-cinchona alkaloid derivatives are also capable 
of functioning as effective chiral Lewis base/nucleophilic organic catalysts in the ring 
opening reaction.188 These modified cinchona alkaloids have been previously used 
by Sharpless as ligands in the asymmetric dihydroxylation and aminohydroxylation 
reaction. Screening of various aryl ethers and esters of cinchona alkaloids in the 
asymmetric alcoholysis reaction showed that the dihydroquinidine-based catalysts, 
DHQD-PHN and (DHQD)2AQN, possess a remarkable ability to promote a highly 
enantioselective reaction. A large range of bi-, and tricyclic anhydrides underwent 
ring opening reaction with methanol (10 eq.) at −20 or −30 °C in ether in the 
presence of 5-20 mol% (DHQD)2AQN, affording the corresponding methyl 
hemiesters in high yields (74-99%) and with excellent enantioselectivities (92-98% 
ee). 
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Scheme 58: Biscinchona Alkaloid Catalyzed Methanolysis of Cyclic Anhydrides. 
 
 
Notable, with (DHQD)2AQN (5-30 mol%) as catalyst, even the monocyclic anhydrides 
were readily converted into enantiomerically enriched (90-98% ee) acyclic 
hemiesters. Furthermore, the anhydride desymmetrization has been applied as a key 
step in the catalytic asymmetric synthesis of (+)-Biotin.189 Recent studies by Deng190 
revealed that the biscinchona alkaloids are able to efficiently mediate the kinetic 
resolution of racemic cyclic anhydrides190a and N-carboxy anhydrides,190b as well as 
the dynamic kinetic resolution of N- and O-carboxy anhydrides.190c,d 
 
A polymer supported (DHQD)2AQN catalyst has been recently introduced and 
evaluated in the asymmetric ring opening reaction of cyclohexene dicarboxylic 
anhydride by Wöltinger.191 By means of a repetitive batch system it was possible to 
run the reaction over 18 cycles achieving a conversion of >95% for each cycle. 
However, the synthetic usefulness of the process is limited since it was only 
optimized for a single substrate and the ee decreased drastically, from almost 90 to 
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60%, during the first 5 runs. Silica gel-supported quinidine as heterogeneous catalyst 
for the anhydride desymmetrization, was synthesized and optimized for the same 
substrate by Carloni.192 More efficient heterogeneous chiral organocatalysts were 
introduced by Han,193 who demonstrated that silica gel-supported bis-cinchona 
alkaloids exhibited higher catalytic activity in comparison to Carloni’s system. In 
addition, they are applicable to a wider substrate spectrum and give products with up 
to 92% ee. 
 
Uozumi focused his attention on the use of noncinchona-based catalysts for the 
enantioselective anhydride desymmetrization.194 A library of five N-chiral bicyclic 
tertiary amines was synthesized and tested in the methanolysis of cyclohexane 
dicarboxylic anhydride. The methyl hemiester 182 was obtained in 72% yield and 
89% ee when stoichiometric amounts of methanol, as nucleophile, and pyrrolo-
imidazolone derivative 183, as chiral catalyst, were used in the reaction. Lowering 
the amount of catalyst to 10 mol% afforded the product in poor yield (33%) and 65% 
ee. 
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Scheme 59: Desymmetrization of meso-Cyclic Anhydrides According to Uozumi. 
 
 
The 5-step procedure for the catalyst synthesis,194,195 the limited substrate spectrum 
(only 3 examples including 163) and the moderate reaction selectivity mark the 
system as inconvenient from practical and synthetic point of view. 
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1.4.4 Mechanistic studies 
 
The mechanism of the alkaloid-mediated ring opening has not been fully elucidated 
yet. So far, two general models are discussed,196 although neither provides a clear 
explanation for the source of distinction between the enantiotopic carbonyl groups. 
On the one hand, a nucleophilic catalysis is suggested in which the quinuclidine 
nitrogen atom of the alkaloid attacks the anhydride at one of the carbonyl 
groups179b,180b to give an acylammonium salt as intermediate. Subsequent 
nucleophilic attack by the alcohol yields the product and regenerates the catalyst 
(Scheme 60, B). This mechanism is similar to the one accepted for the amine-
catalyzed kinetic resolution of secondary alcohols by acylation.197 
 
On the other hand, the alkaloid could serve as chiral base for the alcohol 
molecule.178a Formation of a hydrogen bonding complex activates the alcohol, 
enabling it to attack the anhydride (Scheme 60, A). The resulting ion pair undergoes 
proton transfer, forming the hemiester and regenerating the chiral catalyst. This 
proposal corresponds to the one suggested by Wynberg for the asymmetric addition 
of thiols to enones.198 
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Scheme 60: Proposed Mechanisms for the Amine-Catalyzed Alcoholysis of meso-Anhydrides. 
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Evidence has been found for both models. Thus the kinetic isotope effect 
(kMeOH/kMeOD = 2.3) observed by Oda and co-workers178a supports the latter, whereas 
Carloni's detection of an anhydride-quinidine adduct by mass spectroscopy192 
indicates the formation of an acylammonium-type intermediate.199 
 
 
2 Aim of the project 
 
As already described in chapter 1.4.3, Bolm and co-workers developed a general 
strategy for the anhydride desymmetrization and after extensive optimization, a 
highly efficient protocol for the enantioselective methanolysis has been elaborated. 
As part of these studies, one target in the beginning of the present work was to 
further investigate the effect of different alcohol nucleophiles on the reaction rate and 
selectivity. Since the deprotection of the methyl ester moiety by saponification 
encountered small difficulties for specific substrates during derivatization, the 
possibility of introducing ester functionalities which are cleavable under very mild 
conditions was of particular interest. Subsequently, the possibility of performing the 
reaction in a non-toxic, non-halogenated solvent system as well as the possibility of 
scaling-up the reaction without affecting its conversion and enantioselectivity should 
also be investigated. Finally, an additional focus of attention lay on the application of 
this improved desymmetrization protocol toward the synthesis of optically active β-
amino acids and new C2- and C1- symmetric bisoxazolines which could serve as 
chiral ligands in the asymmetric catalysis. 
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3 Results and discussions 
 
 
3.1 Asymmetric anhydride opening 
 
3.1.1 Investigation of different nucleophiles 
 
It has already been established that careful choice of the solvent system, optimal 
temperature and mediator had a remarkable effect on the methanolysis of various bi-, 
and tricyclic anhydrides, affording products in 61-99% yield and excellent 
enantioselectivities (85-99% ee in the case of quinidine).180b In view of the synthetic 
utility of this methodology, the possibility of introducing various ester functionalities 
was studied at the beginning of this project. With the norbornene anhydride as model 
substrate and carrying out the reactions under the previously optimized conditions we 
have evaluated now different alcohol nucleophiles in the asymmetric ring opening 
reaction and the results are summarized in Table 1.200 
 
In agreement with the preliminary investigations,180b the steric properties of the 
nucleophile had a great influence on the rate and selectivity of the anhydride 
opening. Among all tested nucleophiles, methanol was the most selective one (Table 
1, entry 1). Ethanol showed a significantly lower reactivity and selectivity when 
compared to methanol.178a Accordingly, the reaction time had to be increased from 
60 to 108 h for achieving complete conversion when methanol was substituted by 
ethanol as the nucleophile (Table 1, entry 2). On the other hand, with 2,2,2-
trifluoroethanol the reaction rate was high, but it led to a racemic product (Table 1, 
entry 3). This result was analogous to the findings of Oda,178a who also found a 
significant decrease in ee when 2,2,2-trifluoroethanol was employed as nucleophile. 
It contrasted, however, the observations made by Deng in his studies on the parallel 
kinetic resolution of monosubstituted succinic anhydrides.190a There, the highest 
enantiomeric excesses were achieved when the fluorinated alcohol was used as 
nucleophile. 
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Table 1: Quinidine-Mediated Opening of Anhydride 160 using Different Alcoholsa 
 
Entry Alcohol ee (%)cHemiester Yield (%)
1
2
3
4
5
6
7
8
99
89
rac.
97
79
97
96
97
99
97d
96
97
97
92
93
93
Methanol
Ethanol
2,2,2-Trifluoroethanol
Allyl alcohol
Propargyl alcohol
Benzyl alcohol
Benzyl alcohol
p-Anisyl alcohol
176
184
185
186
187
188
ent-188e
189
    major
enantiomer b
    minor
enantiomer
COOR
COOH
O
O
O
COOH
COOR
 Quinidine
ROH R
S
+
160
176 - 189 ent-176 - ent-189
 
a All reactions were performed at −55 °C for 60 h using 1.1 eq. of quinidine and 3.0 eq. 
of alcohol in a toluene/CCl4-mixture (1:1), 0.2 M solution related to anhydride. b For 
determination of the absolute configuration, see text and ref. 180b. c Determined by 
GC-analysis of the corresponding lactone using a chiral stationary phase. d Complete 
conversion was only achieved after 108 h. e Quinine was used as chiral mediator. 
 
Unlike methanol and ethanol, almost no reaction took place with more sterically 
hindered alcohols such as 2-propanol, even when they were used as solvent. 
Surprisingly, allyl alcohol exhibited selectivity comparable to methanol, affording the 
product in 97% yield and 97 % ee (Table 1, entry 4). Since the irreversible Pd(0)-
catalyzed transfer of allyl to weakly basic morpholine offers the possibility of a mild 
cleavage of allylic esters,190c,201 the synthesis of 186 with 97% ee already fulfilled our 
initial criteria. However, taking into account the potentially tedious product purification 
in an amino acid synthesis (see also chapter 3.2.2) this ester functionality appeared 
not advantageously enough.202 We therefore decided to focus our attention on the 
establishment of a benzyl ester functionality. 
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Thus, using benzyl alcohols as nucleophiles, hemiesters 188 and 189 were obtained 
in high yields (92 and 93% respectively, Table 1, entries 6, 8) and in analytically pure 
form with 97% ee. In contrast to the nucleophiles described so far, the required 
excess of the alcohol could not completely be removed in vacuum after terminating 
the reaction. Nevertheless, the preparative advantage of a simple workup without 
chromatographic purification was maintained for most products. Thus, an acidic wash 
permitted the recovery of the alkaloid and a subsequent mild basic extraction 
removed the remaining benzyl alcohol. Furthermore, benzyl hemiester 188 
crystallizes nicely from ether, allowing the enantiomeric excess to be increased from 
a single recrystallization to >99% in only a few hours. 
 
Pseudoenantiomeric quinine generated ent-188 with 96% ee (Table 1, entry 7). The 
ease of the benzyl ester deprotection by simple hydrogenation performed after 
derivatization reactions broadens the applicability of the alkaloid-mediated anhydride 
opening favorably and encouraged us to evaluate the scope of the benzyl 
alcoholysis. 
 
 
3.1.2 Variation of the substrate 
 
Since the monocyclic anhydrides were not suitable substrates for the 
methanolysis,180b,182 they were not included in our present research project, and we 
focused our attention on bi- and tricyclic anhydrides. Under the conditions optimized 
in our primary investigation,180 a large variety of bicyclic anhydrides were converted 
with benzyl alcohol into the corresponding products in high yields and with excellent 
enantioselectivities (Table 2). 
 
As previously observed, quinidine-mediated ring openings furnished monoesters with 
slightly higher enantiomeric excesses in comparison to the quinine mediated ones. 
We were pleased to see that this difference was rather low with benzyl alcohol as 
nucleophile (∆ee benzylester enantiomers = 1-4%). Remarkably, in most of the cases 
the benzyl hemiesters were furnished with slightly higher enantiomeric excesses 
compared to their methyl analogues. 
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Table 2: Quinidine- and Quinine-Mediated Opening of Bicyclic meso-Anhydridesa 
 
Entry Anhydride
Quinine-Mediated
Ester
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
Quinidine-Mediated
Ester
172
191
177
194
163
1
2
3
4
5
6
7
190
192
193
195
196
198
200
92
93
97
97
95
94
98
95
90
93
78c
88
84
88
ent-190
ent-192
ent-193
ent-195
ent-196
ent-198
ent-200
88
90
95
95
93
95
97
94
85
89
83c
84
84
87
O
O
O
197
O
O
O
199
ee
(%)b
Yield Yieldee
(%)b(%) (%)
 
a All reactions were performed at −55 °C for 60 h using 1.1 eq. of alkaloid and 3.0 eq. of benzyl alcohol 
in a toluene/CCl4-mixture (1:1); for quinidine: 0.2 M with respect to the anhydride, for quinine: 0.05 M. b 
Determined by GC-analysis of the corresponding lactones using a chiral stationary phase. c After 
chromatographic purification (see experimental section). 
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This effect was more pronounced especially for the quinine mediated reactions, 
where the variation ∆ee (benzylester/corresponding methylester) was established 
between 2 and 6% for the bicyclic anhydrides. 
 
 
Table 3: Quinidine- and Quinine-Mediated Opening of Tricyclic meso-Anhydridesa 
 
1
2
3
4
188
202
204
206
97
96
99
96
92
95
84c
79c
ent-188
ent-202
ent-204
ent-206
96
92
94
90
93
81
77c
85c
O
O
O
O
O
O
O
O
O
201
203
205
O
O
O
O
O
160
Entry Anhydride
Quinine-Mediated
Ester
Quinidine-Mediated
Ester
ee
(%)b
Yield Yieldee
(%)b(%) (%)
 
a All reactions were performed at −55 °C for 60 h using 1.1 eq. of alkaloid and 3.0 eq. of benzyl alcohol 
in a toluene/CCl4-mixture (1:1); for quinidine: 0.2 M with respect to the anhydride, for quinine: 0.05 M. b 
Determined by GC-analysis of the corresponding lactones using a chiral stationary phase. c After 
chromatographic purification (see experimental section). 
 
Concerning the tricyclic anhydrides the results were even more positive. For 
example, both benzyl ester enantiomers derived from oxanorbornene anhydride 203 
were formed in a highly enantioselective manner (Table 3, entry 3). In contrast, the 
corresponding methanolysis gave both stereoisomers with 18% ee difference. Also 
the yields of 204 and ent-204 were significantly higher than those of products which 
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were obtained from the opening with methanol. This is probably due to a lower water 
solubility of the benzyl hemiesters, which results in a reduced loss of product during 
the aqueous workup. Since such oxatricyclic molecules are known to react with basic 
reagents,203 the second extraction procedure was omitted and the products were 
purified by chromatography (entries 3 and 4). 
 
The enantiomeric excesses of the benzyl esters were determined by GC-analysis of 
the corresponding lactones, which were obtained by selective reduction of the ester 
group with LiBEt3H followed by acid-catalyzed lactonization.172b Since the absolute 
configurations of the methanolysis products were already established,180b the 
retention times of the lactones derived from these methyl esters permitted a direct 
assignment also for the benzyl analogues. As expected, in all cases the 
stereochemical outcome of the desymmetrization was uniform: the quinidine-
mediated ring opening of anhydrides generated the ester function at the carbonyl 
group indicated in Scheme 61. 
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Scheme 61: Stereoselective Desymmetrization of meso-Anhydrides with Benzyl Alcohol. 
 
For the anhydrides containing unsubstituted all-carbon backbones, this is the pro-S-
carbonyl group and, due to the reversal of the CIP-priorities, it is the pro-R-carbonyl 
group of anhydrides 172, 203 and 205. Analogously, pseudoenantiomeric quinine 
always showed the opposite selectivity. Due to the fact that this stereoselection rule 
is strictly valid for a wide range of substrates, the absolute configurations of other 
alcoholysis products become highly predictable.180b 
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This newly developed methodology is of practical utility since a wide range of benzyl 
hemiesters are for the first time easily available in enantiomerically enriched forms. 
The protocol is also net superior to the enzymatic methods, since no enzyme has 
been shown to be able to hydrolyze benzyl diesters.  
 
 
3.1.3 Investigation of the solvent system 
 
In the methanolysis reaction, the highest enantiomeric excesses were achieved using 
a solvent system consisting of a 1:1 mixture of toluene and CCl4.180b However, 
combinations of solvents without the potentially harmful halogenated solvent204 were 
also applicable and gave products with high ee values.180b 
 
In the course of the present study it was found that using benzyl alcohol as 
nucleophile, the anhydride openings occurred with almost the same 
enantioselectivities and yields in pure toluene; the fact that now the quinine-mediated 
alcoholysis requires less solvent differs from the previous observations. The largest 
difference in enantioselectivity between reactions performed in mixtures of 
toluene/CCl4 (Table 2, entry 1) and pure toluene (Table 4, entry 2) was  ∆ee = 3% for 
ester ent-190. In some cases, avoiding the use of CCl4 led to even a slightly higher 
enantiomeric excess (Table 4, entries 3 and 5). These results stimulated and 
encouraged us to evaluate the performance of the ring opening reaction on a large 
scale. 
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Table 4: Opening of Various meso-Anhydrides in Toluene as Solventa 
 
O
O
O
O
O
O
O
O
O
O
O
O
172
191
177
163
1
2
3
4
5
188
190
192
193
196
96
90
95
95
96
84
93
94
94
85
ent-188
ent-190
ent-192
ent-193
ent-196
95
85
90
94
93
90
86
90
90
86
O
O
O
160
Entry Anhydride
Quinine-Mediated
Ester
Quinidine-Mediated
Ester
ee
(%)b
Yield Yieldee
(%)b(%) (%)
 
a All reactions were performed at −55 °C for 60 h using 1.1 eq. of alkaloid and 3.0 eq. of benzyl alcohol 
in toluene as solvent; for quinidine: 0.2 M with respect to the anhydride, for quinine: 0.1 M. b 
Determined by GC-analysis of the corresponding lactones using a chiral stationary phase. 
 
 
3.1.4 Reaction scale-up 
 
With the norbornene anhydride as test substrate, we carried out the reactions in the 
presence of quinidine, respectively quinine, on a 20 mmol scale in pure toluene as 
solvent. Surprisingly, both enantiomers were isolated with 97% ee and in excellent 
yields (95% and 94%, respectively).205 Guided by these results, we next selected 
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other representative substrates and evaluated them in the reaction with benzyl 
alcohol and quinidine as mediator. In all cases, the hemiesters were obtained in 
higher yields and greater enantioselectivities compared to the 1 mmol version. 
Remarkably, the oxanorbornene derivative 204 was isolated in 89% yield, after 
column chromatography, and >99% ee. This result is even more relevant when one 
consider that cleavage of the oxygen bridge offers easy access to carba-sugar 
derivatives.203a Investigations for the development of useful asymmetric syntheses, 
involving the alkaloid-mediated anhydride opening as a key step, are currently in 
progress. 
 
COOBn
COOH
COOBn
COOH
COOBn
COOH
93% y, 97% ee 95% y, 97% ee97% y, 96% ee
COOBn
COOH
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COOH
COOBn
COOH
COOBn
O
97% y, 96% ee 89% y, 99% ee
188 202 204
192 193 196
 
Scheme 62: Quinidine-Mediated Ring Opening of Various meso-Anhydrides. 
 
An advantage of the present protocol using benzyl alcohol as nucleophile, is that it 
allows the reactions to be performed in toluene as solvent, avoiding the use of the 
previously applied toxic carbon tetrachloride. 
 
 
3.2 Synthesis of β-amino acids 
 
Considerable attention has been drawn, in recent years, to the development of 
efficient strategies for the synthesis of optically pure β-amino acids206 and especially 
cyclic ones.207 The increasing interest in such cyclic β-amino acids is a result, on the 
one hand of the fact that many of these compounds show antibiotic, antifungal, 
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cytotoxic or other important biological properties in free form or as part of peptidic 
products.202,207,208 On the other hand, Gellman’s reports on oligopeptidic trans-2-
aminocycloalkane carboxylic acid chains, which can fold into stable helical 
structures,209 raised the demand of efficient synthetic routes to β-amino acid 
derivatives. Furthermore, cyclic β-amino acids are of considerable significance in 
synthetic organic chemistry for the preparation of pharmacologically active 
heterocyclic products.207,210 
 
 
3.2.1 Preparation of N-Cbz protected amino acid benzyl esters 
 
Representative benzyl monoesters were selected to demonstrate that they are 
valuable intermediates for the synthesis of highly enantiomerically enriched β-amino 
acids. For the synthesis of N-Cbz protected β-amino acid benzyl esters, the 
corresponding dicarboxylic monoesters were activated by treatment with ethyl 
chloroformate and triethylamine. Addition of an aqueous solution of sodium azide 
afforded crude acyl azides, which were dissolved in benzene and subjected to 
thermal rearrangement. After removal of the solvent, addition of benzyl alcohol to a 
methylene chloride solution of the resulting isocyanates in the presence of 
triethylamine gave the desired amino ester derivatives without purification of any of 
the intermediates.181,200 
 
The results shown in Table 5 were obtained by performing the reactions on a 15 
mmol laboratory scale. However, due to the ease of all the synthetic steps, and the 
accessibility of the substrates, larger quantities are easily manageable. The 
enantiomeric excesses of the products were determined by HPLC using columns 
with chiral stationary phases. Samples of racemic compounds were used as 
reference. Only in a single case, the conversion of hemiester 190, we encountered 
difficulties. Presumably, they were due to the donor-acceptor substituted 
cyclopropane core of the corresponding β-amino acid which is prone to undergo rapid 
ring opening reactions.211 Although the Curtius degradation has frequently been 
applied to such three-membered cyclic systems,211e,212,213 210 was only obtained with 
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a low ee (entry 4). It is most likely that this (partial) racemization proceeded via an 
open-chain intermediate which then underwent a stereospecific ring closure (as 
revealed by NMR spectroscopy). 
 
Table 5: Preparation of N-Cbz-Protected β-Amino Acids 
 
R
COOBn
COOH
R
COOBn
NHCbz
1. ClCOOEt, Et3N, −20  °C
2. NaN3 (aq.), −10  °C
3. Benzene, 80 °C
4. BnOH, Et3N  
 
a The ee-values given in parentheses refer to the ones of the mono-benzyl esters obtained by the
asymmetric opening of the corresponding anhydrides on a 15 mmol scale. b Determined by HPLC-
analysis using a chiral stationary phase. c Recrystallization furnished an increase on >99.7% ee
(HPLC-analysis).
207
Mono-Benzyl Estera β-Amino Ester
NHCbz
COOBn
208
COOBn
NHCbz
209
COOBn
NHCbz
210
NHCbz
COOBn
202
ent-193
ent-192
190
(95% ee)
(94% ee)
(93% ee)
(92% ee)
Entry
1
2
3
4
72
77
74
70
Yield (%)ee (%)b
93
94c
93
19
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3.2.2 Synthesis of the free β-amino acids 
 
Finally, the ester and the carbamate protecting groups were removed in a single step 
by a simple hydrogenation delivering the free β-amino acids in excellent yields 
(Scheme 63). The Pd/C-catalyzed deprotection step, which was performed at 1 atm 
hydrogen, required a reaction time of 1-2 h for complete conversion (monitored by 
t.l.c.). 
 
R
COOBn
NHCbz
R
COOH
NH2
H2, MeOH, Pd/C
COOH
NH2
NH2
COOH
COOH
NH2COOH
NH2
97% y98% y93% y
211 212 213 214
 
Scheme 63: Synthesis of Cyclic β-Amino Acids. 
 
The instability of the three-membered ring also became apparent during the 
attempted hydrogenolytic deprotection of 210 to give the free amino acid. Even in the 
presence of HCl the desired product was not obtained and the only identified product 
(NMR spectroscopy) was the corresponding ring-opened achiral γ-amino acid 211. 
 
Along these lines, another interesting observation was made in the hydrogenolytic 
deprotection of 209. In this case, the corresponding free amino acid 212 was 
obtained in high yield, when the hydrogenation was performed under standard 
conditions. However, extending the reaction time to 12 hours also led to C-C-bond 
cleavage. Hence, with this substrate, the deprotection is substantially faster than the 
ring-opening of the cycloalkyl backbone allowing to isolate the desired cyclobutane 
amino acid in high yield. In the first synthesis of optically active cyclobutane amino 
acid 212, Ortuño and co-workers recently used the methyl ester analogue of ent-192 
as starting material, which was prepared by pig liver esterase-catalyzed 
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chemoselective hydrolysis of the corresponding meso-diester.213,214 Subsequent 
Curtius rearrangement afforded the amino methyl ester equivalent to 209, whose 
saponification required particularly mild reaction conditions due to its tendency to 
epimerize. Finally, hydrogenation led to the highly hygroscopic free amino acid 212 
with 91% ee in 73% yield. It is worthy of note that the last two steps in Ortuño’s 
approach gave products which were unsuitable for microanalysis so our synthetic 
route represents a considerable improvement in terms of product purity, 
enantioselectivity and yield as it provided analytically pure 212 in 93% yield and 93% 
ee. In this context, it should be also mentioned that the ee value of 93% was 
correlated with an optical rotation of [α]rtD = −80 (c = 1.0, H2O), a fact which is in 
contrast with Ortuño’s findings where the ee value of 91% was correlated with [α]rtD = 
−9 (c = 1.5, H2O). However, recent studies from Aitken on the stability of the 
cyclobutane β-amino acid have shown that subjection of the N-Cbz protected β-
amino acid to Ortuño’s deprotection conditions resulted in a mixture of three amino 
acids, of which the least abundant one possesses NMR data identical with those of 
the expected product.215 Recently, an alternative strategy which allowed the 
synthesis of both enantiomers with >97% ee has been described.216 Furthermore, 
(−)-2-aminocyclobutane-1-carboxylic acid 212 has been used by Ortuño for the 
synthesis and structural investigation of conformationally constrained β-
dipeptides.214,217 
 
The application of this new protocol allowed the simplified asymmetric synthesis of 
cispentacin (213), an antifungal antibiotic which was independently isolated a decade 
ago by two Japanese groups from Bacillus cereus and Streptomyces setonii,218 and 
was first prepared enantioselectively by Davies.219 Recrystallization of 208 allowed to 
increase the ee to >99.7%. In our previous approach towards cispentacin, which 
involved the meso-anhydride opening with methanol as nucleophile, epimerization of 
the amino ester during its saponification was observed. Consequently, a mixture of 
diastereomeric products was obtained.181a This problem was solved by employing an 
acidic hydrolysis which yielded the hydrochloric salt of the fungicide. However, in this 
case an additionally ion exchange chromatography was required to liberate the 
unprotected amino acid. 
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While carbon-carbon double bonds in substrates with a cyclohexene backbone do 
not react under these conditions,220 hydrogenation of norbornene amino ester 207 
delivered the saturated amino acid 214. Although quite expensive, racemic 214221 is 
commercially available and was recently used in a Ugi four-center, three-component 
reaction to produce the appropriate β-lactams.222 In addition, a simple and efficient 
direct method for the synthesis of both enantiomers has been developed by Fülöp.223 
Herein, 1,2-dipolar cycloaddition of chlorosulfonyl isocyanate (CSI) to the 
(bicyclo[2.2.1]hept-2-ene) norbornene afforded racemic exo-3-
azatricyclo[4.2.1.02.5]nonan-4-one. Enzyme catalyzed enantioselective ring opening 
of the racemic β-lactam (±)-216 yielded the enantiomerically enriched amino acid ent-
214 and the lactam (1S,2R,5S,6R)-216. Treatment of the lactam (1S,2R,5S,6R)-216 
with 18% HCl furnished enantiopure 214. Furthermore, the unsaturated analogs are 
also available from norbornadiene by following a similar reaction sequence. 
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Scheme 64: Amino Acids Synthesis According to Fülöp. 
 
 
3.3 Chiral bisoxazolines 
 
Over the last few years, C2-symmetric chiral bisoxazolines have proved to be an 
efficient class of ligands in a large variety of asymmetric transformations and several 
general methods are now available for their synthesis.224 C3- and pseudo C3- 
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symmetric trisoxazolines have also been designed and successfully applied in 
asymmetric catalysis.225 
Due to their great potential which was proved in the initial applications, much effort 
has been devoted to the modification of the bisoxazoline framework in order to 
achieve superior ligands. The conformationally constrained metal chelate and the 
presence of stereocenters close to the nitrogen donor atoms assure a well ordered 
chiral environment at the catalytic site. Generally, the chirality in these ligands is 
derived from the optically active β-amino alcohols employed for the oxazoline ring 
formation. Since a large variety of optically pure amino alcohols are easily accessible 
either by simple reduction of the corresponding α-amino acids, or by means of 
asymmetric synthesis employing chiral auxiliaries, the ligand optimization with 
respect to variation of the oxazoline groups encountered no problems so far. The 
size of the chelate also proved to be important since it controls the orientation of the 
substituents around the metal centre. Beside this, the number of possible transition 
states in a particular reaction is minimized by the presence of a C2-symmetry axis in 
the chiral ligand. Among all known C2-symmetric bisoxazolines, the most widely used 
ones are those forming five- and six-membered metal chelates. In contrast, the 
development and application of seven-membered chelate systems is still limited. 
Recently, a new class of 1,4-bisoxazolines with a rigid, chiral, cyclic 1,3-dioxolane 
backbone was introduced and optimized by Andersson for the asymmetric copper-
catalyzed cyclopropanation of olefins.226 Two sets of diastereomeric ligands were 
readily available from L-amino acids and either L- or D- tartaric acid. The effect of 
both, different oxazolinyl groups and different substituents on the dioxolane ring, on 
the reaction diastereo- and enantioselectivity has been carefully investigated. In the 
same context, Knight carried out a direct comparison of the level and sense of 
asymmetric induction in the cyclopropanation and aziridination of styrene.227 
Independently, Ikeda has design such ligands for the rhodium(I) catalyzed 
hydrosilylation of acetophenone.228 
 
C2-symmetric bisoxazolines, bearing a bicyclic chiral backbone, have been 
developed and introduced by Takacs for the room temperature enantioselective 
Diels-Alder reaction.229 For this purpose, enantiomerically pure bicyclo[2.2.1]hept-5-
ene-(2S,3S)-trans-dicarboxylic acid was synthesized by saponification of the diester 
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obtained in the Diels-Alder reaction between cyclopentadiene and L-menthol-derived 
dimenthyl fumarate. Coupling of the diacid with (S)-phenylglycinol and subsequent 
cyclization afforded the 1,4-box ligand containing all four stereogenic centers of (S) 
absolute configuration. Since the (2R,3R)-diacid is also available in optically pure 
form from the same approach, coupling with (S)-phenylglycinol led to a second, 
diastereomeric ligand. 
In a similar fashion, chiral box ligands based on a trans-1,2-cyclohexane skeleton 
were developed and evaluated together with a series of common ligands in the 
palladium(II) asymmetric cyclization-carbonylation of 2-propargyl-1,3-dione.230 
 
 
3.3.1 C2-symmetric chiral bisoxazolines 
 
In chapter 1.4.3 we demonstrated that our desymmetrization methodology offers 
easy access to enantiomerically enriched cis-1,2-dicarboxylic methylmonoesters.180 
Consequently the trans hemiesters and the corresponding diacids are also available 
in optically active form.182,183 This led us to the idea of taking advantage of the 
organocatalytic asymmetric ring opening of cis-cyclopentanedicarboxylic anhydride, 
which would allow us to synthesize novel box ligands with a rigid, chiral, cyclic 
backbone. While designing these compounds, we had in mind several structural 
features which would make them effective in the metal-catalyzed reactions. 
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Scheme 65: Possible Cyclopentane Derivatives. 
 
Firstly, they possess four stereogenic centers, two from the chiral backbone and two 
from the amino alcohol (Scheme 65). The presence of stereogenic centers on the 
backbone in addition to those on the oxazoline rings introduces an extra element of 
complexity in the ligand structure. Since both enantiomers of the diacid are readily 
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available from the desymmetrization reaction, the stereochemistry of the four 
asymmetric centers is easily adjustable, giving us the possibility to investigate and 
compare their effect on the ligand activity. Secondly, the bulkiness of the substituent 
on the oxazoline ring is adjustable by simply changing the amino alcohol so the best 
ligand structure for a particular reaction can be obtained by appropriate selection of 
stereochemistry and bulkiness of the substituent on the oxazoline ring. 
 
Our synthetic route started with the quinidine mediated methanolysis of cis-
cyclopentanedicarboxylic anhydride which afforded the corresponding methyl 
hemiester 219 in very good yield (95%) and high enantioselectivity (96% ee). 
Selective epimerization184,231 and saponification provided the corresponding trans 
(1R,2R)-diacid 220 in 78% yield. Activation of the acid functions and subsequent 
coupling with an optically pure amino alcohol yielded the desired C2-symmetric 
dihydroxy diamide (Scheme 66). The Vilsmeier reagent, chloromethylene 
dimethylammonium chloride, generated in situ from DMF and oxalyl chloride, was 
employed as activating reagent. Conversion of the diacid into the corresponding acid 
dichloride was accomplished within one hour, the solvent and the excess oxalyl 
chloride were removed in high vacuum delivering the product which was used in the 
next step without further purification. Overnight reaction with 2.2 eq. amino alcohol 
and triethylamine afforded the expected bis hydroxyamide as a white solid which was 
insoluble in methylenchloride. All attempts to purify the crude product by an aqueous 
work up therefore failed and the bisamide was isolated in optically and analytically 
pure form by simple filtration and washing with methylenchloride. The NMR-analysis 
confirmed the presence of the desired product as a single diastereomer. 
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Scheme 66: Synthesis of bis-Hydroxyamides from Hemiester 219. 
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Following this general reaction scheme, four derivatives were readily available in 
good yields starting from the diacid 220. Reaction with R- and S-phenylglycinol, 
respectively, afforded the products 221 and 222 as a pair of two diastereomers. 
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Scheme 67: C2-Symmetric Dihydroxy Diamides. 
 
The isopropyl and tert-butyl analogs of 222, derived from amino alcohols of S- 
absolute configuration, were synthesized in order to investigate the effect of different 
substituents on the ligand activity. Since examination of the effect of their different 
orientations around the metal site was desirable, amino alcohols of R configuration 
were next required. Taking in consideration the high cost of R-tert-leucine, and 
consequently R-tert-leucinol, we decided, as an alternative, to synthesize the 
corresponding enantiomer by using the trans (1S,2S)-diacid ent-220 as precursor 
and S-tert-leucinol as coupling partner and leading to the bisoxazoline containing all 
four stereogenic centers of (S) absolute configuration. For this purpose, the 
enantioselective methanolysis was carried out in the presence of quinine, affording 
the hemiester ent-219. Selective epimerization and saponification provided the 
corresponding trans (1S, 2S)-diacid ent-220 in 72% yield. The subsequent activation 
and coupling steps were carried out in the same manner as described above. 
Accordingly three derivatives were readily available in good yields starting from ent-
220 (Scheme 68). 
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Scheme 68: Synthesis of bis-Hydroxyamides from Hemiester ent-219. 
 
With the (R)-phenylglycinol derivative 221 as model substrate the conditions for the 
oxazolin ring closure were optimized (Scheme 69). Activation with thionyl chloride, 
treatment with base and purification afforded the product in 78% yield. Surprisingly, 
no product could be detected under Appel conditions (PPh3, Et3N, CCl4, MeCN). 
Unsatisfactory yield was observed when the bisamide was treated with mesyl 
chloride to give the corresponding bismesylate followed by heating to reflux in an 
aqueous methanolic NaOH solution. However, activation with diethyl amino sulfur 
trifluoride at −78 °C in methylenechloride232 followed by base induced cyclization and 
purification by column chromatography afforded the desired product in 87% yield. We 
therefore decided to apply this set of conditions to all substrates. 
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Scheme 69: Selected Methods for the Oxazolin Ring Closure. 
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Accordingly, four derivatives were isolated in high yields, in optically and analytically 
pure form (Scheme 70). To our surprise, 227 did not cyclize under these mild 
conditions and 223 gave a crude mixture which was not suitable for purification by 
column chromatography. Alternative routes for their cyclization and purification are 
currently being researched. 
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Scheme 70: C2-Symmetric Bisoxazolines. 
 
 
3.3.2 C1-symmetric chiral bisoxazolines 
 
The presence of an acid and an ester functional group in the same molecule allows a 
sequential functionalization. We therefore investigated the possibility of a stepwise 
introduction of two different amino alcohols in the same molecule. This would permit 
the synthesis of C1-symmetric chiral bisoxazolines and demonstrate whether a C2-
symmetric ligand is essential for achieving high levels of diastereo- and 
enantiocontrol for a specific reaction (in the case of a C1-symmetric ligand the 
situation is more complex since the number of possible TS is double). 
 
There are only two examples in the literature for the synthesis of asymmetric 
bisoxazolines.233 Early work from Nishiyama describes the synthesis of an asymmetric 
bisoxazoline ligand by a stepwise introduction of two different amino alcohols on an 
achiral backbone.233a The first coupling step in the sequence made use of dimethyl 
pyridine-2,6-dicarboxylate and 2-aminoethanol, leading to the corresponding achiral 
monoamide methyl ester. A chiral amino alcohol was employed in the second step, to 
give after cyclization, the so-called “single chiral” pybox type ligand. The resulting 
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ligands were evaluated in the ruthenium-catalyzed cyclopropanation of styrene with 
various alkyl diazoacetate and enantioselectivities with up to 94% ee were obtained 
for the trans cyclopropane. More recently, Guiry described the synthesis of a new 
class of tridentate bisoxazoline ligands by a four-step convergent synthesis, 
employing a Hartwig-Buchwald type Pd-catalyzed aryl amination as a key step.233b 
 
Our present approach should allow the introduction of two different chiral amino 
alcohols on the same chiral backbone. In order to validate our design we first 
synthesized the mono amido ester derivative 233 and examined the possibility of 
introducing a second, different amino alcohol into this molecule. Cyanide catalyzed 
trans amidation234 afforded the desired mixed bisamide 234 in only 33% yield after 
chromatographic purification. 
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Scheme 71: Synthesis of mixed-Dihydroxydiamide 234 from trans Hemiester ent-232. 
 
Due to the low yield obtained, even after extended reaction time, we decided to focus 
on alternative protocols which may allow an increase in the reaction yield. Hence, the 
amido ester 233 was converted into the corresponding mono amido acid derivative 
235. The saponification was completed within four hours (t.l.c. controlled) and the 
reaction mixture was acidified and extracted with methylenchloride. Evaporation of 
the solvent and drying in high vacuum afforded the product in 95% yield in 
analytically pure form. 
 
The presence of a free OH group in the molecule excluded the use of activating 
reagents such as thionyl and oxalyl chloride, so use of the mixed anhydride formation 
as activating method was chosen. Activation with isobutyl chloroformate in THF and 
reaction with (S)-phenylglycinol afforded the desired product in 64% yield after 
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chromatographic purification. In comparison with our first approach, the result was 
promising but still not satisfactory, so alternative coupling reagents were investigated. 
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Scheme 72: Synthesis of mixed-Dihydroxydiamide 234 from 233. 
 
Typical coupling reagents such as DCC and EDCI were excluded due to the potential 
problems which could encounter during the purification process. Highly reactive DCC 
is the most widely used reagent for amide bond formation and usually gives good 
yields within short reaction times. However, since the dicyclohexylurea byproduct is 
almost insoluble in most organic solvents used for coupling reactions and taking into 
account the above mentioned product solubility problem (the bis amide proved to be 
insoluble in both water and most of the organic solvents) difficulties in product 
purification were envisaged. Water-soluble derivatives such as 1-ethyl-3-(3’-
dimethylaminopropyl)carbodiimide hydrochloride (EDCI), were also eliminated since 
the purification would require an aqueous extraction in order to remove the urea 
byproduct. 
 
Initially developed as a depressor for the central nervous system,235 1-
ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (236) (EEDQ) also proved to be an 
efficient and selective coupling reagent for the formation of peptide bonds.236 With 
the aid of EEDQ, the carboxylic acid is converted via intermediate A into the highly 
active mixed anhydride B, which reacts with an amino acid (or peptide ester) to form 
the peptide. The byproducts obtained in the reaction are quinoline, ethanol and CO2, 
all easily removable. It was also proved that no racemization occurred during this 
process and that the formation of A is slow, while its consumption by the nucleophile 
is very fast. The great advantage of EEDQ as coupling reagent is that hydroxy amino 
acids do not require side-chain protection under these reaction conditions. 
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Scheme 73: EEDQ as Coupling Reagent. 
 
Taking in consideration the advantages of the above protocol, we decided to apply it 
in test on our substrates under different reaction conditions. Initially, the reactions 
were carried out on a 1 mmol scale and the results are summarized in Scheme 73. In 
a first approach (S)-phenylglycinol was added, as a methylenechloride solution, to 
the precooled solution (0 °C) of the hydroxy amido acid (CH2Cl2 + 20% THF). The 
mixture was then cooled to −15 °C and a solution of EEDQ was added via syringe. 
The reaction was stirred at r.t. for 48 h, the solvent and ethanol byproduct were 
removed in vacuum and the crude mixture was purified by column chromatography, 
yielding the desired product in 82% yield in analytically and diastereomerically pure 
form. Extention of the reaction time to 120 h resulted in a slight increase in the 
reaction yield (86 vs. 82%). In a third approach, the EEDQ was added as a solid to a 
cooled solution (0 °C) of the two reactants in THF. The mixture was allowed to warm 
to r.t. and stirred for 120 h. The product was purified as previously described and 
isolated in 88% yield. After this preliminary investigation, the latter version seemed to 
be more suitable since the reaction was easier to perform compared to the first 
approaches. 
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Scheme 74: Alternative Synthesis of mixed-Dihydroxydiamides 234 and 238 from 233. 
 
 
Furthermore, the reaction scale-up was achieved without any problems, so that 234 
was isolated in good yield (83%) on a 7 mmol scale. In the same manner, reaction of 
235 with (R)-phenylglycinol afforded the corresponding mixed bis-amide 238 in 84% 
yield. Since the two amino alcohols are available in both enantiomeric forms, it 
should be possible to synthesize all four oxazoline combinations of a potential ligand 
with the same chiral backbone. 
 
Since a comparative study on the effect of these two different oxazolinyl substituents 
on the ligand activity and selectivity was desired, our next targets were the two 
remaining bis-amides precursors. Again, in order to avoid the use of expensive (R)-
tert-leucinol, our attention was drawn to the preparation of the corresponding 
enantiomeric ligands which required the opposite stereochemistry in the substrates. 
For this purpose, the same methodology was successfully applied on the hemiester 
obtained from the quinidine mediated methanolysis of cis-cyclopentanedicarboxylic 
anhydride, affording in the end the two mixed dihydroxy diamides 241 and 244 in 
good overall yields (Scheme 75). 
 
 87
Results and Discussion 
COOMe
NH
O
HO
COOMe
NH
O
HO
Ph
COOH
NH
O
HO
COOH
NH
O
HO
Ph
COOMe
COOH
NH
O
NH
O
HO
HO
Ph
 244, 81% y
241, 83% y239, 82% y
242, 80% y
240, 98% y
243, 97% y
NH
O
NH
O
HO
HO
Ph
a)
a)
b)
b)
c)
c)
232
a) (1) 1.5 eq. (COCl)2, 7 mol% DMF; (2) 1.1 eq. Amino alcohol, 2.5 eq. Et3N, CH2Cl2
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Scheme 75: Synthesis of mixed-Dihydroxydiamides from trans Hemiester 232. 
 
Cyclization of these four mixed derivatives under the previously described protocol 
(activation with DAST and subsequent base induced ring closure) afforded the 
corresponding C1-symmetric bisoxazolines in high yields (Scheme 76). 
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Scheme 76: C1-Symmetric Bisoxazolines. 
 
On the one hand these four mixed bisoxazolines offer us the possibility of studying 
the effect induced by a combination between phenyl as substituent on one oxazoline 
ring and the bulky tert-butyl group on the other one. On the other hand the effect 
induced by their different orientation around the metal site is also easy to follow. 
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Compound 247 (Scheme 77) was synthesized in order to study the influence of a 
less bulky group in combination with phenyl on the ligand activity. Unlike all our 
previous mixed substrates, 247 could not be cyclized under the same conditions and 
only traces of the starting material were isolated at the end of the reaction. 
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a) (1) 1.5 eq. (COCl)2, 7 mol% DMF; (2) 1.1 eq. Amino alcohol, 2.5 eq. Et3N, CH2Cl2
b) 3 eq. NaOH/MeOH; c) 1 eq. Amino alcohol, 1.2 eq. EEDQ, THF  
Scheme 77: Synthesis of mixed-Dihydroxydiamide 247 from trans Hemiester 232. 
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3.3.3 Application in catalysis 
 
The enantioselective Diels-Alder reaction229,237 was chosen as the first catalytic test 
reaction in order to determine the efficiency of the new ligand system. The results of 
the room temperature [M(box)]-(OTf)2 catalyzed Diels-Alder reaction between N-
acryloyl oxazolidinone 248 and cyclopentadiene are summarized in Table 6. 
 
Table 6: Influence of Ligand Structure on the Enantioselective Diels-Alder Reaction. 
 
10 mol% M(OTf)2
11 mol% Ligand
r.t., CH2Cl2
ON
OO
(S)
(R)
C
+ +
10 eq. 1 eq. 248
OON
O
C OON
O
249 ent-249  
 
Cu(OTf)2 (12 h) Zn(OTf)2 (36 h) Ligand 
endo:exoa eeb (%) Yield (%) endo:exoa eeb (%) Yield (%) 
L1 52:48 11c 93 85:15 38c 36 
L2 77:23 71 96 85:15 71 99 
L3 − − − − − − 
L4 − − − − − − 
L5 62:38 16 93 86:14 10 33 
L6 66:34 23 91 78:22 0 33 
L7 73:27 17c 98 81:19 55c 99 
L8 − − − − − − 
a Endo:exo ratios were determined by HPLC-analysis and confirmed by NMR. 
b Determined by HPLC-analysis using a chiral stationary phase. 
c Opposite enantiomer. 
 
The catalysts were prepared by stirring a solution of the corresponding ligand (11 
mol%) with the respective metal triflate, M(OTf)2 (10 mol%) in CH2Cl2 at r.t., under 
argon, for 2-3 h. In the case of copper triflate the time was adjusted by checking the 
solution for the presence of colorless, undissolved triflate salt and by the formation, in 
all cases, of a clear, green or blue solution. At this stage the dienophile (0.25 mmol) 
was added, followed by freshly distilled cyclopentadiene (10 eq.). 
In all cases the copper complexes exhibited faster reaction rates, affording the 
products in over 90% yield within 12 h whereas the zinc complexes required longer 
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reaction times, affording products in satisfactory yield in only two cases. On the other 
hand zinc complexes showed a better endo:exo selectivity compared with the copper 
analogs. 
 
Ligand L2, leads to a complex in which the two phenyl substituents are pointing 
toward the metal site and gives the best results in both copper and zinc catalyzed 
Diels-Alder reaction, namely affording the endo product with moderate 
diastereoselectivity and 71% ee. A substantial enhancement in the 
diastereoselectivity (70 vs 54% de) was observed when the zinc complex was 
employed in the reaction. In contrast, the diastereomeric ligand, L1, showed only a 
low level of asymmetric induction, affording the product with opposite absolute 
configuration. 
 
In the case of L3 and L4 the product was detected in only trace amounts, even if the 
reaction time was extended to several days. Since Cu(OTf)2 itself is insoluble in 
methylene chloride and since a clear solution was obtained by mixing it with the 
ligand (L3 and L4, respectively), we assume that copper coordinated to both nitrogen 
atoms, but the presence of the two bulky tert-butyl group did not offer sufficient space 
for the dienophile to approach the metal centre. This is also the case for the mixed 
ligand L8 where the two oxazolinyl groups are pointing toward the metal centre. If we 
compare the structure of our best ligand L2 with the one of ligand L8, it is obvious that 
the only difference between them is the presence of the bulky tert-butyl group instead 
of the planar phenyl group on one oxazoline ring. This slight modification in the ligand 
structure causes finally the change from an active complex into an inactive one. In 
the remaining three mixed ligands, at least one substituent points away from the 
metal site so that the approach of the dienophile is less hindered compared with L8. 
Among them, the metal complex derived from L7 showed the opposite sense of 
asymmetric induction. 
 
The copper complexes derived from the five ligands which showed low to moderate 
activity in the r.t. catalyzed Diels-Alder reaction were next tested in the reaction at 0 
°C. As can be seen in Table 7, the reaction time had to be extended from 12 h to 5 
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days to achieve good yields. Generally, the reaction at 0 °C afforded the endo 
products with slightly higher enantiomeric excesses. 
 
Table 7: Effect of Temperature on the Diels-Alder Reaction. 
 
Cu(OTf)2 (5 d) Ligand 
endo:exoa eeb (%) Yield (%) 
L1 51:49 23 81 
L2 83:17 75 99 
L5 60:40 40 81 
L6 70:30 16 72 
L7 82:18 42c 80 
a Endo:exo ratios were determined by HPLC-analysis and confirmed by NMR. 
b Determined by HPLC-analysis using a chiral stationary phase. 
c Opposite enantiomer. 
 
Next the effect of the counterion on the catalyst activity was investigated. Thus, with 
the bisoxazoline 229 as chiral ligand, different copper sources were tested and it was 
observed that the yield and the endo:exo ratio remained essentially unaffected 
whereas the ee of the endo product dropped down (Table 8). 
 
Table 8: Effect of the Counterion on the Reaction Selectivity. 
 
Copper salt endo:exoa eeb (%) Yield (%) 
Cu(OTf)2 77:23 71 96 
Cu(SbF6)2 81:19 54 99 
Cu(ClO4)2 75:25 46 99 
a Endo:exo ratios were determined by HPLC-analysis and confirmed by NMR. 
b Determined by HPLC-analysis using a chiral stationary phase. 
 
Subsequently, the related hetero Diels-Alder reaction was investigated,238 taking 1,3-
cyclohexadiene and ethyl glyoxalate as test substrates. The chiral metal catalyst was 
prepared by mixing equimolar amounts of Cu(OTf)2 (10 mol%) with the respective 
bisoxazoline ligand (10 mol%) in methylenechloride at r.t. for approximately 2 h. At 
this stage, freshly distilled ethyl glyoxalate was added, followed by 1,3-
 92
Results and Discussion 
cyclohexadiene and the reaction was stirred for 14 h. The results are summarized in 
Table 9. 
 
The [Cu(box)]-(OTf)2 catalyzed reaction of 1,3-cyclohexadiene and ethyl glyoxalate 
provided the HDA-adduct with high diastereoselectivities (>97% endo product) but in 
moderate yields and with low enantioselectivities (30-49% ee as determined by GC-
analysis). It should be noted that the complex derived from ligand L7 resulted in the 
opposite enantioselectivity. 
 
Table 9: Copper Catalyzed Hetero Diels-Alder Reaction. 
 
10 mol% M(OTf)2
10 mol% Ligand
r.t., CH2Cl2
OCO2Et
H
O
O
OEt+
250  
 
Cu(OTf)2 (14 h) Ligand 
endo:exoa eea (%) Yield (%) 
L1 97:3 39 65 
L2 97:3 49 68 
L3 − − − 
L4 − − − 
L5 97:3 45 70 
L6 98:2 30 50 
L7 98:2 37b 55 
L8 − − − 
a Determined by GC-analysis using a chiral chiral stationary phase. 
b Opposite enantiomer. 
 
 
The catalytic behavior of the ruthenium complexes derived from our ligands was next 
investigated in the asymmetric transfer hydrogenation of acetophenone.239 In all 
cases the catalytic system gave only low enantioselectivities (22-26% ee). 
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Table 10: Ruthenium Catalyzed Transfer Hydrogenation. 
 
O
∗
OH
1 mol% [Ru(p-cymene)Cl2]2
4 eq. Ligand
8 eq. KOtBu, iPrOH  
 
[Ru(p-cymene)Cl2]2 (10 h) [Ru(p-cymene)Cl2]2 (10 h) Ligand 
eea (%) Conv. (%) 
Ligand 
eea (%) Conv. (%) 
L1 26 (R) 73 L5 24 (S) 77 
L2 24 (S) 97 L6 22 (R) 51 
L3 0 26 L7 26 (R) 90 
a Determined by GC-analysis using a chiral chiral stationary phase. 
 
 
The enantioselective cyclopropanation of olefins is an area of current interest.104,240 A 
major advance in this field was achieved by Pfaltz, who demonstrated that the Cu(I) 
complexes derived from C2-symmetric chiral semicorrins are useful catalysts for the 
enantioselective cyclopropanation of olefins with diazo compounds.241 Subsequently, 
copper and ruthenium-box complexes emerged as efficient catalysts for the 
enantioselective cyclopropanation reaction.242 Recent reports from Andersson on 
comparative studies on the effect of the chelate ring size on the ligand activity226 
encouraged us to evaluate our set of ligands in the intermolecular cyclopropanation 
reaction. 
 
In a preliminary study, styrene and ethyl diazoacetate were chosen as standard 
substrates in order to determine the efficiency of our ligand system. The 
cyclopropanation was carried out in the presence of 1 mol% CuOTf and 1.05 mol% of 
chiral ligand in dry methylenechloride. The optimum complexation time was 
established to one hour. Then, the catalyst solution was cooled to 0 °C, styrene was 
added, followed by slow addition of the ethyl diazoacetate solution (in 
methylenechloride) over 5 h via syringe pump. The reaction was stirred overnight at 
r.t. and the results are summarized in Table 11. 
 
All four mixed ligands showed low or no asymmetric induction. The two 
diastereomeric C2-symmetric ligands bearing phenyl groups on the oxazoline rings 
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exhibited slightly higher levels of asymmetric induction (but still insufficient) compared 
to the mixed ones, affording the trans products with 36 and 35% ee, respectively. 
 
Table 11: Enantioselective Cyclopropanation of Styrene. 
 
Ph COOEtPh COOEt
1 mol% Cu(OTf)
1.05 mol% Ligand
CH2Cl2, 0 °C-r.t. 251 (1R,2R) 251 (1R,2S)
Ph N2CHCOOEt+ +
10 : 1  
 
Ligand trans:cisa eeb (trans) 
(%) 
eec (cis) 
(%) 
Yield 
(%) 
L1 72:28 36 (1S,2S)d 26(1S,2R) 65 
L2 72:28 35 (1R,2R) 8(1R,2S) 67 
L3 50:50 10 (1S,2S) 9 (1S,2R) 70 
L4 63:37 83 (1R,2R) 87 (1R,2S) 72 
L5 65:35 21 (1R,2R) 20(1R,2S) 68 
L6 63:37 11 (1S,2S) 8 (1R,2S) 63 
L7 66:34 13 (1R,2R) 11(1R,2S) 60 
L8 61:39 0 0 65 
a Trans:cis ratios were determined by NMR-analysis of the crude reaction mixture. 
b Determined by HPLC-analysis using a chiral stationary phase. 
c Determined by optical rotation. 
d The absolute configuration was confirmed by the sign of the optical rotation. 
 
The tert-butyl derivative L4 was the most effective ligand, delivering the trans and cis 
cyclopropanated products with 83 and 87% ee, respectively. Most probably, in this 
particular case, the bulky tert-butyl groups pointing away from the metal centre are 
capable of controlling the olefin approach in an efficient manner, while the planar 
phenyl groups are not. In situ generation of the active Cu(I) catalyst by reduction of 
the Cu(II) complex with phenylhydrazine afforded the products with slightly lower 
enantioselectivities. Addition of the ethyl diazoacetate at r.t. over 5 h also resulted in 
a decrease in the enantioselectivity. In contrast, the diastereomeric ligand L3 afforded 
products with 10 and 9% ee, respectively. This is, most probably, due to the steric 
hindrance induced by two bulky oxazolinyl groups pointing in such a way that does 
not allow the metal to simultaneously coordinate to both nitrogen atoms of the 
oxazoline rings. The reaction is probably catalyzed by free or mono-coordinated Cu 
species, leading to almost racemic products in good yields. 
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Studies concerning the efficiency of the complex derived from L4 in the reaction of 
different diazoacetate esters with various olefins are currently in progress. 
 
 
3.4 Chiral 1,2-diamines 
 
In recent years, the interest in the development of stereocontrolled syntheses of 
chiral 1,2-diamines has increased considerably.243 Vicinal diamines have become 
important synthetic targets, particularly due to their use as intermediates in the 
preparations of important biologically active compounds such as biotin,244 balanol,245 
a broad range of κ-opioid receptor agonists,246 which are used pharmacologically as 
analgesic agents without the clinical side effects that characterize morphine, and 1,2-
diamino platinum complexes, which serve as cytostatic remedies in chemotherapy 
with increased antitumoral activity and less toxicity as compared to cisplatin.247 In 
addition, vicinal diamines have found application in the resolution of racemates,248 as 
chiral auxiliaries in the enantio- and diastereoselective syntheses243 and in the 
preparation of a large number of ligands for asymmetric catalysis including those for 
epoxidations,249 alkene aziridinations,250 epoxide openings,251 Diels-Alder 
reactions252 and transfer hydrogenations.239 In the light of their synthetic significance, 
it is surprising that most of these studies have been focused on the use of a limited 
number of diamines. The most widely applied ones are trans-1,2-diphenylethylene 
diamine (252) and trans-1,2-diaminocyclohexane (253). They are readily accessible, 
and their large-scale preparations have been described in full detail.253 Interestingly, 
the related trans-diamine 254 which has a more rigid norbornane backbone, 
remained almost unnoticed. Since, in contrast to 252 and 253, diamine 254 is C1-
symmetric, special effects could result when ligands stemming from 254 are used in 
asymmetric catalysis. Enantiopure 254 was first isolated only a few years ago, by 
resolution of its racemate with O,O’-dibenzoyltartaric acid.254 Unsatisfyingly, however, 
this approach afforded the tartaric salt of ent-254 in only 16% yield, based on the 
racemate. Hence, a more efficient preparation, which would allow a broader 
application of this interesting 1,2-diamine, was desirable. 
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Scheme 78: Selected Chiral 1,2-Diamines. 
 
As shown in Scheme 79, our overall reaction sequence involved the asymmetric 
desymmetrization of meso-anhydride 160 followed by selective epimerization of cis-
hemiester 176 to its trans-isomer 255,184,231 which is then converted into the 
saturated diacid 256 by saponification and hydrogenation. Activation of the diacid by 
treatment with ethyl chloroformate and triethylamine, followed by addition of an 
aqueous solution of sodium azide afforded the corresponding dicarboxylic diazide 
which was subjected to thermal rearrangement without further purification. Curtius 
degradation of the crude diazide in benzene followed by acidic hydrolysis of the 
resulting isocyanate led to the dihydrochloric salt of diamine 254 in 70% yield. 
 
COOH
COOMe
COOH
COOH
NH2
NH2
HCl
HCl1. H2, Pd/C
256, 88% y
2. 1N NaOH
1. ClCOOEt, Et3N
2. NaN3 (aq.)
3. Benzene, 80 °C
4. 8N HCl
254, 70% y255, 98% ee
 
Scheme 79: Synthesis of the Norbornane-Type Diamine Dihydrochloric Salt 254·2HCl. 
 
The absolute configuration of 254·2HCl was determined by comparison of its sense 
of optical rotation with that reported in the literature.254 Since the value of the optical 
rotation differed strongly from the published data, the enantiomeric ratio of 99:1 was 
confirmed by HPLC analysis of the corresponding ditosylate, using a racemic sample 
of this compound as reference. As a consequence of the stereospecificity of the 
epimerization and the Curtius degradation, the enantiomeric excess of this product 
was identical with the one of the starting material 176. 
 
During the course of our investigations, Trost reported on the application of the 
diphenylphosphinobenzoyl substituted diamine 254 as a ligand in asymmetric allylic 
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alkylations.255 Their synthesis involved a Diels-Alder reaction between (+)-dimenthyl 
fumarate and cyclopentadiene256 followed by saponification of the resulting diester 
and subsequent degradation similar to that shown in Scheme 79. 
 
In contrast to the free diamines,257 the corresponding dihydrochloric salts are stable 
to air and easy to handle. Since treatment of 3·2HCl with KOH and distillation under 
reduced pressure led to the free diamine in only moderate yield,254 the preferred 
method was to liberate 3 in situ by addition of an excess of triethylamine before 
further derivatization. As shown in Scheme 80, direct condensation between 2,4-
dichloro-benzaldehyde and the free diamine 254, led to the salen type ligand 257 in 
excellent yield. 
 
NN
Cl
Cl
Cl
Cl 2,6-dichlorobenzaldehyde
NH2
NH2 HCl
HCl
257, 92% y
Et3N, MeOH
HCl254
 
Scheme 80: Derivatization of the Diamine Dihydrochloric Salt 254·2HCl. 
 
Currently, we are focusing our efforts on the application of this new compound as 
ligand in asymmetric catalysis. 
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4 Summary and outlook 
 
It was demonstrated that the desymmetrization of easily accessible meso-anhydrides 
by cinchona alkaloid-mediated opening with benzyl alcohol258 is applicable to a 
variety of structurally different substrates and leads to the corresponding optically 
active hemiesters with high enantioselectivities (up to 99% ee).200 A simple reaction 
protocol was developed which allows the synthesis of either enantiomer selectively, 
generally without an additional need of purification of the resulting benzyl monoester 
by chromatography or recrystallization. 
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Scheme 81: Stereoselective Desymmetrization: Substrate Spectrum. 
 
The procedure described above is an improved version of previously reported 
alkaloid mediated asymmetric anhydride openings.180,181 An advantage of the present 
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protocol using benzyl alcohol as nucleophile is that it allows the reactions to be 
performed in toluene as solvent, avoiding the use of the previously applied toxic 
carbon tetrachloride. 
 
The synthetic usefulness of the method was demonstrated by the preparation of 
optically active β-amino acids through a reaction sequence involving a Curtius 
degradation as a key step. Their complete deprotection could be obtained in a single 
step by simple hydrogenation enabling the isolation of rather sensitive products.200 
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Scheme 82: Synthesis of Enantiomerically Enriched β-Amino Acids. 
 
In the initial studies a highly efficient protocol for the cinchona alkaloid mediated 
enantioselective methanolysis, leading to a broad variety of hemiesters in excellent 
yields with up to 99% ee has been elaborated. Methylesters of such type have found 
application in the synthesis of mono- and bicyclic β-amino esters,181  γ-amino 
alcohols182 and 1,2-diamines.182,183 
 
As an extension of our work in this field, we have now developed a general strategy 
for the synthesis of optically active C2-symmetric bisoxazolines. Accordingly, four 
cyclopentane derivatives have been prepared in good overall yields (Scheme 83). 
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Scheme 83: C2-Symmetric Bisoxazolines. 
 
Furthermore, the presence of an ester and acid functional group in the 
methylhemiester allows a sequential functionalization. Consequently, C1-symmetric 
bisoxazolines are also readily available in good overall yields (Scheme 84). 
 
Ph
O
N
O
N
O
O
N
N
Ph
O
N
O
N Ph
O
N
O
N
Ph
246 247 248245
O
O
O
 
Scheme 84: C1-Symmetric Bisoxazolines. 
 
The catalytic activity of the copper (II) and zinc (II) complexes derived from these 
eight ligands has been tested in the asymmetric Diels-Alder reaction. In addition, the 
effect of temperature and counterion on the reaction selectivity has been also 
investigated. Enantioselectivities of up to 75% were attained with the copper complex 
derived from the C2-symmetric bisoxazoline 229. Future studies for optimization of 
the ligand structure are currently in progress. 
 
The catalytic behavior of the copper (II) complexes has been evaluated also in the 
related hetero Diels-Alder reaction between 1,3-cyclohexadiene and ethyl glyoxalate. 
The HDA-adducts were obtained always with high diastereoselectivities (>97% endo 
product) and promising enantioselectivities of 30-49% ee (as determined by GC-
analysis). 
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Enantioselective cyclopropanation of styrene was chosen in order to determine the 
efficiency of the [Cu(box)]-(OTf) system. In this context it has been demonstrated that 
the copper (I) complex derived from 231 is capable of controlling the chirality of the 
CH center which comes from the ethyl diazoacetate, delivering the trans and cis 
cyclopropanated products with 83 and 87% ee respectively. 
 
In summary, an efficient method for the asymmetric synthesis of a wide variety of C2- 
and C1-symmetric bisoxazolines was developed. 
 
In future, the same methodology could be also applied in the synthesis of a 
cyclopentane derivative containing a homo chiral backbone and a meso-line 
configuration of the two oxazoline moieties, which could be of beneficial effect in the 
above mentioned catalytic reactions (Scheme 85). 
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Scheme 85: Synthesis of C1-Symmetric Bisoxazolines with a Chiral Backbone and a  
meso-line Configuration of the two Oxazoline Moieties. 
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5 Experimental section 
 
 
5.1 General methods and chemicals 
 
5.1.1 Inert atmosphere conditions 
 
All reactions involving air- or moisture-sensitive compounds were carried out under 
argon using standard Schlenk and vacuum line techniques.259 Glassware were 
heated under vacuum with a heat gun and flushed with argon. Addition of all 
reagents as well as solvents was carried out with glass or polypropylene syringes 
equipped with V2A steel needles under argon steam. Labile chemicals were kept in a 
glove-box or refrigerator and stored under argon. 
 
 
5.1.2 Solvents 
 
The solvents were dried and distilled under argon according to standard 
procedures:260 
 
Acetone:  was purchased from Fluka and used as received. 
Acetonitrile  was purchased from Sigma-Aldrich and used as supplied. 
Benzene:  was purchased from Merck and used as received. 
Benzyl alcohol: was purchased from Sigma-Aldrich and used as supplied. 
CCl4:   was purchased from Merck and used as received. 
CH2Cl2:  was distilled from CaH2 under Ar. 
Diethyl ether: was predried over KOH distilled from sodium benzophenone 
ketyl radical under argon. 
Methanol: analytically pure MeOH required for the desymmetrization was 
purchased from Fluka or Merck and used as supplied.  
THF: was predried over KOH and distilled from sodium benzophenone 
ketyl radical under argon. 
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Toluene: was distilled from sodium benzophenone ketyl radical under 
argon and stored over 4 Å molecular sieves. 
 
Unless otherwise specified, all reagents were purchased from commercial suppliers 
(Acros, Aldrich, Fisher-Scientific, Fluka, Lancaster, Merck, Strem) and used without 
further purification. All the amino acids employed in practice, as well as the Pd/C 
catalyst were received from Degussa. 
 
 
5.1.3 Determination of the physical data 
 
1H NMR-Spectra: 
 
1H NMR-spectra were recorded at room temperature on a Varian VXR 300 (300 
MHz), Varian Gemini 300 (300 MHz) or Inova 400 (400 MHz) spectrometer. The 
chemical shifts are given in ppm using tetramethylsilane (δ = 0.00 ppm) as internal 
standard, and in the absence of tetramethylsilane, they are based on the deuterated 
solvent peak (Acetone δ = 2.09 ppm, Chloroform δ = 7.25 ppm, DMSO δ = 2.50 ppm, 
Methanol δ = 3.34 ppm). The coupling constants J are given in Hertz. The following 
abbreviations are used in order to describe the signals observed in the 1H NMR-
spectra: s (singlet), d (doublet), t (triplet), q (quartet), quin (quintet), m (multiplet), br 
(broad signal). The diastereomeric ratio (dr) was determined by analysis of the 1H 
NMR-spectra of the crude reaction product. 
 
13C NMR-Spectra: 
 
13C NMR-spectra were 1H-broad band-decoupled and measured with a Varian VXR 
300 (75 MHz), Varian Gemini 300 (75 MHz) or Inova 400 (100 MHz) spectrometer. 
The chemical shifts are given in ppm using tetramethylsilane (δ = 0.00 ppm) or the 
deuterated solvent peak as internal standard. 
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Mass spectrometry: 
 
Mass spectra were recorded on a Varian MAT 212 and a Finnigan MAT 95 
spectrometer. All values are given in atomic units of mass per elemental charge 
(m/z). The intensity is given as a percentage of the base peak. 
 
IR-spectroscopy: 
 
Infrared spectra were recorded on a Perkin-Elmer PE-1760 FT apparatus. All bands 
are given in cm−1. Only the strongest bands (50-100%) are listed. 
 
Optical rotation: 
 
Optical rotations were determined on a Perkin Elmer PE-241 instrument at room 
temperature (ca. 20 °C) using solvents of Merck UVASOL-quality. The 
measurements were carried out using a light frequency of 589 nm (D-line of a sodium 
vapour lamp) in a cuvette (length d = 10 cm; concentration c is given in g/100 mL). 
 
Melting point: 
 
Melting Points were measured in open glass capillaries with a Büchi B-540 apparatus 
and are uncorrected. 
 
Elemental analysis: 
 
All microanalyses were conducted on a Heraeus CHN RAPID instrument. All values 
are given as mass percentages. 
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5.1.4 Chromatography 
 
Thin layer chromatography (TLC): 
 
TLC was performed using precoated aluminium backed sheets (Merck silica gel 60 
F254). Detection was performed by using UV radiation (254 nm) or by developing the 
TLC plate with: (a) a basic solution of KMnO4 in water, 
                         (b) an acidic cerium molybdate solution in ethanol. 
 
Column chromatography: 
 
Separations by column chromatography were conducted according to the suggestion 
of Still.261 Silica gel 60 (Merk, mesh 40-63 µm) was employed as stationary phase. All 
solvents have been distilled prior to use. 
 
Analytic HPLC: 
 
For analyses by means of high performance liquid chromatography a HPLC system 
from the company Gynkothek was used. The system comprised a GINA 50 
Autosampler, a UVD170S UV/VIS detector, a M480G pump and a DG503 degassing 
apparatus. The peaks were detected via the pre-set wavelength. Chiral columns (250 
× 4.6 nm) from Daicel Chemical Industries Ltd. were used as stationary phases. 
 
Gas chromatography: 
 
Gas chromatographic analyses with an achiral stationary phase were performed on a 
Hewlett-Packard 5890 Series II gas chromatograph equipped with a split mode 
injection system and a fid detector with mechanical pressure control. The stationary 
phase was an Ultra 2 column from Hewlett-Packard. Gas chromatographic analyses 
for the determination of the enantiomeric excesses were performed on a Hewlett-
Packard 5890 Series II with electronic pressure control (EPC). In order to ensure an 
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unequivocal determination of enantiomeric excesses, the corresponding racemates 
were separately measured as well. All chromatograms were baseline separated. Pre-
columns used were FS-Phenyl-Sil columns (Chromatographie Service GmbH). The 
data acquisition and data integration were performed by a Hewlett-Packard 
ChemStation (Rev.A.05.04[273]) which was connected to the gas chromatographs 
via buffered HP-IB interfaces. When a pressure value is given in conjunction with a 
temperature value the pressure is to be considered as temperature dependent (EPC; 
constant flow). Otherwise the pressure given is meant to be a constant pressure on 
the column. 
The enantiomeric excess of the benzyl esters, as well as of the methyl esters, were 
determined by GC analysis of the corresponding lactones which were obtained by 
selective reduction of the ester group with LiBEt3H followed by acid-catalyzed 
lactonization. Capillary gas chromatograms were obtained using the following column 
and temperature program: Lipodex E: 2,6-O-Dipentyl-3-O-butyryl-γ-cyclodextrin 
(Macherey-Nagel GmbH & Co.KG). Column head pressure: 1.0 bar N2; 100 °C (50 
min), heating rate 3.0 °C/min up to 180 °C (60 min). Injector temperature 200 °C, 
detector temperature 250 °C. 
 
 
5.1.5 Compounds synthesized according to literature procedures 
 
Cis-3,3-dimethylcyclopropane-1,2-dicarboxylic anhydride 172,262 cis-1,2-
cyclopentane-dicarboxylic anhydride 177,263 cis-4,4-dimethylcyclopentane-1,2-
dicarboxylic anhydride 194,264 exo-bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic 
anhydride 201265 were prepared according to literature procedures. 
 
Cis-1,2-cyclobutanedicarboxylic anhydride was obtained by refluxing cis-cyclobutane-
1,2-dicarboxylic acid (Fluka) in trifluoroacetic anhydride (Acros Organics) for 16 h. 
Endo-bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic anhydride 160 and exo-7-oxabicyclo 
[2.2.1]hept-5-ene-2,3-dicarboxylic anhydride 203 were prepared by Diels-Alder 
reaction of maleic anhydride and the corresponding diene. Exo-7-oxabicyclo 
[2.2.1]hept-5-ane-2,3-dicarboxylic anhydride 205 was prepared by hydrogenation of 
the unsaturated analogue 203 over 10% Pd/C. 
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The amino alcohols employed for the bisoxazolines formation were synthesized 
according to Drauz, Meyers and co-workers.266 
 
The racemic hemiesters were prepared by opening with the alcohol nucleophile in the 
presence of 1,4-diazabicyclo[2.2.2]octane (the corresponding alcohol was employed 
as solvent). 
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5.2 Asymmetric anhydride opening 
 
5.2.1 General procedure for the alkaloid-mediated ring opening of cyclic 
meso-anhydrides (GP-1) 
 
Benzyl alcohol (0.310 mL, 3.00 mmol) was added dropwise to a stirred suspension of 
the anhydride (1.00 mmol) and the alkaloid (0.357 g, 1.10 mmol) in a 1:1-mixture of 
toluene and tetrachloromethane (5.0 mL in the case of quinidine, 20.0 mL in the case 
of quinine) at –55 °C under argon. The reaction mixture was stirred at this 
temperature for 60 h. During this period the material gradually dissolved. 
Subsequently, the resulting clear solution was concentrated in vacuum to dryness 
and the resulting residue was dissolved in diethyl ether (10.0 mL). The solution was 
washed with 2 N HCl (3 × 3.0 mL), followed by extraction of the aqueous phase with 
diethyl ether (5 × 5.0 mL) and the combined organic layers were extracted with a 
saturated solution of sodium carbonate (5 × 15.0 mL). The resulting aqueous phase 
was washed with diethyl ether (1 × 25.0 mL) in order to remove traces of benzyl 
alcohol, acidified with conc. HCl, extracted with CH2Cl2 (5 × 20.0 mL) and the organic 
phase was dried over MgSO4, filtered and concentrated providing the corresponding 
hemiester. Analogously, the quinidine- and quinine-mediated opening was performed 
in pure toluene using 5.0 or 10.0 mL solvent/mmol anhydride, respectively. To 
recover the alkaloid, the acidic aqueous phase was neutralized with Na2CO3 and 
extracted with CH2Cl2. The combined organic phases were dried over MgSO4 and 
filtered. Evaporation of the solvent yielded the alkaloid almost quantitatively. 
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5.2.2 Synthesis of (2R,3S)-3-endo-ethoxycarbonyl-bicyclo[2.2.1]hept-5-ene-2-
endo-carboxylic acid (184) 
 
COOCH2CH3
COOH  
 
The product was obtained according to GP-1 from the quinidine opening of anhydride 
160 in the presence of ethanol in 97% yield (204 mg, 0.970 mmol). 
 
Mp: 71 °C (rac), colorless oil (en), lit.267 mp: 74-75 °C (rac). 
[α]rtD = −5.8 (c = 3.13, CHCl3). 
ee = 89% [GC-analysis of the lactone: Lipodex E, t1 = 80.7, t2 = 81.1 (major)]. 
1H NMR (300 MHz, CDCl3): δ = 1.20 (br t, J = 7.2 Hz, 3H), 1.34 (br d, J = 8.6 Hz, 
1H), 1.48 (dt, J = 1.7, 8.6 Hz, 1H), 3.17-3.18 (m, 2H), 3.27 (dd, J = 2.7, 10.1 Hz, 1H), 
3.33 (dd, J = 3.0, 10.1 Hz, 1H), 4.03 (dq, J = 7.1, 10.8 Hz, 1H), 4.07 (dq, J = 7.1, 10.8 
Hz, 1H), 6.21 (dd, J = 3.0, 5.7 Hz, 1H), 6.31 (dd, J = 3.0, 5.7 Hz, 1H), 10.54 (br s, 
1H). 
13C NMR (75 MHz, CDCl3): δ = 14.3, 46.4, 46.8, 48.3, 48.7, 49.0, 60.6, 134.6, 135.7, 
172.6, 179.0. 
IR (KBr): 2980, 1736, 1701, 1259, 1215, 1181 cm−1. 
EI-MS: m/z = 210 (M+, 1), 192 (5), 165 (24), 164 (11), 145 (36), 137 (13), 127 (9), 
119 (21), 99 (22), 91 (22), 66 (100), 65 (11). 
Elemental Analysis for C11H14O4 (210.23):                            Calcd.: C 62.85; H 6.71. 
                                                                                                 Found: C 62.83; H 6.71. 
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5.2.3 Synthesis of 3-endo-(2’,2’,2’-trifluorethoxycarbonyl)-bicyclo[2.2.1]hept-5-
ene-2-endo-carboxylic acid (185) 
 
COOCH2CF3
COOH  
 
The product was obtained according to GP-1 from the quinidine opening of anhydride 
160 in the presence of 2,2,2-trifluoroethanol in 96% yield (254 mg, 0.961 mmol) in a 
racemic form. 
 
Mp: 87.5 °C (rac). 
1H NMR (300 MHz, CDCl3): δ = 1.37 (d, J = 8.6 Hz, 1H), 1.54 (dt, J = 1.7, 8.6 Hz, 
1H), 3.22 (br d, J = 10.1 Hz, 2H), 3.25 (dd, J = 3.0, 10.1 Hz, 1H), 3.41 (dd, J = 3.2, 
10.1 Hz, 1H), 4.23 (dq, J = 8.6, 12.6 Hz, 1H), 4.47 (dq, J = 8.6, 12.6 Hz, 1H), 6.21 
(dd, J = 3.0, 5.4 Hz, 1H), 6.34 (dd, J = 3.0, 5.4 Hz, 1H), 10.39 (br s, 1H). 
13C NMR (75 MHz, CDCl3): δ = 46.1, 46.7, 47.7, 48.2, 48.8, 60.4 (q, J = 36.5 Hz), 
121.2 (q, J = 277.0 Hz), 134.5, 135.6, 171.0, 178.5. 
IR (KBr): 2981, 1757, 1707, 1417, 1312, 1277, 1260, 1230, 1212, 1168, 1088 cm−1. 
EI-MS: m/z = 164 (12), 120 (12), 119 (9), 92 (36), 91 (100). 
Elemental Analysis for C11H11F3O4 (264.20): 
 
 
 
Calcd.: C 50.01; H 4.20. 
Found: C 50.28; H 4.30. 
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5.2.4 Synthesis of (2R,3S)-3-endo-allyloxycarbonyl-bicyclo[2.2.1]hept-5-ene-2-
endo-carboxylic acid (186) 
 
COOH
O
O
 
 
The product was obtained according to GP-1 from the quinidine opening of anhydride 
160 in the presence of allyl alcohol in 97% yield (223 mg, 0.973 mmol). 
 
Mp: 84 °C (rac), colorless oil (en), lit.268 mp: 83 °C (rac). 
[α]rtD = −1.7 (c = 3.20, CHCl3). 
ee = 97% [GC-analysis of the lactone: Lipodex E, t1 = 80.7, t2 = 81.1 (major)]. 
1H NMR (300 MHz, CDCl3): δ = 1.34 (d, J = 8.6 Hz, 1H), 1.49 (dt, J = 1.7, 8.6 Hz, 
1H), 3.18 (br s, 2H), 3.28-3.36 (m, 2H), 4.45 (ddt, J = 1.5, 5.9, 13.1 Hz, 1H), 4.54 
(ddt, J = 1.5, 5.9, 13.1 Hz, 1H), 5.17-5.22 (m, 1H), 5.25-5.32 (m, 1H), 5.87 (ddt, J = 
5.9, 10.4, 16.3 Hz, 1H), 6.21 (dd, J = 3.0, 5.5 Hz, 1H), 6.31 (dd, J = 3.0, 5.5 Hz, 1H), 
10.67 (br s, 1H). 
13C NMR (75 MHz, CDCl3): δ = 46.4, 46.8, 48.3, 48.6, 49.0, 65.5, 118.5, 132.4, 
134.6, 135.7, 172.3, 178.9. 
IR (KBr): 2980, 1736, 1703, 1342, 1261, 1216, 1173, 1153, 930 cm−1. 
EI-MS: m/z = 222 (M+, 2), 204 (3), 176 (6), 165 (7), 157 (31), 139 (16), 137 (13), 119 
(14), 99 (18), 91 (19), 66 (100), 65 (4). 
Elemental Analysis for C12H14O4 (229.24):                            Calcd.: C 64.85; H 6.35. 
                                                                                                 Found: C 64.79; H 6.35. 
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5.2.5 Synthesis of (2R,3S)-3-endo-propargyloxycarbonyl-bicyclo[2.2.1]hept-5-
ene-2-endo-carboxylic acid (187) 
 
COOH
O
O
 
 
The product was obtained according to GP-1 from the quinidine opening of anhydride 
160 in the presence of propargyl alcohol in 97% yield (214 mg, 0.972 mmol). 
 
Mp: 115 °C (rac), colorless oil (en). 
[α]rtD = −1.40 (c = 3.06, CHCl3). 
ee = 79% [GC-analysis of the lactone: Lipodex E, t1 = 80.7, t2 = 81.1 (major)]. 
1H NMR (300 MHz, CDCl3): δ = 1.34 (d, J = 8.6 Hz, 1H), 1.50 (dt, J = 1.7, 8.6 Hz, 
1H), 2.47 (t, J = 2.5 Hz, 1H), 3.19-3.21 (m, 2H), 3.30 (dd, J = 3.0, 10.1 Hz, 1H), 3.37 
(dd, J = 3.2, 10.1 Hz, 1H), 4.53 (dd, J = 2.5, 15.8 Hz, 1H), 4.67 (dd, J = 2.5, 15.8 Hz, 
1H), 6.21 (dd, J = 3.0, 5.7 Hz, 1H), 6.34 (dd, J = 3.0, 5.7 Hz, 1H), 10.70 (br s, 1H). 
13C NMR (75 MHz, CDCl3): δ = 46.3, 46.9, 48.1, 48.4, 49.0, 52.1, 75.1, 77.9, 134.6, 
135.8, 171.8, 178.5. 
IR (KBr): 3284, 1744, 1705, 1344, 1260, 1216, 1169, 1073 cm−1. 
EI-MS: m/z = 220 (M+, 1), 175 (3), 165 (5), 155 (22), 137 (13), 119 (12), 99 (20), 91 
(16), 66 (100). 
Elemental Analysis for C12H12O4 (220.22):                            Calcd.: C 65.45; H 5.49. 
                                                                                                 Found: C 65.24; H 5.60. 
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5.2.6 Synthesis of (2R,3S)-3-endo-benzyloxycarbonyl-bicyclo[2.2.1]hept-5-ene-
2-endo-carboxylic acid (188) 
 
COOBn
COOH  
 
The product was obtained according to GP-1 from the quinidine opening of anhydride 
160 in 92% yield (250 mg, 0.918 mmol) as a white solid. 
 
Mp: 120 °C (rac), 92 °C (en). 
[α]rtD = +8.0 (c = 1.95, CHCl3). 
ee = 97% [GC-analysis of the lactone: Lipodex E, t1 = 80.7, t2 = 81.1 (major)]. 
1H NMR (400 MHz, CDCl3): δ = 1.32 (d, J = 8.5 Hz, 1H), 1.47 (dt, J = 1.7, 8.5 Hz, 
1H), 3.18 (br s, 2H), 3.30-3.32 (m, 2H), 4.92/5.09 (AB-system, J = 12.4 Hz, 2H), 6.21 
(dd, J = 3.0, 5.7 Hz, 1H), 6.28 (dd, J = 3.0, 5.7 Hz, 1H), 7.27-7.36 (m, 5H), 9.50 (br s, 
1H). 
13C NMR (100 MHz, CDCl3): δ = 46.4, 46.8, 48.4, 48.6, 49.0, 66.7, 128.4, 128.6, 
128.7, 134.7, 135.7, 136.2, 172.5, 178.8. 
IR (KBr): 3034, 2989, 2944, 1747, 1701, 1436, 1340, 1262, 1226, 1173, 1143, 1028 
cm−1. 
EI-MS: m/z = 272 (M+, 2), 254 (3), 226 (3), 181 (58), 163 (3), 137 (5), 119 (2), 91 
(100), 66 (20). 
Elemental Analysis for C16H16O4 (272.30):                            Calcd.: C 70.57; H 5.92. 
                                                                                                 Found: C 70.55; H 6.01. 
 
 
5.2.7 Synthesis of (2S,3R)-3-endo-benzyloxycarbonyl-bicyclo[2.2.1]hept-5-ene-
2-endo-carboxylic acid (ent-188) 
 
The product was obtained according to GP-1 from the quinine opening of anhydride 
160 in 93% yield (253 mg, 0.929 mmol) as a white solid. 
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[α]  = −7.4 (c = 1.00, CHCl ). rtD 3
ee = 96% [GC-analysis of the lactone: Lipodex E, t1 = 80.7 (major), t  = 81.1]. 2
 
 
5.2.8 Synthesis of (2R,3S)-3-endo-(4-methoxy-benzyloxycarbonyl)-bicyclo 
[2.2.1]hept-5-ene-2-endo-carboxylic acid (189) 
 
COOH
O
O
OMe  
 
The product was obtained according to GP-1 from the quinidine opening of anhydride 
160 in the presence of p-anisyl alcohol in 93% yield (282 mg, 0.933 mmol). 
 
Mp: 94 °C (rac), colorless oil (en). 
[α]rtD = +7.3 (c = 3.06, CHCl3). 
ee = 97% [GC-analysis of the lactone: Lipodex E, t1 = 80.7, t2 = 81.1 (major)]. 
1H NMR (300 MHz, CDCl3): δ = 1.32 (br d, J = 8.6 Hz, 1H), 1.48 (dt, J = 1.7, 8.6 Hz, 
1H), 3.18 (br d, J = 8.9 Hz, 2H), 3.31-3.32 (m, 2H), 3.79 (s, 3H), 4.87/5.03 (AB-
system, J = 12.1 Hz, 2H), 6.22 (dd, J = 3.0, 5.4 Hz, 1H), 6.28 (dd, J = 3.0, 5.4 Hz, 
1H), 6.84-6.89 (m, 2H), 7.22-7.27 (m, 2H), 10.25 (br s, 1H). 
13C NMR (75 MHz, CDCl3): δ = 46.4, 46.8, 48.4, 48.6, 49.0, 55.5, 66.5, 114.1, 128.3, 
130.4, 134.6, 135.8, 159.8, 172.5, 178.8. 
IR (KBr): 2952, 1733, 1706, 1516, 1265, 1215, 1165, 1073 cm−1. 
EI-MS: m/z = 302 (M+, 8), 121 (100), 91 (6). 
Elemental Analysis for C17H18O5 (302.32):                            Calcd.: C 67.54; H 6.00. 
                                                                                                 Found: C 67.49; H 6.08. 
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5.2.9 Synthesis of (1S,2R)-cis-2-benzyloxycarbonyl-3,3-dimethylcyclopropane-
1-carboxylic acid (190) 
 
COOBn
COOH  
 
The product was obtained according to GP-1 from the quinidine opening of anhydride 
172 in 95% yield (259 mg, 0.951 mmol). 
 
Mp: 79 °C (rac), colorless oil (en). 
[α]rtD = −1.8 (c = 1.58, CHCl3). 
ee = 92% [GC-analysis of the lactone: Lipodex E, column head pressure: 0.6 bar N2, 
100 °C (20 min), heating rate 1.0 °C/min up to 140 °C (20 min), heating rate 20.0 
°C/min up to 180 °C (3 min), t1 = 61.1, t2 = 64.6 (major)]. 
1H NMR (400 MHz, CDCl3): δ = 1.26 (s, 3H), 1.41 (s, 3H), 1.96/1.99 (AB-system, J = 
8.8 Hz, 2H), 5.12/5.17 (AB-system, J = 12.1 Hz, 2H), 7.30-7.38 (m, 5H), 10.60 (br s, 
1H). 
13C NMR (100 MHz, CDCl3): δ = 15.6, 27.7, 28.4, 33.1, 33.1, 67.4, 128.6, 128.7, 
128.8, 135.6, 170.7, 174.1. 
IR (KBr): 3042, 2961, 2881, 1741, 1691, 1502, 1445, 1257, 1191, 1097 cm−1. 
EI-MS: m/z = 248 (M+, 7), 230 (1), 202 (1), 142 (5), 141 (3), 113 (19), 108 (7), 95 (4), 
91 (100), 67 (3), 65 (6). 
Elemental Analysis for C14H16O4 (272.30):                            Calcd.: C 67.73; H 6.50. 
                                                                                                 Found: C 67.67; H 6.54. 
 
 
5.2.10 Synthesis of (1R,2S)-cis-2-benzyloxycarbonyl-3,3-dimethylcyclo-
propane-1-carboxylic acid (ent-190) 
 
The product was obtained from the quinine opening of anhydride 172 in 94% yield 
(257 mg, 0.944 mmol) as a colorless oil. 
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[α]rtD = +1.7 (c = 1.00, CHCl3). 
ee = 88% [GC-analysis of the lactone: Lipodex E, column head pressure: 0.6 bar N2, 
100 °C (20 min), heating rate 1.0 °C/min up to 140 °C (20 min), heating rate 20.0 
°C/min up to 180 °C (3 min), t1 = 61.1 (major), t2 = 64.6]. 
 
 
5.2.11 Synthesis of (1R,2S)-cis-2-benzyloxycarbonyl-cyclobutane-1-carboxylic 
acid (192) 
 
COOBn
COOH  
 
The product was obtained according to GP-1 from the quinidine opening of anhydride 
191 in 90% yield (210 mg, 0.896 mmol). 
 
Mp: 72.5 °C (rac), colorless oil (en), lit.269 mp: 66 °C (rac). 
[α]rtD = −10.9 (c = 1.75, MeOH). 
ee = 93% [GC-analysis of the lactone: Lipodex E, t1 = 64.4 (major), t2 = 64.9]. 
1H NMR (400 MHz, CDCl3): δ = 2.17-2.28 (m, 2H), 2.36-2.45 (m, 2H), 3.41-3.49 (m, 
2H), 5.08/5.13 (AB-system, J = 12.1 Hz, 2H), 7.26-7.36 (m, 5H), 10.10 (br s, 1H). 
13C NMR (100 MHz, CDCl3): δ = 22.4, 22.5, 40.8, 40.9, 66.9, 128.4, 128.5, 128.7, 
135.9, 173.1, 179.3. 
IR (KBr): 2955, 1744, 1700, 1336, 1307, 1242, 1189, 1055 cm−1. 
EI-MS: m/z = 234 (M+, 7), 216 (4), 188 (1), 127 (30), 110 (47), 108 (91), 99 (16), 91 
(100), 82 (13), 77 (9), 66 (19), 55 (34). 
Elemental Analysis for C13H14O4 (234.25):                            Calcd.: C 66.66; H 6.02. 
                                                                                                 Found: C 66.72; H 6.02. 
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5.2.12 Synthesis of (1S,2R)-cis-2-benzyloxycarbonyl-cyclobutane-1-carboxylic 
acid (ent-192) 
 
The product was obtained from the quinine opening of anhydride 191 in 85% yield 
(200 mg, 0.854 mmol) as a colorless oil. 
 
[α]rtD = +11.5 (c = 1.25, MeOH). 
ee = 90% [GC-analysis of the lactone: Lipodex E, t1 = 64.4, t2 = 64.9 (major)]. 
 
 
5.2.13 Synthesis of (1R,2S)-cis-2-benzyloxycarbonyl-cyclopentane-1-
carboxylic acid (193) 
 
COOBn
COOH  
 
The product was obtained according to GP-1 from the quinidine opening of anhydride 
177 in 93% yield (231 mg, 0.930 mmol). 
 
Mp: 37.5 °C (rac), colorless oil (en). 
[α]rtD = +0.6 (c = 1.65, CHCl3), [α]rtD = +1.8 (c = 0.94, MeOH). 
ee = 97% [GC-analysis of the lactone: Lipodex E, t1 = 68.6 (major), t2 = 69.6]. 
1H NMR (300 MHz, CDCl3): δ = 1.56-1.71 (m, 1H), 1.79-2.11 (m, 5H), 3.03-3.14 (m, 
2H), 5.05/5.11 (AB-system, J = 12.4 Hz, 2H), 7.25-7.37 (m, 5H), 11.30 (br s, 1H). 
13C NMR (75 MHz, CDCl3): δ = 24.0, 29.0, 47.1, 66.1, 66.7, 128.4, 128.4, 128.7, 
136.1, 173.9, 180.7. 
IR (capillary): 2961, 1736, 1706, 1183 cm−1. 
EI-MS: m/z = 248 (M+, 8), 230 (6), 202 (9), 141 (46), 108 (100), 107 (89), 95 (19), 91 
(87), 67 (27), 65 (16). 
Elemental Analysis for C14H16O4 (248.27):                            Calcd.: C 67.73; H 6.50. 
                                                                                                 Found: C 67.62; H 6.58. 
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5.2.14 Synthesis of (1S,2R)-cis-2-benzyloxycarbonyl-cyclopentane-1-
carboxylic acid (ent-193) 
 
The product was obtained from the quinine opening of anhydride 177 in 89% yield 
(220 mg, 0.886 mmol) as a colorless oil. 
 
[α]rtD = −1.3 (c = 0.90, MeOH). 
ee = 95% [GC-analysis of the lactone: Lipodex E, t1 = 68.6, t2 = 69.6 (major)]. 
 
 
5.2.15 Synthesis of (1R,2S)-cis-2-benzyloxycarbonyl-4,4-dimethylcyclo- 
pentane-1-carboxylic acid (195) 
 
COOBn
COOH  
 
The product was obtained from the quinidine opening of anhydride 194 according to 
GP-1 with a modified work-up: the crude product, obtained after washing the organic 
layer with 2 N HCl and evaporation of the solvent, was purified by column 
chromatography (pentane:EtOAc, 6:1 to 2:1) to give the hemiester 195 in 78% yield 
(215 mg, 0.778 mmol). 
 
Mp: 61 °C (rac), colorless oil (en). 
[α]rtD = +4.2 (c = 1.00, MeOH). 
ee = 97% [GC-analysis of the lactone: Lipodex E, t1 = 68.2, t2 = 70.0 (major)]. 
1H NMR (300 MHz, CDCl3): δ = 0.90 (s, 3H), 1.03 (s, 3H), 1.69-1.76 (dd, J = 8.2, 
13.4 Hz, 2H), 1.82-1.89 (dd, J = 8.4, 11.4 Hz, 2H), 3.11-3.24 (m, 2H), 4.95/5.05 (AB-
system, J = 12.4 Hz, 2H), 7.20-7.30 (m, 5H), 9.40 (br s, 1H). 
13C NMR (75 MHz, CDCl3): δ = 29.0, 29.7, 38.8, 43.7, 46.3, 66.8, 128.4, 128.5, 
128.7, 136.1, 174.2, 180.8. 
IR (KBr): 2958, 2930, 1736, 1702, 1285, 1207 cm−1. 
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EI-MS: m/z = 276 (M+, 4), 258 (5), 230 (6), 169 (45), 123 (10), 108 (100), 107 (16), 
95 (31), 91 (67), 65 (10). 
Elemental Analysis for C16H20O4 (276.33):                            Calcd.: C 69.54; H 7.30. 
                                                                                                 Found: C 69.53; H 7.19. 
 
 
5.2.16 Synthesis of (1S,2R)-cis-2-benzyloxycarbonyl-4,4-dimethylcyclo- 
pentane-1-carboxylic acid (ent-195) 
 
The product was obtained analogously to 5.2.15 from the quinine opening of 
anhydride 194 in 83% yield (230 mg, 0.832 mmol) as a colorless oil. 
 
[α]rtD = −3.9 (c = 1.00, MeOH). 
ee = 95% [GC-analysis of the lactone: Lipodex E, t1 = 68.2 (major), t2 = 70.0]. 
 
 
5.2.17 Synthesis of (1R,2S)-cis-2-benzyloxycarbonyl-cyclohexane-1-
carboxylic acid (196) 
 
COOBn
COOH  
 
The product was obtained according to GP-1 from the quinidine opening of anhydride 
163 in 88% yield (230 mg, 0.877 mmol) as a colorless oil. 
 
[α]rtD = +2.9 (c = 1.95, CHCl3). 
ee = 95% [GC-analysis of the lactone: Lipodex E, t1 = 71.7 (major), t2 = 73.1]. 
1H NMR (400 MHz, CDCl3): δ = 1.36-1.56 (m, 4H), 1.76-1.80 (m, 2H), 2.01-2.07 (m, 
2H), 2.86-2.89 (m, 2H), 5.09/5.15 (AB-system, J = 12.4 Hz, 2H), 7.26-7.35 (m, 5H), 
10.70 (br s, 1H). 
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13C NMR (100 MHz, CDCl3): δ = 23.9, 24.0, 26.3, 26.5, 42.7, 42.8, 66.6, 128.3, 
128.3, 128.7, 136.2, 173.6, 180.5. 
IR (capillary): 3064, 3034, 2940, 2864, 1733, 1740, 1453, 1256, 1218, 1176 cm−1. 
EI-MS: m/z = 262 (M+, 8), 244 (8), 216 (3), 155 (30), 108 (89), 107 (87), 91 (99), 81 
(40), 45 (100). 
Elemental Analysis for C15H18O4 (262.30):                            Calcd.: C 68.68; H 6.92. 
                                                                                                 Found: C 68.70; H 6.98. 
 
 
5.2.18 Synthesis of (1S,2R)-cis-2-benzyloxycarbonyl-cyclohexane-1-
carboxylic acid (ent-196) 
 
The product was obtained from the quinine opening of anhydride 163 in 84% yield 
(221 mg, 0.843 mmol) as a colorless oil. 
 
[α]rtD = −2.8 (c = 1.09, CHCl3). 
ee = 93% [GC-analysis of the lactone: Lipodex E, t1 = 71.7, t2 = 73.1 (major)]. 
 
 
5.2.19 Synthesis of (1R,2S)-cis-2-benzyloxycarbonyl-cyclohex-4-ene-1-
carboxylic acid (198) 
 
COOBn
COOH  
 
The product was obtained according to GP-1 from the quinidine opening of anhydride 
197 in 84% yield (219 mg, 0.841 mmol). 
 
Mp: 65-67 °C (rac), colorless oil (en). 
[α]rtD = +11.0 (c = 1.13, MeOH). 
ee = 94% [GC-analysis of the lactone: Lipodex E, t1 = 75.1 (major), t2 = 75.7]. 
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1H NMR (300 MHz, CDCl3): δ = 2.32-2.43 (m, 2H), 2.52-2.68 (m, 2H), 3.08-3.13 (m, 
2H), 5.12/5.15 (AB-system, J = 12.4 Hz, 2H), 5.64-5.72 (m, 2H), 7.26-7.37 (m, 5H), 
10.10 (br s, 1H). 
13C NMR (75 MHz, CDCl3): δ = 25.8, 26.0, 39.8, 39.9, 66.8, 125.3, 125.4, 128.3, 
128.4, 128.7, 136.1, 173.3, 180.0. 
IR (capillary): 3031, 2924, 1735, 1707, 1296, 1255, 1190, 1163 cm−1. 
EI-MS: m/z = 260 (M+, 1), 242 (13), 214 (11), 169 (4), 123 (18), 107 (5), 91 (100), 79 
(26), 65 (9). 
Elemental Analysis for C15H16O4 (260.29):                            Calcd.: C 69.22; H 6.20. 
                                                                                                 Found: C 68.83; H 6.27. 
 
 
5.2.20 Synthesis of (1S,2R)-cis-2-benzyloxycarbonyl-cyclohex-4-ene-1-
carboxylic acid (ent-198) 
 
The product was obtained from the quinine opening of anhydride 197 in 84% yield 
(218 mg, 0.838 mmol) as a colorless oil. 
 
[α]rtD = −12.1 (c = 1.00, MeOH). 
ee = 95% [GC-analysis of the lactone: Lipodex E, t1 = 75.1, t2 = 75.7 (major)]. 
 
 
5.2.21 Synthesis of (1R,2S)-cis-2-benzyloxycarbonyl-4,5-dimethylcyclohex-4-
ene-1-carboxylic acid (200) 
 
COOBn
COOH  
 
The product was obtained according to GP-1 from the quinidine opening of anhydride 
199 in 88% yield (255 mg, 0.884 mmol). 
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Mp: 81-83 °C (rac), colorless oil (en). 
[α]rtD = +1.9 (c = 4.87, CHCl3). 
ee = 98% [GC-analysis of the lactone: Lipodex E, t1 = 76.6 (major), t2 = 77.4]. 
1H NMR (300 MHz, CDCl3): δ = 1.60 (s, 6H), 2.27-2.30 (m, 2H), 2.44-2.55 (m, 2H), 
3.03-3.07 (m, 2H), 5.09/5.16 (AB-system, J = 12.4 Hz, 2H), 7.25-7.37 (m, 5H), 9.80 
(br s, 1H). 
13C NMR (75 MHz, CDCl3): δ = 19.1, 19.2, 31.9, 32.1, 40.5, 40.6, 66.7, 124.2, 124.3, 
128.2, 128.3, 128.7, 136.2, 173.4, 180.1. 
IR (capillary): 2916, 2859, 1736, 1706, 1255, 1197, 1173 cm−1. 
EI-MS: m/z = 288 (M+, 12), 270 (3), 242 (5), 197 (33), 179 (15), 151 (86), 107 (100), 
91 (92), 79 (8), 65 (15). 
Elemental Analysis for C17H20O4 (288.34):                            Calcd.: C 70.81; H 6.99. 
                                                                                                 Found: C 70.70; H 6.64. 
 
 
5.2.22 Synthesis of (1S,2R)-cis-2-benzyloxycarbonyl-4,5-dimethylcyclohex-4-
ene-1-carboxylic acid (ent-200) 
 
The product was obtained from the quinine opening of anhydride 199 in 87% yield 
(250 mg, 0.867 mmol) as a colorless oil. 
 
[α]rtD = −2.3 (c = 1.00, CHCl3). 
ee = 97% [GC-analysis of the lactone: Lipodex E, t1 = 76.6, t2 = 77.4 (major)]. 
 
 
5.2.23 Synthesis of (2R,3S)-3-exo-benzyloxycarbonyl-bicyclo[2.2.1]hept-5-ene-
2-exo-carboxylic acid (202) 
 
COOH
COOBn  
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The product was obtained according to GP-1 from the quinidine opening of anhydride 
201 in 95% yield (258 mg, 0.947 mmol). 
 
Mp: 115 °C (rac), 77 °C (en). 
[α]rtD = −24.6 (c = 1.17, CHCl3). 
ee = 96% [GC-analysis of the lactone: Lipodex E, t1 = 73.8, t2 = 74.8 (major)]. 
1H NMR (300 MHz, CDCl3): δ = 1.50 (dt, J = 1.7, 9.1 Hz, 1H), 2.13 (d, J = 9.1 Hz, 
1H), 2.64 (dd, J = 1.7, 9.6 Hz, 1H), 2.69 (dd, J = 1.7, 9.6 Hz, 1H), 3.10-3.13 (m, 2H), 
5.00/5.13 (AB-system, J = 12.4 Hz, 2H), 6.21 (br t, J = 1.7 Hz, 2H), 7.26-7.37 (m, 
5H), 10.40 (br s, 1H). 
13C NMR (75 MHz, CDCl3): δ = 45.6, 45.8, 46.1, 47.7, 47.8, 67.0, 128.4, 128.5, 
128.8, 136.0, 138.2, 138.3, 173.5, 180.2. 
IR (KBr): 2979, 1744, 1694, 1437, 1327, 1259, 1223, 1186, 1151, 1018 cm−1. 
EI-MS: m/z = 272 (M+, 3), 254 (7), 226 (1), 181 (5), 165 (9), 163 (7), 120 (9), 108 
(47), 91 (100), 66 (40). 
Elemental Analysis for C16H16O4 (272.30):                            Calcd.: C 70.57; H 5.92. 
                                                                                                 Found: C 70.67; H 5.99. 
 
 
5.2.24 Synthesis of (2S,3R)-3-exo-benzyloxycarbonyl-bicyclo[2.2.1]hept-5-ene-
2-exo-carboxylic acid (ent-202) 
 
The product was obtained from the quinine opening of anhydride 201 in 81% yield 
(221 mg, 0.812 mmol) as a white solid. 
 
[α]rtD = +21.6 (c = 1.00, CHCl3). 
ee = 92% [GC-analysis of the lactone: Lipodex E, t1 = 73.8 (major), t2 = 74.8]. 
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5.2.25 Synthesis of (2S,3R)-3-exo-benzyloxycarbonyl-7-oxabicyclo[2.2.1]hept-
5-ene-2-exo-carboxylic acid (204) 
 
COOBn
O
COOH
 
 
It was obtained from the quinidine opening of anhydride 203 according to GP-1 with a 
modified work-up: the crude product, obtained after washing the organic layer with 2 
N HCl and evaporation of the solvent, was purified by column chromatography 
(pentane:EtOAc, 2:1 followed by CH2Cl2:Et2O, 1:1 +1% AcOH) to give the hemiester 
204 in 84% yield (230 mg, 0.839 mmol) as a white solid. In order to determine the ee, 
the benzylmonoester was converted by DCC-coupling into the corresponding methyl- 
benzyldiester which has been hydrogenated over Pd/C to yield the saturated 
methylmonoester. Next, the corresponding lactone has been analyzed by GC. 
 
Mp: 121 °C (rac), 123 °C (en). 
[α]rtD = −27.8 (c = 3.23, MeOH). 
ee = 99%. [GC-analysis of the lactone: Lipodex E, t1 = 95.9 (major), t2 = 98.7]. 
1H NMR (300 MHz, CDCl3): δ = 2.84/2.89 (AB-system, J = 8.9 Hz, 2H), 5.06/5.17 
(AB-system, J = 12.4 Hz, 2H), 5.25 (br s, 1H), 5.32 (br s, 1H), 6.43-6.48 (m, 2H), 
7.28-7.38 (m, 5H), 8.50 (br s, 1H). 
13C NMR (75 MHz, CDCl3): δ = 46.9, 47.3, 67.2, 80.4, 80.7, 128.4, 128.5, 128.6, 
135.5, 136.4, 136.8, 171.1, 176.8. 
IR (KBr): 3022, 1737, 1677, 1334, 1313, 1288, 1214, 1198, 1168, 1008 cm−1. 
EI-MS: m/z = 228 (1), 206 (19), 139 (9), 121 (6), 108 (23), 107 (81), 100 (55), 91 
(100), 79 (30), 68 (90), 65 (26), 55 (12), 51 (14). 
Elemental Analysis for C15H14O5 (274.24):                            Calcd.: C 65.69; H 5.15. 
                                                                                                 Found: C 65.69; H 5.33. 
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5.2.26 Synthesis of (2R,3S)-3-exo-benzyloxycarbonyl-7-oxabicyclo[2.2.1]hept-
5-ene-2-exo-carboxylic acid (ent-204) 
 
The product was obtained analogously to 5.2.25 from the quinine opening of 
anhydride 203 in 77% yield (211 mg, 0.769 mmol) as a white solid. 
 
[α]rtD = +29.8 (c = 1.00, MeOH). 
ee = 94% [GC-analysis of the lactone: Lipodex E, t1 = 95.9 t2 = 98.7 (major)]. 
 
 
5.2.27 Synthesis of (2S,3R)-3-exo-benzyloxycarbonyl-7-oxabicyclo[2.2.1] 
heptane-2-exo-carboxylic acid (206) 
 
COOBn
O
COOH
 
 
It was obtained from the quinidine opening of anhydride 205 according to GP-1 with a 
modified work-up: the crude product, obtained after washing the organic layer with 2 
N HCl and evaporation of the solvent, was purified by column chromatography 
(pentane:EtOAc, 2:1 followed by CH2Cl2:Et2O, 1:1 +1% AcOH) to give the hemiester 
206 in 79% yield (218 mg, 0.789 mmol) as a white solid. 
 
Mp: 135 °C (rac), 126 °C (en), lit.270 mp: 122-124 °C (rac). 
[α]rtD = −10.8 (c = 1.00, MeOH). 
ee = 96% [GC-analysis of the lactone: Lipodex E, t1 = 95.9, t2 = 98.7 (major)]. 
1H NMR (400 MHz, CDCl3): δ = 1.42-1.48 (m, 2H), 1.70-1.78 (m, 2H), 2.94/2.97 (AB-
system, J = 9.4 Hz, 2H), 4.81-4.89 (m, 2H), 4.94/5.06 (AB-system, J = 12.4 Hz, 2H), 
7.21-7.30 (m, 5H), 8.20 (br s, 1H). 
13C NMR (100 MHz, CDCl3): δ = 29.3, 52.5, 52.6, 67.3, 78.7, 78.9, 128.5, 128.6, 
128.8, 135.7, 170.8, 176.5. 
IR (KBr): 2982, 1736, 1681, 1332, 1301, 1196, 1001 cm−1. 
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EI-MS: m/z = 276 (M+, 1), 258 (9), 169 (10), 141 (5), 123 (25), 108 (77), 91 (100), 79 
(18), 68 (19), 65 (15). 
Elemental Analysis for C15H16O5 (276.28):                            Calcd.: C 65.21; H 5.84. 
                                                                                                 Found: C 65.32; H 5.96. 
 
 
5.2.28 Synthesis of (2R,3S)-3-exo-benzyloxycarbonyl-7-oxabicyclo[2.2.1] 
heptane-2-exo-carboxylic acid (ent-206) 
 
The product was obtained analogously to 5.2.27 from the quinine opening of 
anhydride 205 in 85% yield (234 mg, 0.847 mmol) as a white solid. 
 
[α]rtD = +10.5 (c = 1.05, MeOH). 
ee = 90% [GC-analysis of the lactone: Lipodex E, t1 = 95.9 (major), t2 = 98.7]. 
 
 
5.3 Synthesis of β-amino acids 
 
5.3.1 General procedure for the preparation of N-Cbz protected amino acid 
benzyl esters (GP-2) 
 
Ethyl chloroformate (2.86 mL, 30.00 mmol) was added to a mixture of the appropriate 
monoester (15.00 mmol) and Et3N (6.27 mL, 45.00 mmol) in dry THF (25.0 mL) at     
–20 °C under argon. The reaction mixture was stirred at this temperature for 1 h. An 
aqueous solution of NaN3 (2.93 g, 45.00 mmol; in 18.0 mL water) was added at –10 
°C. The temperature was gradually increased to r.t. and stirring was continued for 2 
h. The mixture was diluted with water, extracted with ethyl acetate and the organic 
phase was washed with aq. NaHCO3, dried over MgSO4, filtered and concentrated 
providing the corresponding acyl azide. The crude acyl azide was dissolved in 
anhydrous benzene (18.0 mL) and heated under reflux for 2 h. After removal of 
benzene, benzyl alcohol (1.55 mL, 15.00 mmol) and Et3N (4.18 mL, 30.00 mmol) 
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were added to a solution of the isocyanate in dry CH2Cl2 (20.0 mL). The reaction 
mixture was heated under reflux for 4 h. Evaporation of the solvent delivered an oily 
residue which was purified by column chromatography providing the corresponding 
N-protected amino acid benzyl ester. 
 
 
5.3.2 Synthesis of (2S,3R)-3-exo-benzyloxycarbonylamino-bicyclo[2.2.1]hept-
5-ene-2-exo-carboxylic acid benzyl ester (207) 
 
COOBn
NHCbz
 
 
The product was synthesized according to GP-2 by reaction of dicarboxylic acid 
monoester 202 (3.72 g, 13.66 mmol) with benzyl alcohol. The crude reaction product 
was purified by flash chromatography (petroleum ether:EtOAc, 4:1) delivering 207 in 
72% yield (3.73 g, 9.88 mmol) as a white solid. 
 
Mp: 44 °C (en). 
[α]rtD = +17.4 (c = 2.63, CHCl3). 
ee = 93% [HPLC-analysis: Chiralpak AD at r.t., n-heptane:2-propanol = 94:6, 0.5 
mL/min, 254 nm, t1 = 30.1 min, t2 = 46.8 min (major)]. 
1H NMR (300 MHz, CDCl3): δ = 1.57 (dt, J = 1.7, 9.4 Hz, 1H), 1.97 (d, J = 9.4 Hz, 
1H), 2.69 (d, J = 8.4 Hz, 1H), 2.73 (br s, 1H), 2.95 (br s, 1H), 4.03 (t, J = 8.4 Hz, 1H), 
4.95-5.13 (m, 4H), 5.52 (d, J = 9.6 Hz, 1H), 6.15-6.25 (m, 2H), 7.24-7.38 (m, 10H). 
13C NMR (75 MHz, CDCl3): δ = 44.7, 46.2, 46.7, 48.8, 53.5, 66.8, 67.0, 128.3, 128.4, 
128.5, 128.7, 128.8, 135.9, 136.8, 137.5, 138.7, 158.0, 174.3. 
IR (KBr): 3352, 2978, 1718, 1529, 1337, 1267, 1252, 1235, 1189, 1032 cm−1. 
EI-MS: m/z = 353 (M+, 1), 262 (9), 218 (39), 91 (100). 
Elemental Analysis for C23H23NO4 (377.43): 
 
Calcd.: C 73.19; H 6.14; N 3.71. 
Found: C 73.20; H 6.16; N 3.77. 
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5.3.3 Synthesis of (1R,2S)-cis-2-benzyloxycarbonylamino-cyclopentane-1-
carboxylic acid benzyl ester (208) 
 
COOBn
NHCbz
 
 
The product was synthesized according to GP-2 by reaction of dicarboxylic acid 
monoester ent-193 (3.45 g, 13.90 mmol) with benzyl alcohol. The crude reaction 
product was purified by flash chromatography (pentane:EtOAc, 4:1) delivering 208 in 
77% (3.78 g, 10.70 mmol) yield as a white solid. 
 
Mp: 55 °C (rac), 77 °C (en). 
[α]rtD = −41.1 (c = 1.83, CHCl3). 
ee = 94% (99.7% after recrystallization) [HPLC-analysis: Chiralpak AD at r.t., n-
heptane:2-propanol = 90:10, 0.8 mL/min, 254 nm, t1 = 14.9 min (major), t2 = 19.2 
min]. 
1H NMR (300 MHz, CDCl3): δ = 1.55-1.85 (m, 3H), 1.89-2.03 (m, 3H), 3.05 (q, J = 7.2 
Hz, 1H), 4.24-4.34 (m, 1H), 5.00/5.08 (AB-system, J = 18.3 Hz, 2H), 5.02/5.11 (AB-
system, J = 12.4 Hz, 2H), 5.25 (d, J = 8.4 Hz, 1H), 7.26-7.39 (m, 10H). 
13C NMR (75 MHz, CDCl3): δ = 22.1, 27.8, 32.1, 46.8, 54.3, 66.4, 66.6, 128.1, 128.2, 
128.2, 128.5, 128.6, 135.8, 136.5, 155.8, 174.1. 
IR (KBr): 3333, 2950, 1719, 1688, 1529, 1455, 1319, 1244, 1184, 1044 cm−1. 
EI-MS: m/z = 353 (M+, 2), 262 (3), 218 (4), 156 (53), 138 (14), 107 (42), 91 (100). 
Elemental Analysis for C21H23NO4 (353.41): 
 
Calcd.: C 71.37; H 6.56; N 3.96. 
Found: C 71.09; H 6.75; N 4.18.
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5.3.4 Synthesis of (1R,2S)-cis-2-benzyloxycarbonylamino-cyclobutane-1-
carboxylic acid benzyl ester (209) 
 
NHCbz
COOBn  
 
The product was synthesized according to GP-2 by reaction of dicarboxylic acid 
monoester ent-192 (3.28 g, 14.00 mmol) with benzyl alcohol. The crude reaction 
product was purified by flash chromatography (pentane:EtOAc, 6:1) delivering 209 in 
74% yield (3.52 g, 10.37 mmol) as a colorless oil. 
 
[α]rtD = −61.6 (c = 5.00, CHCl3). 
ee = 93% [HPLC-analysis: Chiralpak AD at r.t., n-heptane:2-PrOH = 95:5, 0.5 
mL/min, 254 nm, t1 = 38.9 min (major), t2 = 45.0 min]. 
1H NMR (400 MHz, CDCl3): δ = 1.97-2.03 (m, 2H), 2.23-2.33 (m, 1H), 2.35-2.38 (m, 
1H), 3.45 (s, 1H), 4.57 (p, J = 8.8 Hz, 1H), 5.02/5.08 (AB-system, J = 12.2 Hz, 2H), 
5.10/5.16 (AB-system, J = 12.4 Hz, 2H), 5.69 (d, J = 8.8 Hz, 1H), 7.29-7.38 (m, 10H). 
13C NMR (100 MHz, CDCl3): δ = 19.0, 30.2, 45.6, 46.5, 66.7, 67.0, 128.3, 128.4, 
128.5, 128.7, 128.8, 136.0, 136.6, 155.4, 174.2. 
IR (capillary): 3350, 2952, 1724, 1515, 1334, 1251, 1213, 1169, 1049 cm−1. 
EI-MS: m/z = 311 (4), 220 (5), 204 (14), 177 (7), 132 (8), 107 (7), 91 (100). 
Elemental Analysis for C20H21NO4 (339.39): 
 
Calcd.: C 70.78; H 6.24; N 4.13. 
Found: C 70.64; H 6.17; N 4.41. 
 
 
5.3.5 Synthesis of (1R,2S)-cis-2-benzyloxycarbonylamino-3,3-dimethyl- 
cyclopropane-1-carboxylic acid benzyl ester (210) 
 
COOBn
NHCbz  
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The product was synthesized according to GP-2 by reaction of dicarboxylic acid 
monoester 190 (3.46 g, 13.94 mmol) with benzyl alcohol. The crude reaction product 
was purified by flash chromatography (pentane:EtOAc, 6:1) delivering 210 in 70% 
(3.47 g, 9.82 mmol) yield as a colorless oil. 
 
[α]rtD = −7.3 (c = 5.00, CHCl3). 
ee = 19% [HPLC-analysis: Chiralpak AD at r.t., n-heptane:2-PrOH = 94:6, 0.7 
mL/min, 254 nm, t1 = 17.8 min, t2 = 21.3 min (major)]. 
1H NMR (400 MHz, CDCl3): δ = 1.13 (s, 3H), 1.20 (s, 3H), 1.69 (d, J = 7.7 Hz, 1H), 
3.20 (t, J = 7.4 Hz, 1H), 5.08-5.14(m, 4H), 6.26 (d, J = 6.0 Hz, 1H), 7.27-7.37 (m, 
10H). 
13C NMR (100 MHz, CDCl3): δ = 13.5, 26.2, 26.6, 27.9, 41.5, 66.8, 67.1, 128.3, 
128.5, 128.6, 128.7, 128.8, 136.0, 136.8, 157.1, 171.5. 
IR (capillary): 3401, 2957, 1725, 1510, 1344, 1221, 1154, 1065 cm−1. 
EI-MS: m/z = 353 (M+, 1), 262 (9), 218 (39), 91 (100). 
Elemental Analysis for C21H23NO4 (353.41): 
 
Calcd.: C 71.37; H 6.56; N 3.96. 
Found: C 71.46; H 6.92; N 4.01. 
 
 
5.3.6 General procedure for the synthesis of the deprotected β-amino acids 
(GP-3) 
 
A solution of the N-protected β-amino acid benzyl ester in dry MeOH (4.0 mL/mmol) 
was hydrogenated over 10% Pd/C for 1-2 h at r.t. and at 1 atm. The complete 
conversion of the reaction was monitored by t.l.c., the catalyst was removed by 
filtration through Celite, washed with MeOH and the filtrate was evaporated to give 
the corresponding free amino acid. 
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5.3.7 Synthesis of (2S,3R)-3-exo-amino-bicyclo[2.2.1]heptane-2-exo-carboxylic 
acid (214) 
 
COOH
NH2
0.5 H2O.
 
 
The product was synthesized from β-amino ester 207 (1.68 g, 4.45 mmol) according 
to GP-3 in 97% yield (709 mg, 4.32 mmol) as a white solid. 
 
Mp: (dec) >250 °C (rac), (dec) >250 °C (en), lit.271 mp: 275-278 °C (rac), lit.223 mp: 
198-207 °C (en, 214·HCl). 
[α]rtD = −8.0 (c = 1.40, H2O), lit.223 [α]rtD (214·HCl) = −3.8 (c = 0.30, MeOH). 
1H NMR (300 MHz, D2O): δ = 1.16-1.18 (m, 2H), 1.23 (d, J = 10.9 Hz, 1H), 1.43-1.60 
(m, 2H), 1.66 (d, J = 10.9 Hz, 1H), 2.30 (s, 1H), 2.42 (s, 1H), 2.53 (d, J = 7.9 Hz, 1H), 
3.30 (d, J = 7.9 Hz, 1H). 
13C NMR (75 MHz, D2O): δ = 25.8, 28.0, 33.5, 41.1, 41.9, 51.3, 54.7, 178.9. 
IR (KBr): 3424, 2955, 2676, 1632, 1537, 1395, 1367, 1316 cm−1. 
EI-MS: m/z = 155 (M+, 70), 138 (13), 127 (52), 110 (43), 82 (45), 70 (100), 56 (90). 
Elemental Analysis for C8H13NO2⋅0.5H2O (164.20): 
Calcd.: C 58.52; H 8.59; N 8.53. 
Found: C 58.24; H 8.36; N 8.40. 
HRMS for C8H13NO2:                      Calcd.: 155.094629. 
        Found: 155.094568. 
 
 
5.3.8 Synthesis of (1R,2S)-cis-2-amino-cyclopentane-1-carboxylic acid (213) 
 
COOH
NH2
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The product was synthesized from β-amino ester 208 (1.59 g, 4.50 mmol) according 
to GP-3 in 98% yield (570 mg, 4.41 mmol) as a white solid. 
 
Mp: (dec) 194 °C (rac), (dec) 192 °C (en), lit.219b mp: 194-197 °C (en). 
[α]rtD = −10.1 (c = 2.81, H2O), lit.272 [α]rtD = −9.6 (c = 1.00, H2O). 
1H NMR (300 MHz, D2O): δ = 1.52-1.74 (m, 4H), 1.86-2.00 (m, 2H), 2.71 (dt, J = 6.4, 
8.4 Hz, 1H), 3.56 (dt, J = 4.2, 6.4 Hz, 1H). 
13C NMR (75 MHz, D2O): δ = 21.3, 28.0, 29.5, 47.6, 53.0, 180.8. 
IR (KBr): 3420, 2955, 1627, 1577, 1506, 1461, 1440, 1411, 1311, 1122, 1073 cm−1. 
EI-MS: m/z = 129 (M+, 12), 100 (8), 82 (7), 69 (7), 56 (100). 
Elemental Analysis for C6H11NO2 (129.16): 
 
Calcd.: C 55.80; H 8.58; N 10.84. 
Found: C 55.52; H 8.46; N 11.19. 
 
 
5.3.9 Synthesis of (1R,2S)-cis-2-amino-cyclobutane-1-carboxylic acid (212) 
 
NH2
COOH  
 
The product was synthesized from β-amino ester 209 (1.02 g, 4.35 mmol) according 
to GP-3 in 93% yield (466 mg, 4.05 mmol) as a white solid. 
 
Mp: (dec) 130 °C (en), lit.273 mp: (dec) 129-132 °C (rac), lit.213 mp: (dec) 130 °C (en). 
[α]rtD = −80.0 (c = 1.00, H2O), lit.216 [α]rtD = −70.0 (c = 1.03, H2O). 
1H NMR (300 MHz, D2O): δ = 1.90-2.00 (m, 1H), 2.07-2.30 (m, 3H), 3.09-3.17 (m, 
1H), 3.79-3.86 (m, 1H). 
13C NMR (75 MHz, D2O): δ = 21.1, 25.0, 41.3, 45.5, 181.0. 
IR (KBr): 3433, 2956, 2190, 1541, 1405, 1293 cm−1. 
MS (FAB): 114 (M+-H). 
Elemental Analysis for C5H9NO2 (115.13):             Calcd.: C 52.16; H 7.88; N 12.17. 
                                                                                  Found: C 51.80; H 7.97; N 11.81. 
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5.4 Synthesis of C2-symmetric chiral bis(hydroxyamides) 
 
5.4.1 General procedure for the alkaloid-mediated methanolysis of cyclic 
meso-anhydrides (GP-4) 
 
Methanol (0.122 mL, 3.00 mmol) was added dropwise to a stirred suspension of the 
anhydride (1.00 mmol) and the alkaloid (0.357 g, 1.10 mmol) in a 1:1-mixture of 
toluene and tetrachloromethane (5.0 mL in the case of quinidine, 20.0 mL in the case 
of quinine) at –55 °C under argon. The reaction mixture was stirred at this 
temperature for 60 h. During this period the material gradually dissolved. 
Subsequently, the resulting clear solution was concentrated in vacuum to dryness 
and the resulting residue was dissolved in ethyl acetate (10.0 mL). The solution was 
washed with 2 N HCl (3 × 3.0 mL), followed by extraction of the aqueous phase with 
ethyl acetate (3 × 5.0 mL). The combined organic layer was dried over MgSO4, 
filtered and concentrated to provide the corresponding hemiester. 
 
 
5.4.2 Synthesis of (1R,2S)-cis-2-methoxycarbonyl-4,4-dimethylcyclopentane-1-
carboxylic acid 
 
COOMe
COOH  
 
The product was obtained according to GP-4 from the quinidine opening of anhydride 
194 in 97% yield (195 mg, 0.974 mmol) as a colorless oil. 
 
Mp: 52-53 °C (rac). 
[α]rtD = +4.26 (c = 1.95, CHCl3). 
ee = 94% [GC-analysis of the lactone: Lipodex E, t1 = 68.2, t2 = 70.0 (major)]. 
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1H NMR (400 MHz, CDCl3): δ = 0.98 (s, 3H), 1.11 (s, 3H), 1.74-1.81 (m, 2H), 1.87-
1.93 (m, 2H), 3.18-3.25 (m, 2H), 3.63 (s, 3H), 11.10 (br s, 1H). 
13C NMR (100 MHz, CDCl3): δ = 29.1, 29.7, 38.9, 43.8, 46.3, 46.3, 52.0, 174.6, 
180.8. 
IR (KBr): 3038, 2961, 2875, 1741, 1699, 1474, 1448, 1421, 1320, 1287, 1230, 1208, 
1161, 1044 cm−1. 
EI-MS: m/z = 182 (13), 169 (M+-31, 36), 154 (45), 140 (31), 128 (55), 114 (47), 95 
(100), 81 (29), 55 (26). 
Elemental Analysis for C10H16O4 (200.23): 
 
Calcd.: C 59.98; H 8.05. 
Found: C 59.88; H 7.83. 
 
 
5.4.3 Synthesis of (1S,2R)-cis-2-methoxycarbonyl-4,4-dimethylcyclopentane-1-
carboxylic acid 
 
The product was obtained according to GP-4 from the quinine opening of anhydride 
194 in 95% yield (190 mg, 0.949 mmol) as a colorless oil. 
[α]rtD = −4.14 (c = 2.15, CHCl3). 
ee = 91% [GC-analysis of the lactone: Lipodex E, t1 = 68.2(major), t2 = 70.0]. 
 
 
5.4.4 Synthesis of (1R,2S)-cis-2-methoxycarbonyl-cyclopentane-1-carboxylic 
acid (219) 
 
COOMe
COOH  
 
The product was obtained according to GP-4 from the quinidine opening of anhydride 
177 in 95% yield (6.57 g, 38.16 mmol) as a colorless oil. 
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[α]rtD = +5.68 (c = 0.95, CHCl3), [α]rtD = +8.3 (c = 2.1, MeOH), lit.274 [α]rtD = +1.00 (c = 
1.00, CHCl3), lit.275 [α]rtD = +5.00 (c = 1.40, MeOH). 
ee = 96% [GC-analysis of the lactone: Lipodex E, t1 = 68.6 (major), t2 = 69.6]. 
1H NMR (400 MHz, CDCl3): δ = 1.62-1.70 (m, 1H), 1.86-2.10 (m, 5H), 3.05-3.12 (m, 
2H), 3.67 (s, 3H), 11.45 (br s, 1H). 
13C NMR (100 MHz, CDCl3): δ = 24.0, 28.8, 46.9, 47.0, 51.8, 174.3, 180.4. 
IR (capillary): 2958, 2880, 1737, 1438, 1205 cm−1. 
EI-MS: m/z = 173 (M++1, <2), 154 (35), 141 (M+-31, 77), 126 (40), 113 (57), 95 (36), 
67(100). 
Elemental Analysis for C8H12O4 (172.18): 
 
Calcd.: C 55.81; H 7.02. 
Found: C 55.86; H 7.04. 
 
 
5.4.5 Synthesis of (1S,2R)-cis-2-methoxycarbonyl-cyclopentane-1-carboxylic 
acid (ent-219) 
 
The product was obtained according to GP-4 from the quinine opening of anhydride 
177 in 94% yield (3.23 g, 18.76 mmol) as a colorless oil. 
 
[α]rtD = −8.0 (c = 2.67, MeOH). 
ee = 93% [GC-analysis of the lactone: Lipodex E, t1 = 68.6, t2 = 69.6 (major)]. 
 
 
5.4.6 Synthesis of (1R,2R)-2-methoxycarbonyl-cyclopentane-1-carboxylic acid 
(232) 
 
COOMe
COOH  
 
A freshly prepared LDA solution (3.0 eq.) in absolute THF (0.75 mL/mmol LDA) was 
added dropwise, over 1.5 h, to a stirred solution of the monomethylester 219 (5.165 
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g, 30.00 mmol) in absolute THF (45.0 mL) at –78 °C under argon. After the complete 
addition, the mixture was stirred at this temperature for 4 h, acidified with 4 N aq. HCl 
and extracted with ethylacetate. The combined organic phases were dried over 
MgSO4, concentrated, and the residue was purified by column chromatography 
(pentane:Et2O, 4:1) to yield 4.135 g (24.02 mmol, 80%) of the title compound as a 
colorless oil. 
 
[α]rtD = −83.6 (c = 3.60, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 1.72-1.94 (m, 4H), 2.05-2.16 (m, 2H), 3.12-3.22 (m, 
2H), 3.72 (s, 3H), 10.70 (br s, 1H). 
13C NMR (100 MHz, CDCl3): δ = 25.3, 30.3, 30.6, 46.8, 47.0, 52.0, 175.1, 180.6. 
IR (capillary): 2959, 2878, 1736, 1708, 1439, 1298, 1203 cm−1. 
EI-MS: m/z = 173 (M++1, <2), 154 (43), 141 (M+-31, 40), 126 (70), 112 (45), 95 (50), 
67 (100), 55(15). 
Elemental Analysis for C8H12O4 (172.18): 
 
Calcd.: C 55.81; H 7.02. 
Found: C 55.84; H 6.88. 
 
 
5.4.7 Synthesis of (1S,2S)-2-methoxycarbonyl-cyclopentane-1-carboxylic acid 
(ent-232) 
 
The product was prepared analogously to 5.4.6, from the cis hemiester ent-219 in 
76% yield (2.035, 11.82 mmol). 
 
[α]rtD = +76.3 (c = 1.07, CHCl3). lit.276 [α]rtD = +84.0 (c = 0.60, MeOH). 
 
 
5.4.8 General procedure for the ester hydrolyses (GP-5) 
 
A solution of the corresponding methyl ester in MeOH (4.0 mL/mmol) was treated 
with NaOH (1N, 3.0 eq.) and stirred at r.t. for 4 h. The mixture was acidified with 2 N 
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HCl and extracted with CH2Cl2. The combined organic layers were dried over 
MgSO4, filtered, and concentrated to provide the desired product. The product 
obtained by this way was used in the next step without further purification. 
 
 
5.4.9 Synthesis of (1R,2R)-cyclopentane-1,2-dicarboxylic acid (220) 
 
COOH
COOH  
 
It was synthesized from trans hemiester 232 (4.305 g, 25.00 mmol) according to GP-
5. The product was obtained as a white solid in 97% yield (3.835 g, 24.25 mmol). 
 
Mp: 184-185 °C. 
[α]rtD = −75.7 (c = 0.65, acetone). 
1H NMR (400 MHz, Acetone-d6): δ = 1.55-1.62 (m, 2H), 1.65-1.74 (m, 2H), 1.89-1.97 
(m, 2H), 2.95-3.01 (m, 2H), 10.20 (br s, 2H). 
13C NMR (100 MHz, Acetone-d6): δ = 25.5, 30.5, 47.0, 175.5. 
IR (KBr): 2985, 2887, 2663, 1704, 1420, 1287, 1223 cm−1. 
EI-MS: m/z = 159 (M++1, <2), 140 (41), 112 (100), 99(29), 95 (29), 86 (11), 67 (99), 
55 (16). 
Elemental Analysis for C7H10O4 (158.15): 
 
Calcd. : C 53.16; H 6.37. 
Found: C 53.17; H 6.41. 
 
 
5.4.10 Synthesis of (1S,2S)-cyclopentane-1,2-dicarboxylic acid (ent-220) 
 
It was synthesized from trans hemiester ent-232 (1.722 g, 10.00 mmol) according to 
GP-5. The product was obtained as a white solid in 95% yield (1.498 g, 9.47 mmol). 
 
[α]rtD = +73.5 (c = 1.00, acetone). 
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5.4.11 General procedure for the synthesis of various C2-symmetric 
bis(hydroxyamides) (GP-6) 
 
Oxalyl chloride (2.56 mL, 30.00 mmol, 3.0 eq.) was added dropwise to a cooled 
suspension (0 °C) of the trans diacid (1.58 g, 10.00 mmol) and dimethylformamide 
(15%) in CH2Cl2 (50.0 mL) under argon. Gas evolution was accompanied by the 
formation of a clear, pale yellow solution which was stirred at r.t. for 1 h. The solvent 
and excess oxalyl chloride were removed in high vacuum, the solid residue was 
taken up in CH2Cl2 (40.0 mL) and added slowly, via syringe, to a cooled solution (0 
°C) of the corresponding amino alcohol (22.00 mmol, 2.2 eq.) and Et3N (6.93 mL, 
50.00 mmol, 5.0 eq.) in CH2Cl2 (50.0 mL) under argon. Stirring was continued for 16 
h at r.t., and it was accompanied by the formation of a white solid. The solid was 
filtered, washed with CH2Cl2 and dried in high vacuum to provide the corresponding 
bis(hydroxyamide). 
 
 
5.4.12 Synthesis of (1R,2R)-cyclopentane-1,2-dicarboxylic acid bis-[(2’-
hydroxy-1’-(R)-phenyl-ethyl)-amide] (221) 
 
NH
NH
O
Ph
HO
HO
Ph
O
 
 
It was synthesized according to GP-6 on a 10.00 mmol scale by reaction of (1R,2R)-
cyclopentane-dicarbonyl dichloride and (R)-phenylglycinol (3.018 g, 22.00 mmol, 2.2 
eq.). The product was obtained in 62% yield (2.466 g, 6.22 mmol) as a white solid. 
 
Mp: (dec) 240-243 °C. 
[α]rtD = −162.5 (c = 1.00, DMSO). 
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1H-NMR (400 MHz, CD3OD): δ = 1.68-1.75 (m, 4H), 1.96-2.01 (m, 2H), 3.00-3.04 (m, 
2H), 3.68 (dd, J = 7.7, 11.3 Hz, 2H), 3.73 (dd, J = 5.2, 11.3 Hz, 2H), 4.98 (dd, J = 5.2, 
7.7 Hz, 2H), (3.68/3.73/4.98 ABX-system), 7.20-7.25 (m, 2H), 7.30 (d, J = 4.4 Hz, 
8H). 
13C-NMR (100 MHz, CD3OD): δ = 25.5, 31.0, 49.2, 56.0, 65.1, 126.7, 127.1, 128.3, 
140.0, 176.0. 
IR (KBr): 3310, 2957, 1647, 1547, 1039 cm−1. 
EI-MS: m/z = 365 (M+-31, 100), 260 (56), 233 (12), 167 (12), 140 (49), 121 (43), 106 
(84), 95(14). 
Elemental Analysis for C23H28N2O4 (396.48):           Calcd.: C 69.67; H 7.12; N 7.07. 
                                                                                    Found: C 69.43; H 7.13; N 7.03. 
 
 
5.4.13 Synthesis of (1R,2R)-cyclopentane-1,2-dicarboxylic acid bis-[(2’-
hydroxy-1’-(S)-phenyl-ethyl)-amide] (222) 
 
NH
NH
O
Ph
HO
HO
Ph
O
 
 
It was synthesized according to GP-6 on a 10.00 mmol scale by reaction of (1R,2R)-
cyclopentane-dicarbonyl dichloride and (S)-phenylglycinol (3.018 g, 22.00 mmol, 2.2 
eq.). The product was isolated in 70% yield (2.780 g, 7.01 mmol) as a white solid. 
 
Mp: (dec) 235-237 °C. 
[α]rtD = +31.5 (c = 1.10, MeOH). 
1H-NMR (400 MHz, DMSO-d6): δ = 1.58-1.71 (m, 4H), 1.91-1.97 (m, 2H), 2.92-2.98 
(m, 2H), 3.47 (dd, J = 6.9, 11.0 Hz, 2H), 3.53 (dd, J = 5.8, 11.0 Hz, 2H), (3.47/3.53 
AB part of an ABX-system), 4.79 (t, J = 5.8 Hz, 2H), 4.81 (q, J = 8.0 Hz, 2H), 7.16-
7.23 (m, 10H), 8.02 (d, J = 8.2 Hz, 2H). 
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13C-NMR (100 MHz, DMSO-d6): δ = 25.3, 31.2, 47.5, 58.8, 64.5, 126.2, 126.5, 127.6, 
140.9, 173.6. 
IR (KBr): 3296, 3066, 2951, 2871, 1645, 1618, 1547, 1251, 1051 cm−1. 
EI-MS: m/z = 365 (M+-31, 100), 260 (53), 233 (8), 167 (12), 140 (68), 121 (40), 106 
(73), 95(15). 
Elemental Analysis for C23H28N2O4 (396.48):           Calcd.: C 69.67; H 7.12; N 7.07. 
                                                                                    Found: C 69.71; H 7.40; N 6.95. 
 
 
5.4.14 Synthesis of (1R,2R)-cyclopentane-1,2-dicarboxylic acid bis-[(2’-
hydroxy-1’-(S)-tert-butyl-ethyl)-amide] (224) 
 
NH
O
NH
O
HO
HO  
 
It was synthesized according to GP-6 on a 10.00 mmol scale by reaction of (1R,2R)-
cyclopentane-1,2-dicarbonyl dichloride and (S)-tert-leucinol (2.578 g, 22.00 mmol, 
2.2 eq.). The product was isolated in 70% yield (2.511 g, 7.04 mmol) as a white solid. 
 
Mp: 210-213 °C. 
[α]rtD = −42.7 (c = 1.10, MeOH). 
1H-NMR (400 MHz, CD3OD): δ = 0.90 (s, 18H), 1.71-1.85 (m, 4H), 2.06-2.12 (m, 2H), 
3.00-3.07 (m, 2H), 3.44 (dd, J = 9.6, 12.1 Hz, 2H), 3.74-3.80 (m, 4H), 7.52 (d, J = 9.4 
Hz, 2H). 
13C-NMR (100 MHz, CD3OD): δ = 25.5, 26.2, 31.6, 33.5, 49.1, 59.6, 61.2, 176.6. 
IR (KBr): 3319, 2959, 2875, 1649, 1547, 1475, 1369, 1245, 1054 cm−1. 
EI-MS: m/z = 357 (M++H, 3), 325 (M+-31, 56), 299 (17), 281 (14), 263 (12), 240 
(100), 222 (7), 212 (6), 194 (3), 140 (6), 100 (9), 86 (16). 
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Elemental Analysis for C19H36N2O4 (356.50):          Calcd.:C 64.01; H 10.18; N 7.86. 
                                                                                  Found: C 63.92; H 10.13; N 7.80. 
 
 
5.4.15 Synthesis of (1S,2S)-cyclopentane-1,2-dicarboxylic acid bis-[(2’-
hydroxy-1’-(S)-tert-butyl-ethyl)-amide] (225) 
 
NH
O
NH
O
HO
HO  
 
It was synthesized according to GP-6 on a 5.00 mmol scale by reaction of (1S,2S)-
cyclopentane-1,2-dicarbonyl dichloride and (S)-tert-leucinol (1.289 g, 11.00 mmol, 
2.2 eq.). The product was isolated in 65% yield (1.163 g, 3.26 mmol) as a white solid. 
 
Mp: (dec) >250 °C. 
[α]rtD = +76.6 (c = 0.50, MeOH). 
1H-NMR (300 MHz, CD3OD): δ = 0.95 (s, 9H), 1.77-2.08 (m, 6H), 2.95-3.04 (m, 2H), 
3.40-3.48 (m, 2H), 3.78-3.86 (m, 4H). 
13C-NMR (75 MHz, CD3OD): δ = 25.6, 25.8, 30.6, 33.2, 49.4, 59.6, 60.7, 176.8. 
IR (KBr): 3291, 2957, 2871, 1640, 1555, 1461, 1397, 1368, 1249, 1050, 1023 cm−1. 
EI-MS: m/z = 357 (M++H, 7), 325 (M+-31, 53), 299 (15), 281 (14), 263 (21), 240 
(100), 222 (11), 212 (7), 194 (6), 140 (8), 100 (8), 86 (15). 
Elemental Analysis for C19H36N2O4 (356.50):         Calcd.: C 64.01; H 10.18; N 7.86. 
                                                                                  Found: C 63.70; H 10.41; N 7.60. 
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5.4.16 Synthesis of (1R,2R)-cyclopentane-1,2-dicarboxylic acid bis-[(2’-
hydroxy-1’-(S)-isopropyl-ethyl)-amide] (223) 
 
NH
O
NH
O
HO
HO  
 
It was synthesized according to GP-6 on a 5.00 mmol scale by reaction of (1R,2R)-
cyclopentane-1,2-dicarbonyl dichloride and (S)-valinol (1.135 g, 11.00 mmol, 2.2 eq.). 
The product was isolated in 70% yield (1.157 g, 3.52 mmol) as a white solid. 
 
Mp: 242 °C. 
[α]rtD = +32.3 (c = 0.60, MeOH). 
1H-NMR (400 MHz, CD3OD): δ = 0.85 (d, J = 6.9 Hz, 6H), 0.89 (d, J = 6.6 Hz, 6H), 
1.70-1.87 (m, 6H), 1.98-2.06 (m, 2H), 2.92-2.99 (m, 2H), 3.51 (dd, J = 6.3, 11.3 Hz, 
2H), 3.55 (dd, J = 4.7, 11.3 Hz, 2H), (3.51/3.55 AB part of an ABX-system), 3.65 (td, 
J = 4.7, 6.3 Hz, 2H). 
13C-NMR (100 MHz, CD3OD): δ = 17.7, 18.8, 25.1, 28.6, 31.3, 49.1, 56.6, 61.7, 
175.9. 
IR (KBr): 3305, 2958, 2873, 1637, 1545, 1243, 1073 cm−1. 
EI-MS: m/z = 297 (M+-31, 64), 279 (17), 226 (100), 208 (8), 198 (6), 140 (5), 104 (8), 
95 (12), 86 (21). 
HRMS for C17H32N2O4-CH2OH+:                                                    Calcd.: 297.217818. 
                                                                                                       Found: 297.217839. 
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5.4.17 Synthesis of (1S,2S)-cyclopentane-1,2-dicarboxylic acid bis-[(2’-
hydroxy-1’-(S)-isopropyl-ethyl)-amide] (226) 
 
NH
O
NH
O
HO
HO  
 
It was synthesized according to GP-6 on a 5.00 mmol scale by reaction of (1S,2S)-
cyclopentane-1,2-dicarbonyl dichloride and (S)-valinol (1.135 g, 11.00 mmol, 2.2 eq.). 
The product was isolated in 66% yield (1.089 g, 3.31 mmol) as a white solid. 
 
Mp: 225.5-226 °C. 
[α]rtD = +32.3 (c = 0.60, MeOH). 
1H-NMR (400 MHz, CD3OD): δ = 0.91 (d, J = 6.8 Hz, 6H), 0.95 (d, J = 6.6 Hz, 6H), 
1.80-1.89 (m, 6H), 2.02-2.04 (m, 2H), 2.95-2.98 (m, 2H), 3.52 (dd, J = 6.6, 11.3 Hz, 
2H), 3.61 (dd, J = 4.1, 11.3 Hz, 2H), (3.52/3.61 AB part of an ABX-system), 3.69-3.73 
(m, 2H). 
13C-NMR (100 MHz, CD3OD): δ = 17.6, 18.8, 25.4, 28.8, 30.9, 49.2, 56.7, 61.9, 
176.1. 
IR (KBr): 3274, 2952, 2873, 1638, 1556, 1245, 1074 cm−1. 
EI-MS: m/z = 297 (M+-31, 61), 279 (19), 226 (100), 208 (9), 198 (8), 180 (4), 168 (7), 
140 (6), 130 (5), 95 (12). 
Elemental Analysis for C17H32N2O4 (328.45):           Calcd.: C 62.17; H 9.82; N 8.53. 
                                                                                    Found: C 62.07; H 9.94; N 8.43. 
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5.4.18 Synthesis of (1S,2S)-cyclopentane-1,2-dicarboxylic acid bis-[(2’-
hydroxy-1’-(S)-methyl-ethyl)-amide] (227) 
 
HO
O
NH
NH
O
HO
 
 
It was synthesized according to GP-6 on a 5.00 mmol scale by reaction of (1S,2S)-
cyclopentane-1,2-dicarbonyl dichloride and (S)-alaninol (0.826 g, 11.00 mmol, 2.2 
eq.). The product was isolated in 74% yield (1.014 g, 3.72 mmol) as a white solid. 
 
Mp: 213-215 °C. 
[α]rtD = +51.5 (c = 0.27, MeOH). 
1H-NMR (400 MHz, CD3OD): δ = 1.12 (d, J = 6.6 Hz, 6H), 1.74-1.82 (m, 4H), 1.94-
2.04 (m, 2H), 2.83-2.90 (m, 2H), 3.45 (dd, J = 5.7, 11.0 Hz, 2H), 3.48 (dd, J = 5.2, 
11.0 Hz, 2H), (3.45/3.48 AB part of an ABX-system), 3.91-3.99 (m, 2H). 
13C-NMR (100 MHz, CD3OD): δ = 15.8, 25.3, 30.7, 48.3, 49.3, 64.9, 175.5. 
IR (KBr): 3281, 2972, 2950, 1633, 1550, 1250, 1087, 1052 cm−1. 
EI-MS: m/z = 273 (M++1, 8), 241 (M+-31, 58), 198 (100), 180 (21), 170 (8), 152 (4), 
140 (9), 102 (12), 95 (11). 
Elemental Analysis for C13H24N2O4 (272.34):         Calcd.: C 57.33; H 8.88; N 10.29. 
                                                                                  Found: C 57.16; H 9.17; N 10.33. 
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5.5. Synthesis of C1-symmetric chiral bis(hydroxyamides) 
 
5.5.1 Synthesis of (1S,2S)-2-[2’-hydroxy-1’-(S)-tert-butyl-ethylcarbamoyl]-
cyclopentane-1-carboxylic acid methyl ester (233) 
 
COOMe
NH
O
HO
 
 
Oxalyl chloride (3.55 mL, 42.00 mmol, 1.5 eq.) was added dropwise with gas 
evolution to a cooled solution (0 °C, ice bath) of the trans hemiester ent-232 (4.821 g, 
28.00 mmol) and dimethylformamide (7%) in CH2Cl2 (112.0 mL) under argon. The 
reaction mixture was stirred for 1 h at r.t., followed by removal of the solvent and 
excess oxalyl chloride in high vacuum. The residue was taken up in CH2Cl2 (90.0 mL) 
and added via syringe to a cooled solution (0 °C) of (S)-tert-leucinol (3.610 g, 30.80 
mmol, 1.1 eq.) and Et3N (9.7 mL, 70.00 mmol, 2.5 eq.) in CH2Cl2 (112.0 mL) under 
argon. After stirring at r.t. overnight, the reaction mixture was acidified with 2 N HCl 
and the aqueous layer was extracted with CH2Cl2. The combined organic layers were 
dried over MgSO4, filtered and concentrated to give the crude product as a yellow 
solid. Purification by column chromatography (pentane:EtOAc, 1:2) yielded 6.582 g 
(24.26 mmol, 87 % yield) of the title compound as a white solid. 
 
Mp: 137-138 °C. 
[α]rtD = +36.1 (c = 1.00, CHCl3). 
1H-NMR (400 MHz, CDCl3): δ = 0.96 (s, 9H), 1.67-1.86 (m, 3H), 1.91-2.01 (m, 2H), 
2.07-2.15 (m, 1H), 2.70 (br s, 1H), 2.88 (q, J = 8.8 Hz, 1H), 3.10 (q, J = 8.8 Hz, 1H), 
3.52 (dt, J = 3.0, 9.1 Hz, 1H), 3.71 (s, 3H), 3.80-3.85 (m, 2H), 6.16 (d, J = 8.5 Hz, 
1H). 
13C-NMR (100 MHz, CDCl3): δ = 25.1, 26.8, 29.8, 30.0, 33.3, 48.3, 48.8, 52.1, 59.8, 
63.0, 175.3, 176.1. 
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IR (KBr): 3304, 3248, 3086, 2873, 1734, 1636, 1567, 1432, 1356, 1193, 1174, 1055 
cm−1. 
EI-MS: m/z = 272 (M++H, 7), 240 (100), 214 (22), 196 (13), 182 (7), 155 (29), 127 
(7), 95 (21), 86 (70), 67 (19). 
Elemental Analysis for C14H25NO4 (271.35): 
 
Calcd.: C 61.97; H 9.29; N 5.16. 
Found: C 62.05; H 9.05; N 5.04. 
 
 
5.5.2 Synthesis of (1R,2R)-2-[2’-hydroxy-1’-(S)-tert-butyl-ethylcarbamoyl]-
cyclopentane-1-carboxylic acid methyl ester (239) 
 
COOMe
NH
O
HO  
 
Oxalyl chloride (1.02 mL, 12.0 mmol, 1.5 eq.) was added dropwise with gas evolution 
to a cooled solution (0 °C, ice bath) of the trans hemiester 232 (1.378 g, 8.00 mmol) 
and dimethylformamide (7%) in CH2Cl2 (32.0 mL) under argon. The reaction mixture 
was stirred for 1 h at r.t., followed by removal of the solvent and excess oxalyl 
chloride in high vacuum. The residue was taken up in CH2Cl2 (24.0 mL) and added 
via syringe to a cooled solution (0 °C) of (S)-tert-leucinol (1.031 g, 8.80 mmol, 1.1 
eq.) and Et3N (2.77 mL, 20.00 mmol, 2.5 eq.) in CH2Cl2 (32.0 mL) under argon. After 
stirring at r.t. overnight, the reaction mixture was acidified with 2 N HCl and the 
aqueous layer was extracted with CH2Cl2. The combined organic layers were dried 
over MgSO4, filtered and concentrated to give the crude product as a yellow solid. 
Purification by column chromatography (pentane:EtOAc, 1:2) yielded 1.772 g (6.53 
mmol, 82% yield) of the title compound as a white solid. 
 
Mp: 101-102 °C. 
[α]rtD = −68.2 (c = 1.00, CHCl3). 
 147
Experimental Part 
1H-NMR (400 MHz, CDCl3): δ = 0.94 (s, 9H), 1.69-1.97 (m, 4H), 2.00-2.13 (m, 2H), 
2.60 (br s, 1H), 2.90-3.02 (m, 2H), 3.54 (dd, J = 8.0, 10.7 Hz, 1H), 3.71 (s, 3H), 3.80-
3.88 (m, 2H), 6.18 (d, J = 8.2 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ = 25.3, 26.8, 29.4, 30.6, 33.4, 48.5, 48.5, 52.0, 59.8, 
63.4, 175.3, 175.9. 
IR (KBr): 3266, 2957, 2873, 1741, 1642, 1568, 1442, 1348, 1267, 1234, 1200, 1143, 
1054 cm−1. 
EI-MS: m/z = 272 (M++H, 24), 240 (M+-31, 100), 214 (24), 196 (18), 182 (10), 155 
(28), 127 (9), 95 (25), 86 (83), 67 (23). 
Elemental Analysis for C14H25NO4 (271.35): 
 
Calcd.: C 61.97; H 9.29; N 5.16. 
Found: C 61.80; H 9.46; N 4.98. 
 
 
5.5.3 Synthesis of (1R,2R)-2-[2’-hydroxy-1’-(R)-phenyl-ethylcarbamoyl]-
cyclopentane-1-carboxylic acid methyl ester (242) 
 
COOMe
NH
O
HO
Ph
 
 
Oxalyl chloride (2.54 mL, 30.00 mmol, 1.5 eq.) was added dropwise with gas 
evolution to a cooled solution (0 °C, ice bath) of the trans hemiester 232 (3.444 g, 
20.00 mmol) and dimethylformamide (7%) in CH2Cl2 (80.0 mL) under argon. The 
reaction mixture was stirred for 1 h at r.t., followed by removal of the solvent and 
excess oxalyl chloride in high vacuum. The residue was taken up in CH2Cl2 (60.0 mL) 
and added via syringe to a cooled solution (0 °C) of (R)-phenylglycinol (3.018 g, 
22.00 mmol, 1.1 eq.) and Et3N (6.93 mL, 50.00 mmol, 2.5 eq.) in CH2Cl2 (80.0 mL) 
under argon. After stirring at r.t. overnight, the reaction mixture was acidified with 2 N 
HCl and the aqueous layer was extracted with CH2Cl2. The combined organic layers 
were dried over MgSO4, filtered and concentrated to give the crude product as a 
yellow solid. Purification by column chromatography (pentane:EtOAc, 1:2) yielded 
4.667 g (16.02 mmol, 80 % yield) of the title compound as a white solid. 
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Mp: 101-102 °C. 
[α]rtD = −84.0 (c = 1.10, CHCl3). 
1H-NMR (400 MHz, CDCl3): δ = 1.58-1.90 (m, 2H), 1.98-2.07 (m, 2H), 2.84 (q, J = 8.5 
Hz, 1H), 3.01(t, J = 5.5 Hz, 1H), 3.05 (q, J = 8.5 Hz, 1H), 3.63 (s, 3H), 3.71-3.77 (m, 
2H), 4.98 (dt, J = 4.4, 7.2 Hz, 1H), 6.64 (d, J = 7.2 Hz, 1H), 7.19-7.30 (m, 5H). 
13C-NMR (100 MHz, CDCl3): δ = 25.4, 30.2, 30.4, 48.2, 48.7, 52.2, 56.0, 66.6, 126.7, 
127.8, 128.8, 139.1, 174.7, 176.1. 
IR (KBr): 3255, 3081, 3031, 2956, 1731, 1638, 1570, 1453, 1439, 1257, 1199, 1172, 
1083, 1047 cm−1. 
EI-MS: m/z = 260 (M+-31, 74); 200 (3), 155 (8), 127 (4), 120 (6), 106 (100), 95 (17), 
67 (17). 
Elemental Analysis for C16H21NO4 (291.34): 
 
Calcd.: C 65.96; H 7.27; N 4.81. 
Found: C 65.95; H 7.04; N 4.81. 
 
 
5.5.4 Synthesis of (1R,2R)-2-[2’-hydroxy-1’-(S)-methyl-ethylcarbamoyl]-
cyclopentane-1-carboxylic acid methyl ester (245) 
 
COOMe
NH
O
HO  
 
Oxalyl chloride (1.02 mL, 12.00 mmol, 1.5 eq.) was added dropwise with gas 
evolution to a cooled solution (0 °C, ice bath) of the trans hemiester 232 (1.378 g, 
8.00 mmol) and dimethylformamide (7%) in CH2Cl2 (32.0 mL) under argon. The 
reaction mixture was stirred for 1 h at r.t., followed by removal of the solvent and 
excess oxalyl chloride in high vacuum. The residue was taken up in CH2Cl2 (24.0 mL) 
and added via syringe to a cooled solution (0 °C) of (S)-alaninol (0.661 g, 8.80 mmol, 
1.1 eq.) and Et3N (2.77 mL, 20.00 mmol, 2.5 eq.) in CH2Cl2 (32.0 mL) under argon.  
After stirring at r.t. overnight, the reaction mixture was acidified with 2 N HCl and the 
aqueous layer was extracted with CH2Cl2. The combined organic layers were dried 
over MgSO4, filtered and concentrated to give the crude product as a yellow solid. 
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Purification by column chromatography (pentane:EtOAc, 1:2) yielded 1.512 g (6.59 
mmol, 82% yield) of the title compound as a white solid. 
 
Mp: 83.5-84.5 °C. 
[α]rtD = −74.6 (c = 0.82, CHCl3). 
1H-NMR (300 MHz, CDCl3): δ = 1.16 (d, J = 6.9 Hz, 3H), 1.64-1.84 (m, 3H), 1.89-
1.97 (m, 2H), 2.04-2.16 (m, 1H), 2.85 (q, J = 8.6 Hz, 1H), 3.04 (q, J = 8.6 Hz, 1H), 
3.13 (br s, 1H), 3.53 (dd, J = 6.0, 10.9 Hz, 1H), 3.64 (dd, J = 3.7, 10.9 Hz, 1H), 
(3.53/3.64 AB part of an ABX-system), 3.70 (s, 3H), 4.04 (qdd, J = 3.7, 6.7, 13.6 Hz, 
1H), 6.20 (d, J = 6.2 Hz, 1H). 
13C-NMR (75 MHz, CDCl3): δ = 17.0, 25.4, 30.1, 30.5, 47.9, 48.0, 48.5, 52.0, 175.1, 
176.1. 
IR (KBr): 3272, 2958, 1734, 1642, 1558, 1447, 1392, 1240, 1203, 1044 cm−1. 
EI-MS: m/z = 230 (M++1, 26), 198 (M+-31, 100), 155 (81), 127 (13), 95 (39), 67 (35). 
Elemental Analysis for C11H19NO4 (229.27): 
 
Calcd.: C: 57.62; H: 8.35; N: 6.11. 
Found: C: 57.49; H: 8.30; N: 5.97. 
 
 
5.5.5 Synthesis of (1S,2S)-2-[2’-hydroxy-1’-(S)-tert-butyl-ethylcarbamoyl]-
cyclopentane-1-carboxylic acid (235) 
 
COOH
NH
O
HO
 
 
The title compound was synthesized from 233 (3.528 g, 13.00 mmol) according to 
GP-5. The product was obtained as a white solid in 95% yield (3.177 g, 12.34 mmol). 
 
Mp: 147 °C. 
[α]rtD = +46.5 (c = 1.03, acetone). 
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1H-NMR (400 MHz, Acetone-d6): δ = 0.92 (s, 9H), 1.60-1.75 (m, 2H), 1.77-1.89 (m, 
2H), 1.94-2.06 (m, 2H), 2.98 (q, J = 8.5 Hz, 1H), 3.10 (q, J = 8.5 Hz, 1H), 3.51 (dd, J 
= 8.0, 11.3 Hz, 1H), 3.70 (dd, J = 3.8, 11.3 Hz, 1H), (3.51/3.70 AB part of an ABX-
system), 3.81 (ddd, J = 3.8, 8.0, 9.6 Hz, 1H), 6.90 (br s, 1H). 
13C-NMR (100 MHz, Acetone-d6): δ = 25.1, 26.5, 29.6, 31.0, 33.7, 47.1, 48.6, 59.4, 
61.6, 174.9, 175.6. 
IR (KBr): 3244, 3088, 2961, 2872, 1701, 1637, 1569, 1369, 1295, 1250, 1054 cm−1. 
EI-MS: m/z = 226 (M+-31, 86), 200 (34), 182 (16), 141 (13), 95 (21), 86 (100), 67 
(22), 60 (58). 
Elemental Analysis for C13H23NO4 (257.33): 
 
Calcd.: C 60.68; H 9.01; N 5.44. 
Found: C 60.32; H 8.77; N 5.45. 
 
 
5.5.6 Synthesis of (1R,2R)-2-[2’-hydroxy-1’-(S)-tert-butyl-ethylcarbamoyl]-
cyclopentane-1-carboxylic acid (240) 
 
COOH
NH
O
HO  
 
The title compound was synthesized from 239 (1.357 g, 5.00 mmol) according to GP-
5. The product was obtained as a white solid in 98% yield (1.265 g, 4.92 mmol). 
 
Mp: 134-135 °C. 
[α]rtD = −55.9, (c = 0.56, acetone). 
1H-NMR (400 MHz, Acetone-d6): δ = 0.94 (s, 9H), 1.63-2.10 (m, 6H), 3.00 (q, J = 8.2 
Hz, 1H), 3.06 (q, J = 8.2 Hz, 1H), 3.55 (dd, J = 7.7, 11.3 Hz, 1H), 3.74 (dd, J = 3.8, 
11.3 Hz, 1H), (3.55/3.74 AB part of an ABX-system), 3.82 (dd, J = 3.8, 7.7 Hz, 1H). 
13C-NMR (100 MHz, Acetone-d6): δ = 26.0, 27.3, 30.9, 31.2, 34.5, 48.3, 49.3, 59.8, 
62.2, 175.4, 176.3. 
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IR (KBr): 3462, 3287, 2960, 2876, 1710, 1619, 1585, 1473, 1424, 1395, 1246, 1222, 
1057 cm−1. 
EI-MS: m/z = 258 (M++1, 19), 226 (M+-31, 91), 208 (11), 200 (30), 182 (17), 141 (10), 
95 (18), 86 (100), 67 (22), 60 (57). 
Elemental Analysis for C13H23NO4 (257.33): 
 
Calcd.: C: 60.68; H: 9.01; N: 5.44. 
Found: C: 60.42; H: 9.24; N: 5.25. 
 
 
5.5.7 Synthesis of (1R,2R)-2-[2’-hydroxy-1’-(R)-phenyl-ethylcarbamoyl]-
cyclopentane-1-carboxylic acid (243) 
 
COOH
NH
O
HO
Ph
 
 
The title compound was synthesized from 242 (4.224 g, 14.50 mmol) according to 
GP-5. The product was obtained as a white solid in 97% yield (3.893 g, 14.04 mmol). 
 
Mp: 133-134 °C. 
[α]rtD = −96.9 (c = 1.00, acetone). 
1H-NMR (400 MHz, Acetone-d6): δ = 1.58-1.79 (m, 3H), 1.82-1.90 (m, 1H), 1.96-2.09 
(m, 2H), 3.07 (q, J = 8.0 Hz, 1H), 3.14 (q, J = 8.0 Hz, 1H), 3.74-3.78 (m, 2H), 5.02-
5.07 (m, 1H), 7.21-7.40 (m, 5H), 7.58 (br s, 1H). 
13C-NMR (100 MHz, Acetone-d6): δ = 26.0, 30.6, 31.6, 47.6, 49.1, 56.5, 66.2, 127.6, 
127.6, 128.8, 141.7, 174.8, 176.2. 
IR (KBr): 3302, 2956, 2870, 1701, 1652, 1548, 1452, 1387, 1301, 1270, 1051 cm−1. 
EI-MS: m/z = 246 (M+-31, 61); 201 (5), 141 (4), 120 (7), 106 (100), 95 (11), 67 (12). 
Elemental Analysis for C15H19NO4 (277.32): 
 
Calcd.: C 64.95; H 6.91; N 5.05. 
Found: C 64.57; H 6.89; N 4.94. 
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5.5.8 Synthesis of (1R,2R)-2-[2’-hydroxy-1’-(S)-methyl-ethylcarbamoyl]-
cyclopentane-1-carboxylic acid (246) 
 
COOH
NH
O
HO  
 
The title compound was synthesized from 245 (1.146 g, 5.00 mmol) according to GP-
5. The product was obtained as a white solid in 98% yield (1.053 g, 4.89 mmol). 
 
Mp: 139.5-141 °C. 
[α]rtD = −66.5 (c = 0.52, acetone). 
1H-NMR (400 MHz, Acetone-d6): δ = 1.10 (d, J = 6.6 Hz, 3H), 1.60-2.02 (m, 6H), 
2.91 (q, J = 8.2 Hz, 1H), 3.07 (q, J = 8.2 Hz, 1H), 3.45 (dd, J = 5.2, 10.7 Hz, 1H), 3.50 
(dd, J = 5.5, 10.7 Hz, 1H), (3.45/3.50 AB part of an ABX-system), 3.92-3.99 (m, 1H). 
13C-NMR (100 MHz, Acetone-d6): δ = 16.5, 25.3, 29.9, 30.9, 46.9, 47.3, 48.4, 65.4, 
174.2, 175.3. 
IR (KBr): 3303, 2975, 2871, 1712, 1646, 1562, 1451, 1293, 1235, 1202, 1098 cm−1. 
EI-MS: m/z = 216 (M++1, 54), 198 (11), 184 (M+-31, 100), 166 (4), 158 (5), 140 (13), 
124 (4), 113 (8), 95 (42), 67 (49). 
HRMS for C10H17NO4: 
 
Calcd.: 215.115758. 
Found: 215.115782. 
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5.5.9 Synthesis of (1S,2S)-cyclopentane-1,2-dicarboxylic acid 1-[(2’-hydroxy-
1’-(S)-tert-butyl-ethyl)-amide]-2-[(2’-hydroxy-1’-(S)-phenyl-ethyl)-amide] 
(234) 
 
NH
O
NH
O
HO
HO
Ph
 
 
Solid EEDQ (2.08 g, 8.40 mmol, 1.2 eq.) was added at 0 °C to a solution of 235 (1.80 
g, 7.00 mmol) and (S)-phenylglycinol (0.960 g, 7.00 mmol, 1.0 eq.) in dry THF (70.0 
mL) and the mixture was stirred at r.t. for 5 days. The solvent was removed in 
vacuum and the crude reaction product was purified by column chromatography 
(pentane:EtOAc, 1:1 + 5% MeOH) delivering the title compound in 83% yield (2.190 
g, 5.82 mmol) as a white solid. 
 
Mp: 185-188 °C. 
[α]rtD = +117.2 (c = 1.00, MeOH). 
1H-NMR (400 MHz, CD3OD): δ = 0.92 (s, 9H), 1.71-1.86 (m, 4H), 1.96-2.05 (m, 2H), 
2.99 (q, J = 8.0 Hz, 1H), 3.05 (q, J = 8.0 Hz, 1H), 3.46 (dd, J = 8.8, 11.0 Hz, 1H), 3.66 
(dd, J = 8.2, 11.5 Hz, 1H), 3.73 (dd, J = 5.0, 11.5 Hz, 1H), (3.66/3.73 AB part of an 
ABX-system), 3.77-3.84 (m, 2H), 5.01 (dd, J = 5.0, 8.2 Hz, 1H), 7.22-7.26 (m, 1H), 
7.31 (d, J = 4.4 Hz, 4H). 
13C-NMR (100 MHz, CD3OD): δ = 25.6, 26.0, 30.5, 31.2, 33.4, 49.0, 49.5, 55.8, 59.6, 
61.0, 64.9, 126.5, 127.0, 128.1, 139.8, 175.9, 176.5. 
IR (KBr): 3291, 2959, 1640, 1553, 1249, 1050 cm−1. 
EI-MS: m/z = 345 (M+-31, 100), 327 (7), 319 (13), 260 (40), 240 (76), 213 (14), 194 
(8), 157 (8), 140 (41), 121 (23), 106 (52), 95 (18), 86 (23). 
Elemental Analysis for C21H32N2O4 (376.49):           Calcd.: C 66.99; H 8.57; N 7.44. 
                                                                                    Found: C 66.96; H 8.58; N 7.26. 
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5.5.10 Synthesis of (1S,2S)-cyclopentane-1,2-dicarboxylic acid 1-[(2’-hydroxy-
1’-(S)-tert-butyl-ethyl)-amide]-2-[(2’-hydroxy-1’-(R)-phenyl-ethyl)-amide] 
(238) 
 
NH
O
NH
O
HO
HO
Ph
 
 
Solid EEDQ (2.08 g, 8.40 mmol, 1.2 eq.) was added at 0 °C to a solution of 235 (1.80 
g, 7.00 mmol) and (R)-phenylglycinol (0.960 g, 7.00 mmol, 1.0 eq.) in dry THF (70.0 
mL) and the mixture was stirred at r.t. for 5 days. The solvent was removed in 
vacuum and the crude reaction product was purified by column chromatography 
(pentane:EtOAc, 1:1 + 5% MeOH) delivering the title compound in 86% yield (2.281 
g, 6.06 mmol) as a white solid. 
 
Mp: 143.5-145 °C. 
[α]rtD = +4.2 (c = 1.15, MeOH). 
1H-NMR (300 MHz, CD3OD): δ = 0.90 (s, 9H), 1.71-1.91 (m, 4H), 1.99-2.13 (m, 2H), 
2.97 (q, J = 8.2 Hz, 1H), 3.12 (q, J = 8.2 Hz, 1H), 3.38 (dd, J = 8.4, 11.4 Hz, 1H), 
3.64-3.78 (m, 4H), 4.94 (dd, J = 5.4, 7.4 Hz, 1H), 7.20-7.27 (m, 1H), 7.31 (d, J = 4.4 
Hz, 4H). 
13C-NMR (75 MHz, CD3OD): δ = 25.1, 25.9, 30.6, 31.5, 33.4, 48.2, 48.9, 55.8, 59.3, 
61.2, 64.8, 126.6, 126.8, 128.1, 139.8, 176.1, 176.2. 
IR (KBr): 3308, 2960, 2873, 1646, 1544, 1457, 1368, 1244, 1049 cm−1. 
EI-MS: m/z = 345 (M+-31, 100), 327 (8), 319 (13), 260 (36), 240 (69), 213 (8), 194 
(6), 157 (8), 140 (50), 121 (26), 106 (42), 95 (18), 86 (22). 
HRMS for C21H32N2O4-CH2OH+:                                                    Calcd.: 345.217817. 
                                                                                                       Found: 345.217812. 
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5.5.11 Synthesis of (1R,2R)-cyclopentane-1,2-dicarboxylic acid 1-[(2’-hydroxy-
1’-(S)-tert-butyl-ethyl)-amide]-2-[(2’-hydroxy-1’-(R)-phenyl-ethyl)-amide] 
(244) 
 
NH
O
NH
O
HO
HO
Ph
 
 
Solid EEDQ (2.08 g, 8.40 mmol, 1.2 eq.) was added at 0 °C to a solution of 243 
(1.941 g, 7.00 mmol) and (S)-tert-leucinol (0.820 g, 7.00 mmol, 1.0 eq.) in dry THF 
(70.0 mL) and the mixture was stirred at r.t. for 5 days. The solvent was removed in 
vacuum and the crude reaction product was purified by column chromatography 
(pentane:EtOAc, 1:1 + 5% MeOH) delivering the title compound in 81% yield (2.131 
g, 5.66 mmol) as a white solid. 
 
Mp: 158-160 °C. 
[α]rtD = −135.5 (c = 0.40, MeOH). 
1H-NMR (400 MHz, CD3OD): δ = 0.94 (s, 9H), 1.62-1.92 (m, 4H), 1.99-2.12 (m, 2H), 
2.97-3.09 (m, 2H), 3.48 (dd, J = 9.3, 12.1 Hz, 1H), 3.70 (dd, J = 6.3, 11.3 Hz, 1H), 
3.73 (dd, J = 6.9, 11.3 Hz, 1H), (3.70/3.73 AB part of an ABX-system), 3.77-3.81 (m, 
2H), 4.95 (t, J = 6.3 Hz, 1H), 7.24-7.32 (m, 1H), 7.33 (d, J = 4.4 Hz, 4H). 
13C-NMR (100 MHz, CD3OD): δ = 24.9, 26.1, 30.3, 31.4, 33.5, 48.8, 49.6, 55.7, 59.4, 
61.1, 64.8, 126.6, 126.9, 128.0, 140.0, 175.3, 176.2. 
IR (KBr): 3275, 3083, 2960, 2872, 1635, 1554, 1455, 1368, 1351, 1243, 1051 cm−1. 
EI-MS: m/z = 345 (M+-31, 100), 327 (8), 319 (14), 260 (39), 240 (74), 213 (12), 194 
(9), 157 (8), 140 (42), 121 (29), 106 (53), 95 (19), 86 (20). 
Elemental Analysis for C21H32N2O4 (376.49):           Calcd.: C 66.99; H 8.57; N 7.44. 
                                                                                    Found: C 66.88; H 8.42; N 7.34. 
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5.5.12 Synthesis of (1R,2R)-cyclopentane-1,2-dicarboxylic acid 1-[(2’-hydroxy-
1’-(S)-tert-butyl-ethyl)-amide]-2-[(2’-hydroxy-1’-(S)-phenyl-ethyl)-amide] 
(241) 
 
NH
O
NH
O
HO
HO
Ph
 
 
Solid EEDQ (1.19 g, 4.80 mmol, 1.2 eq.) was added at 0 °C to a solution of 240 
(1.029 g, 4.00 mmol) and (S)-phenylglycinol (0.549 g, 4.00 mmol, 1.0 eq.) in dry THF 
(40.0 mL) and the mixture was stirred at r.t. for 5 days. The solvent was removed in 
vacuum and the crude reaction product was purified by column chromatography 
(pentane:EtOAc, 1:1 + 5% MeOH) delivering the title compound in 83% yield (1.250 
g, 3.32 mmol) as a white solid. 
 
Mp: 207 °C. 
[α]rtD = +6.0 (c = 1.00, MeOH). 
1H-NMR (400 MHz, CD3OD): δ = 0.74 (s, 9H), 1.75-1.92 (m, 4H), 1.99-2.07 (m, 1H), 
2.11-2.18 (m, 1H), 2.96-3.05 (m, 2H), 3.36-3.43 (m, 1H), 3.69 (dd, J = 7.4, 11.3 Hz, 
1H), 3.74 (dd, J = 5.5, 11.3 Hz, 1H), (3.69/3.74 AB part of an ABX-system), 3.68-3.74 
(m, 2H), 4.99 (dd, J = 5.5, 7.4 Hz, 1H), 7.22-7.32 (m, 5H). 
13C-NMR (100 MHz, CD3OD): δ = 25.2, 26.0, 30.6, 31.8, 33.3, 48.7, 49.6, 55.8, 59.4, 
61.0, 64.9, 126.8, 126.9, 128.0, 139.8, 175.6, 176.1. 
IR (KBr): 3317, 2961, 2872, 1623, 1540, 1368, 1253, 1086, 1049 cm−1. 
EI-MS: m/z = 377 (M++1, 4), 345 (M+-31, 100), 327 (9), 319 (14), 260 (29), 240 (54), 
194 (4), 157 (6), 140 (35), 121 (16), 106 (25), 95 (10), 86 (12). 
Elemental Analysis for C21H32N2O4 (376.49):           Calcd.: C 66.99; H 8.57; N 7.44. 
                                                                                    Found: C 66.79; H 8.83; N 7.48. 
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5.5.13 Synthesis of (1R,2R)-cyclopentane-1,2-dicarboxylic acid 1-[(2’-hydroxy-
1’-(S)-methyl-ethyl)-amide]-2-[(2’-hydroxy-1’-(S)-phenyl-ethyl)-amide] 
(247) 
 
HO
O
NH
NH
O
Ph
HO
 
 
Solid EEDQ (1.19 g, 4.80 mmol, 1.2 eq.) was added at 0 °C to a solution of 246 
(0.861 g, 4.00 mmol) and (S)-phenylglycinol (0.549 g, 4.00 mmol, 1.0 eq.) in dry THF 
(40.0 mL) and the mixture was stirred at r.t. for 5 days. The solvent was removed in 
vacuum and the crude reaction product was purified by column chromatography 
(pentane:EtOAc, 1:1 + 5% MeOH) delivering the title compound in 82% yield (1.10 g, 
3.29 mmol) as a white solid. 
 
Mp: 235 °C. 
[α]rtD = +1.6 (c = 0.55, MeOH). 
1H-NMR (400 MHz, CD3OD): δ = 0.93 (d, J = 6.9 Hz, 3H), 1.69-1.86 (m, 4H), 1.95-
2.07 (m, 2H), 2.77 (q, J = 8.8 Hz, 1H), 2.98 (q, J = 8.8 Hz, 1H), 3.35 (dd, J = 5.8, 11.0 
Hz, 1H), 3.40 (dd, J = 5.5, 11.0 Hz, 1H), (3.35/3.40 AB part of an ABX-system), 3.65 
(dd, J = 7.4, 11.3 Hz, 1H), 3.70 (dd, J = 5.5, 11.3 Hz, 1H), (3.65/3.70 AB part of an 
ABX-system), 3.80-3.88 (m, 1H), 4.94 (dd, J = 5.5, 7.4 Hz, 1H), 7.19-7.22 (m, 1H), 
7.23 (d, J = 4.4 Hz, 4H). 
13C-NMR (100 MHz, CD3OD): δ = 15.8, 25.0, 30.6, 31.0, 47.0, 55.7, 64.7, 64.9, 
126.5, 126.8, 128.0, 139.9, 175.2, 175.5. 
IR (KBr): 3290, 2959, 1643, 1553, 1040 cm−1. 
EI-MS: m/z = 335 (M++1, 2), 303 (M+-31, 64), 260 (21), 198 (71), 180 (11), 140 (24), 
121 (12), 106 (46), 95 (13), 67 (10), 58 (21). 
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Elemental Analysis for C18H26N2O4⋅H2O (334.41+H2O): 
                                                                                     Calcd.: C 64.65; H 7.84; N 8.38. 
                                                                                     Found: C 64.45; H 8.07; N 8.26. 
 
 
5.6 Synthesis of C2- and C1-symmetric chiral bisoxazolines with 
cyclopentane as backbone 
 
5.6.1 General procedure for the preparation of various C2- and C1-symmetric 
chiral bisoxazolines with cyclopentane as backbone (GP-7) 
 
Diethylaminosulfur trifluoride (0.67 mL, 5.50 mmol, 2.2 eq.) was added dropwise to a 
cooled (−78 °C) suspension of the corresponding bis-hydroxyamide (2.50 mmol) in 
dry CH2Cl2 (25.0 mL). After stirring for 3-5 h at the indicated temperature, anhydrous 
K2CO3 (1.04 g, 7.50 mmol, 3.0 eq.) was added and the reaction mixture was allowed 
to warm to r.t.. A saturated aq. NaHCO3 solution was added and after phase 
separation the aqueous layer was extracted with CH2Cl2. The combined organic 
layers were dried over MgSO4, filtered and concentrated in vacuum to yield the crude 
product which was purified by column chromatography. 
 
 
5.6.2 Synthesis of (1R,2R)-bis-[4’-(R)-phenyl-oxazolin-2’-yl]-cyclopentane (228) 
 
O
N
O
N
Ph
Ph
 
 
The product was synthesized from 221 (0.991 g, 2.50 mmol) according to GP-7. 
Purification by column chromatography (pentane:EtOAc, 1:2) yielded 0.818 g (2.27 
mmol, 90%) of the title compound as a colorless oil. 
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[α]rtD = −20.8 (c = 0.65, CHCl3). 
1H-NMR (300 MHz, CDCl3): δ = 1.72-1.82 (m, 2H), 1.86-1.98 (m, 2H), 2.06-2.17 (m, 
2H), 3.20-3.30 (m, 2H), 4.02 (t, J = 8.2 Hz, 2H), 4.54 (dd, J = 8.2, 10.1 Hz, 2H), 5.10 
(dd, J = 7.9, 10.1 Hz, 2H), 7.13-7.26 (m, 10H). 
13C-NMR (75 MHz, CDCl3): δ = 25.5, 31.3, 42.6, 69.6, 75.0, 126.7, 127.5, 128.7, 
142.7, 170.3. 
IR (capillary): 3061, 3029, 2962, 2899, 1660, 1493, 1453, 1360, 1177, 1079 cm−1. 
EI-MS: m/z = 360 (M+, 96), 242 (59), 214 (100), 199 (15), 187 (20), 174 (45), 120 
(12), 104 (48), 95 (21), 91 (27), 67 (17). 
HRMS for C23H24N2O2: 
 
Calcd.: 360.183780. 
Found: 360.183767. 
 
 
5.6.3 Synthesis of (1R,2R)-bis-[4’-(R)-phenyl-oxazolin-2’-yl]-cyclopentane (229) 
 
O
N
O
N Ph
Ph
 
 
The product was synthesized from 222 (0.991 g, 2.50 mmol) according to GP-7. 
Purification by column chromatography (pentane:EtOAc, 1:2) yielded 0.721 g (2.00 
mmol, 80%) of the title compound as a colorless oil. 
 
[α]rtD = −189.6 (c = 3.00, CHCl3). 
1H-NMR (400 MHz, CDCl3): δ = 1.80-1.89 (m, 2H), 1.95-2.04 (m, 2H), 2.15-2.23 (m, 
2H), 3.28-3.35 (m, 2H), 4.09 (t, J = 8.2 Hz, 2H), 4.63 (dd, J = 8.5, 10.2 Hz, 2H), 5.18 
(dd, J = 8.0, 10.2 Hz, 2H), 7.22-7.33 (m, 10H). 
13C-NMR (100 MHz, CDCl3): δ = 25.5, 31.2, 42.6, 69.6, 75.1, 126.6, 127.5, 128.7, 
142.5, 170.5. 
IR (in CHCl3): 2964, 2900, 1660, 1494, 1453, 1359, 1176, 1026 cm−1. 
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EI-MS: m/z = 360 (M+, 96), 242 (48), 214 (100), 199 (16), 187 (24), 174 (55), 120 
(54), 104 (51), 95 (21), 91 (26), 67 (17). 
HRMS for C23H24N2O2: 
 
Calcd.: 360.183780. 
Found: 360.183806. 
 
 
5.6.4 Synthesis of (1R,2R)-bis-[4’-(S)-tert-butyl-oxazolin-2’-yl]-cyclopentane 
(230) 
 
O
N
O
N
 
 
The product was synthesized from 224 (0.891 g, 2.5 mmol) according to GP-7. 
Purification by column chromatography (pentane:EtOAc, 1:2) yielded 0.742 g (2.31 
mmol, 92% yield) of the title compound as a white solid. 
 
Mp: 53.5-54.5 °C. 
[α]rtD = −186.9 (c = 1.08, CHCl3). 
1H-NMR (400 MHz, CDCl3): δ = 0.86 (s, 18 H), 1.72-1.89 (m, 4H), 2.02-2.10 (m, 2H), 
3.13 (t, J = 5.8 Hz, 2H), 3.79 (dd, J = 7.4, 9.9 Hz, 2H), 4.04 (dd, J = 7.4, 8.5 Hz, 2H), 
4.12 (dd, J = 8.5, 9.9 Hz, 2H). 
13C-NMR (100 MHz, CDCl3): δ = 25.4, 25.7, 31.3, 33.7, 42.0, 68.5, 75.3, 168.7. 
IR (KBr): 2959, 2905, 2869, 1670, 1480, 1359, 1258, 1229, 1019 cm−1. 
EI-MS: m/z = 320 (M+, 14), 305 (6), 263 (100), 205 (6), 194 (15), 163 (24), 136 (21), 
95 (2), 67 (3). 
Elemental Analysis for C19H32N2O2 (320.47):         Calcd.: C 71.21; H 10.06; N 8.74. 
                                                                                    Found: C 70.81; H 9.74; N 8.68. 
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5.6.5 Synthesis of (1S,2S)-bis-[4’-(S)-tert-butyl-oxazolin-2’-yl]-cyclopentane 
(231) 
 
O
N
O
N
 
 
The product was synthesized from 225 (0.891 g, 2.50 mmol) according to GP-7. 
Purification by column chromatography (pentane:EtOAc, 1:2) yielded 0.663 g (2.07 
mmol, 83%) of the title compound as a white solid. 
 
Mp: 51 °C. 
[α]rtD = +2.5 (c = 0.69, CHCl3). 
1H-NMR (400 MHz, CDCl3): δ = 0.87 (s, 18 H), 1.70-1.77 (m, 2H), 1.81-1.89 (m, 2H), 
2.00-2.08 (m, 2H), 3.09-3-16 (m, 2H), 3.80 (dd, J = 7.4, 10.2 Hz, 2H), 4.03 (dd, J = 
7.4, 8.5 Hz, 2H), 4.12 (dd, J = 8.5, 10.2 Hz, 2H). 
13C-NMR (100 MHz, CDCl3): δ = 25.4, 25.7, 31.2, 33.6, 42.1, 68.5, 75.3, 168.5. 
IR (KBr): 2956, 2902, 2873, 1670, 1476, 1360, 1249, 1188 cm−1. 
EI-MS: m/z = 320 (M+, 15), 305 (5), 263 (100), 205 (4), 194 (9), 163 (15), 136 (18). 
HRMS for C19H32N2O2: 
 
Calcd.: 320.246378. 
Found: 320.246389. 
 
 
5.6.6 Synthesis of (1S,2S)-[4’-(S)-tert-butyl-oxazolin-2’-yl]-[4’’-(S)-phenyl-
oxazolin-2’’-yl]-cyclopentane (245) 
 
O
N
O
N
Ph
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The product was synthesized from 234 (0.941 g, 2.50 mmol) according to GP-7. 
Purification by column chromatography (pentane:EtOAc, 1:2) yielded 0.705 g (2.07 
mmol, 83% yield) of the title compound as a colorless oil. 
 
[α]rtD = +9.6 (c = 1.56, CHCl3). 
1H-NMR (400 MHz, CDCl3): δ = 0.88 (s, 9H), 1.77-1.98 (m, 4H), 2.04-2.15 (m, 2H), 
3.17-3.28 (m, 2H), 3.83 (ddd, J = 0.8, 7.7, 10.2 Hz, 1H), 4.06 (dd, J = 7.7, 8.8 Hz, 
1H), 4.07 (dd, J = 8.0, 8.2 Hz, 1H), 4.16 (dd, J = 8.8, 10.2 Hz, 1H), 4.59 (dd, J = 8.2, 
9.9 Hz, 1H), 5.14 (dd, J = 8.0, 9.9 Hz, 1H), 7.21-7.28 (m, 3H), 7.30-7.35 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ = 25.4, 25.7, 31.1, 31.2, 33.6, 42.1, 42.2, 68.5, 69.4, 
74.8, 75.3, 126.4, 127.2, 128.4, 142.4, 168.4, 170.3. 
IR (capillary): 2957, 2902, 2872, 1664, 1477, 1454, 1361, 1180, 1025 cm−1. 
EI-MS: m/z = 340 (M+, 39), 325 (4), 283 (100), 242 (11), 214 (29), 163 (55), 136 (34), 
120 (13), 103 (7), 95 (8), 67 (8). 
HRMS for C21H28N2O2: 
 
Calcd.: 340.215078. 
Found: 340.215054. 
 
 
5.6.7 Synthesis of (1S,2S)-[4’-(S)-tert-butyl-oxazolin-2’-yl]-[4’’-(R)-phenyl-
oxazolin-2’’-yl]-cyclopentane (246) 
 
O
N
O
N
Ph
 
 
The product was synthesized from 238 (0.941 g, 2.50 mmol) according to GP-7. 
Purification by column chromatography (pentane:EtOAc, 1:2) yielded 0.692 g (2.03 
mmol, 81%) of the title compound as a white solid. 
 
Mp: 61 °C. 
[α]rtD = +110.2 (c = 1.00, CHCl3). 
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1H-NMR (400 MHz, CDCl3): δ = 0.88 (s, 9H), 1.76-2.04 (m, 4H), 2.05-2.18 (m, 2H), 
3.15-3.26 (m, 2H), 3.84 (ddd, J = 0.8, 7.4, 10.2 Hz, 1H), 4.05 (dd, J = 8.0, 8.5 Hz, 
1H), 4.06 (dd, J = 7.4, 8.5 Hz, 1H), 4.16 (dd, J = 8.5, 10.2 Hz, 1H), 4.59 (dd, J = 8.5, 
10.2 Hz, 1H), 5.14 (dd, J = 8.0, 10.2 Hz, 1H), 7.21-7.27 (m, 3H), 7.30-7.35 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ = 25.3, 25.9, 31.0, 31.2, 33.8, 42.4, 43.1, 68.8, 69.5, 
74.9, 75.6, 126.6, 127.4, 128.6, 142.6, 168.4, 170.5. 
IR (KBr): 2952, 2874, 1668, 1476, 1451, 1398, 1352, 1245, 1180, 1026, 1004 cm−1. 
EI-MS: m/z = 340 (M+, 25), 283 (100), 242 (8), 214 (28), 163 (76), 136 (62), 120 (19), 
103 (11), 95 (11), 67 (13). 
Elemental Analysis for C21H28N2O2 (340.46):        Calcd.: C: 74.08; H: 8.29; N: 8.23. 
                                                                                 Found: C: 73.94; H: 7.95; N: 8.23. 
 
 
5.6.8 Synthesis of (1R,2R)-[4’-(S)-tert-butyl-oxazolin-2’-yl]-[4’’-(R)-phenyl-
oxazolin-2’’-yl]-cyclopentane (247) 
 
O
N
O
N Ph
 
 
The product was synthesized from 244 (0.941 g, 2.50 mmol) according to GP-7. 
Purification by column chromatography (pentane:EtOAc, 1:2) yielded 0.712 g (2.09 
mmol, 83%) of the title compound as a colorless oil. 
 
[α]rtD = −96.9 (c = 2.00, CHCl3). 
1H-NMR (400 MHz, CDCl3): δ = 0.88 (s, 9H), 1.77-2.00 (m, 4H), 2.07-2.18 (m, 2H), 
3.16-3.23 (m, 2H), 3.83 (dd, J = 7.4, 10.2 Hz, 1H), 4.06 (dd, J = 7.4, 8.5 Hz, 1H), 4.07 
(dd, J = 8.0, 8.2 Hz, 1H), 4.16 (dd, J = 8.5, 10.2 Hz, 1H), 4.59 (dd, J = 8.2, 10.2 Hz, 
1H), 5.14 (dd, J = 8.0, 10.2 Hz, 1H), 7.21-7.28 (m, 3H), 7.30-7.35 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ = 25.4, 25.9, 31.1, 31.2, 33.9, 42.6, 42.6, 68.7, 69.6, 
75.0, 75.5, 126.6, 127.4, 128.6, 142.6, 168.6, 170.4. 
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IR (capillary): 2957, 2902, 2872, 1665, 1477, 1361, 1180, 1025 cm−1. 
EI-MS: m/z = 340 (M+, 36), 283 (100), 242 (7), 214 (30), 163 (72), 136 (51), 120 (20), 
103 (10), 95 (9), 67 (10). 
HRMS for C21H28N2O2: 
 
Calcd.: 340.215078. 
Found: 340.215017. 
 
 
5.6.9 Synthesis of (1S,2S)-[4’-(S)-tert-butyl-oxazolin-2’-yl]-[4’’-(S)-phenyl-
oxazolin-2’’-yl]-cyclopentane (248) 
 
O
N
O
N
Ph
 
 
The product was synthesized from 241 (0.941 g, 2.50 mmol) according to GP-7. 
Purification by column chromatography (pentane:EtOAc, 1:2) yielded 0.719 g (2.11 
mmol, 84% yield) of the title compound as a white solid. 
 
Mp: 36 °C. 
[α]rtD = −197.3 (c = 1.02, CHCl3). 
1H-NMR (400 MHz, CDCl3): δ = 0.87 (s, 9H), 1.77-1.99 (m, 4H), 2.08-2.18 (m, 2H), 
3.16-3.26 (m, 2H), 3.82 (dd, J = 7.1, 9.9 Hz, 1H), 4.05-4.09 (m, 1H), 4.07 (dd, J = 7.1, 
8.5 Hz, 1H), 4.16 (dd, J = 8.5, 9.9 Hz, 1H), 4.59 (dd, J = 8.2, 10.2 Hz, 1H), 5.15 (dd, J 
= 8.0, 10.2 Hz, 1H), 7.21-7.28 (m, 3H), 7.30-7.34 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ = 25.5, 25.9, 31.3, 31.4, 33.9, 42.3, 42.6, 68.7, 69.5, 
75.0, 75.5, 126.6, 127.4, 128.6, 142.6, 168.7, 170.6. 
IR (KBr): 2956, 2904, 2875, 1667, 1360, 1189 cm−1. 
EI-MS: m/z = 340 (M+, 51), 283 (100), 242 (6), 214 (21), 163 (46), 136 (31), 120 (10), 
103 (6), 95 (6), 67 (6). 
Elemental Analysis for C21H28N2O2 (340.46):        Calcd.: C: 74.08; H: 8.29; N: 8.23. 
                                                                                 Found: C: 74.14; H: 8.64; N: 8.08. 
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5.7 Applications in the catalysis 
 
5.7.1 General procedure for the asymmetric cyclopropanation reaction (GP-7) 
 
A solution of the corresponding ligand (0.015 mmol, 1.05 mol%) in dry CH2Cl2 was 
added via syringe to a flask containing CuOTf·0.5C6H6 (3.5 mg, 0.014 mmol, 1 mol%) 
under argon. After stirring at r.t. for 1 h, the mixture was cooled to 0 °C. Styrene (1.7 
mL, 14.00 mmol, 10.0 eq.) was added followed by slow addition of a solution of ethyl 
diazoacetate (0.16 g, 1.40 mmol in 2.5 mL CH2Cl2) over 5 h via syringe pump. The 
mixture was allowed to warm to r.t. and it was stirred for an additional 16 h before 
quenching with a 10% aq. solution of NH4Cl (5.0 mL). The solution was diluted with 
Et2O (25.0 mL) and washed with water (5.0 mL) and brine (5.0 mL). The organic 
layer was dried over MgSO4, filtered and the solvent was removed in vacuum to yield 
the cyclopropanated products as a mixture of cis and trans isomers. The 
diastereomeric ratio was determined by 1H NMR analysis of the crude reaction 
mixture. In order to determine the enantiomeric excesses, the cis and trans isomers 
have been separated by column chromatography (2% ethylacetate in pentane). The 
ee of the trans isomer was determined by HPLC analysis, while comparison of optical 
rotation was used for the cis isomer. The absolute configuration of the products was 
confirmed by the sign of the optical rotation. 
 
ee = 83% [HPLC-analysis: Chiralcel OD-H at r.t., n-heptane:2-propanol = 95:5, 0.5 
mL/min, 254 nm, t1 = 9.6 min (major, (1R,2R)), t2 = 12.0 min]. 
1H-NMR (400 MHz, CDCl3): δ = 1.28 (t, J = 7.1 Hz, 3H), 1.29-1.33 (m, 1H), 1.60 
(ddd, J = 4.1, 5.2, 9.1 Hz, 1H), 1.90 (ddd, J = 4.1, 5.2, 8.2 Hz, 1H), 2.51 (ddd, J = 4.1, 
6.6, 9.3 Hz, 1H), 4.17 (q, J = 7.1 Hz, 2 H), 7.08-7.11 (m, 2H), 7.17-7.22 (m, 1H), 
7.25-7.29 (m, 2 H). 
13C-NMR (100 MHz, CDCl3): δ = 14.2, 17.0, 24.1, 26.1, 60.6, 126.0, 126.3, 128.3, 
139.9, 173.1. 
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5.7.2 General procedure for the Asymmetric Diels-Alder reaction (GP-8) 
 
A mixture of Cu(OTf)2 or CuCl2 (0.025 mmol, 10 mol%) and the ligand (0.0275 mmol, 
11 mol%) in dry CH2Cl2 was stirred for 2 h at r.t. under argon. In the case of the 
counterion screening, silver salts (0.05 mmol) were added to the precursor complex 
synthesized from CuCl2. Stirring was continued for 30 min and the catalysis was 
started by adding the dienophile (0.25 mmol), followed by freshly distilled 
cyclopentadiene. The reaction was monitored by t.l.c. and stopped by filtration 
through a plug of silica gel using CH2Cl2 as solvent. Evaporation of the solvent and 
purification by column chromatography affords the product as a white solid. The 
endo/exo ratio was determined by 1H NMR analysis of the reaction mixture and 
confirmed by HPLC analysis. 
 
endo/exo = 77:23; eeendo = 71% [HPLC-analysis: Chiralcel OD-H at r.t., n-heptane:2-
propanol = 98:2, 1.0 mL/min, 210 nm, t1 (exo) = 27.7 min, t2 (endo, major) = 32.0 min, 
t2 (endo, minor) = 34.9 min]. 
 
 
5.8 Synthesis of the salen type ligand 
 
5.8.1 Synthesis of (2R,3S)-3-endo-methoxycarbonyl-bicyclo[2.2.1]hept-5-ene-
2-endo-carboxylic acid (176) 
 
COOCH3
COOH  
 
The product was obtained according to GP-4 from the quinidine opening of anhydride 
160 in 97% yield (7.63 g, 38.88 mmol) as a white solid. 
 
Mp: 74 °C (rac), 75-78 °C (en), lit.277 mp: 74-76 °C (rac). 
[α]rtD = +7.73 (c = 4.0, CCl4), lit.277 [α]rtD = +7.90 (c = 4.8, CCl4). 
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ee = 98% [GC-analysis of the lactone: Lipodex E, t1 = 80.7, t2 = 81.1 (major)]. 
1H NMR (300 MHz, CDCl3): δ = 1.27 (d, J = 8.7 Hz, 1H), 1.42 (dt, J = 1.7, 8.7 Hz, 
1H), 3.07-3.14 (m, 2H), 3.21 (dd, J = 3.0, 10.1 Hz, 1H), 3.27 (dd, J = 3.0, 10.1 Hz, 
1H), 3.52 (s, 3H), 6.14 (dd, J = 3.0, 5.7 Hz, 1H), 6.25 (dd, J = 3.0, 5.7 Hz, 1H), 10.80 
(br s, 1H). 
13C NMR (75 MHz, CDCl3): δ = 46.2, 46.7, 48.2, 48.4, 48.9, 51.6, 134.3, 135.7, 
172.5, 178.8. 
IR (KBr): 3071, 3002, 2949, 2877, 1746, 1709, 1434, 1339, 1259, 1233, 1188, 1049 
cm−1. 
EI-MS: m/z = 196 (M+, 2), 178 (7), 165 (M+−31, 15), 137 (10), 131 (53), 119 (21), 113 
(17), 99 (19), 91 (12), 66 (100). 
Elemental Analysis for C10H12O4 (196.20): 
 
Calcd.: C 61.22; H 6.16. 
Found: C 61.43; H 6.16. 
 
 
5.8.2 Synthesis of (2R,3R)-3-exo-methoxycarbonyl-bicyclo[2.2.1]hept-5-ene-2-
endo-carboxylic acid (255) 
 
COOCH3
COOH  
 
A freshly prepared LDA solution (3.0 eq.) in absolute THF (0.75 mL/mmol LDA) was 
added dropwise, over 1.5 h, to a stirred solution of the monomethylester (5.89 g, 30.0 
mmol) in absolute THF (45.0 mL) at –78 °C under Ar. After the complete addition, the 
mixture was stirred at this temperature for 4 h, acidified with 4 N aq. HCl and 
extracted with ethylacetate. The combined organic phases were dried over MgSO4, 
concentrated, and the residue was purified by column chromatography 
(pentane:Et2O, 1:1 + 1% acetic acid) to yield 4.77 g (25.00 mmol, 83% yield) of the 
title compound as a white solid. 
 
Mp: 95.5 °C (rac), 73 °C (en), lit.278 mp: 78-79 °C (en). 
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[α]rtD = −152.40 (c = 1.54 CHCl3), lit.278 [α]rtD = −184.20 (c = 1.52 CHCl3). 
1H NMR (300 MHz, CDCl3): δ = 1.41 (dq, J = 1.7, 8.9 Hz, 1H), 1.56 (dt, J = 1.5, 8.9 
Hz, 1H), 2.59 (dd, J = 1.5,4.7 Hz, 1H), 3.06-3.08 (m, 1H), 3.21-3.24 (m, 1H), 3.36 
(dd, J = 4.0, 4.5 Hz, 1H), 3.65 (s, 3H), 6.07 (dd, J = 2.7, 5.7 Hz, 1H), 6.22 (dd, J = 
3.2, 5.5 Hz, 1H), 10.20 (br s, 1H). 
13C NMR (75 MHz, CDCl3): δ = 45.8, 47.2, 47.7, 47.8, 48.2, 52.4, 135.4, 140.0, 
175.0, 179.6. 
Elemental Analysis for C10H12O4 (196.20): 
 
Calcd.: C 61.22; H 6.16. 
Found: C 61.43; H 6.16. 
 
 
5.8.3 Synthesis of (2R,3R)-bicyclo[2.2.1]heptane-2-endo-3-exo-diamine 
dihydrochloric salt (3·2HCl) (254) 
 
NH2
NH2 HCl
HCl
 
 
Ethyl chloroformate (3.82 mL, 40.00 mmol, 4.0 eq) was added to a mixture of 
(2R,3R)-bicyclo[2.2.1]heptane-2-endo-3-exo-dicarboxylic acid (1.84 g, 10.00 mmol) 
and Et3N (8.36 mL, 60.00 mmol, 6.0 eq.) in THF (16.0 mL) at –20 °C and the reaction 
mixture was stirred at this temperature for 1 h. A solution of NaN3 (3.90 g, 60.00 
mmol, 6.0 eq.) in H2O (24.0 mL) was added at –10 °C. The temperature was 
gradually increased to r.t. and stirring continued for 2 h. The mixture was diluted with 
water, extracted with EtOAc and the organic phase was washed with NaHCO3, dried 
over MgSO4, filtered and concentrated to provide the coresponding acyl azide 6, 
which was dissolved in benzene (16.0 mL) and heated under reflux for 2 h. To the 
cooled isocyanate solution conc. aq. HCl (30.0 mL) was added and the resulting 
mixture was refluxed for 4 h. The reaction mixture was extracted with Et2O and the 
aqueous layer was concentrated to give a solid which was washed with THF and 
dried in high vacuum to give 1.4 g (7.05 mmol, 70% yield) of the title compound as a 
colorless solid. 
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Mp: >250 °C (rac, en), lit.257 mp: >350 °C (rac). 
[α]rtD = –9.3 (c = 1.52, MeOH), [α]rtD = –16.4 (c = 1.18, H2O), lit.254 for ent-3·2HCl: 
[α]rtD = +26.0 (c = 2.0, MeOH). 
1H NMR (400 MHz, DMSO-d6): δ = 1.22 (d, J = 10.2 Hz, 1H), 1.30-1.39 (m, 2H), 
1.49-1.59 (m, 2H), 1.98 (d, J = 10.2 Hz, 1H), 2.3 (s, 1H), 2.95 (s, 1H), 3.30 (s, 1H), 
3.46 (s, 1H), 8.54 (s, 3H), 8.59 (s, 3H). 
13C NMR (100 MHz, DMSO-d6): δ = 21.0, 27.5, 35.3, 39.8, 40.9, 57.2, 58.0. 
IR (KBr): 2970, 2614, 1604, 1565, 1496, 1120, 1061 cm-1. 
EI-MS: m/z = 126 (44), 108 (16), 97 (20), 92 (18), 85 (25), 70 (43), 56 (100). 
Elemental Analysis for C7H16Cl2N2 (199.12): 
 
Calcd.: C 42.22; H 8.10; N 14.07. 
Found: C 42.22; H 8.19; N 14.00. 
 
 
5.8.4 Synthesis of (2R,3R)-N,N’-bis-(2,6-dichloro-benzylidene)-bicyclo[2.2.1] 
heptane-2-endo-3-exo-diamine (257) 
 
NN
Cl
Cl
Cl
Cl
 
 
To a solution of 3·2HCl (398.24 mg, 2.00 mmol) and 2,6-dichlorobenzaldehyde (700 
mg, 4.00 mmol, 2.0 eq.) in MeOH was added Et3N (4.17 mL, 30.00 mmol, 15.0 eq), 
and the mixture was stirred for 16 h at r.t. The solvent was removed in vacuum to 
give a solid which was dissolved in CH2Cl2, washed with water, dried over MgSO4 
and concentrated to provide 0.81 g (1.84 mmol, 92% yield) of the title compound as a 
white solid. 
 
Mp: 85.0 °C (en). 
[α]rtD = –128.00 (c = 1.00, CHCl3). 
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1H NMR (400 MHz, CDCl3): δ = 1.48-1.60 (m, 3H), 1.70-1.79 (m, 1H), 2.16-2.23 (m, 
2H), 2.40 (d, J = 4.1 Hz, 1H), 2.51 (br s, 1H), 3.41 (t, J = 2.2 Hz, 1H), 3.75 (br s, 1H), 
7.20 (dd, J = 7.4, 8.5 Hz, 2H), 7.31 (d, J = 3.1 Hz, 2H), 7.33 (d, J = 3.0 Hz, 2H), 8.32 
(s, 1H), 8.48 (s, 1H). 
13C NMR (100 MHz, CDCl3): δ = 22.3, 28.0, 36.8, 44.3, 45.2, 80.8, 81.6, 128.7, 
128.8, 130.3, 130.4, 133.6, 133.8, 134.8, 134.8, 155.3, 156.9. 
IR (KBr): 2954, 2870, 1642, 1579, 1557, 1429, 1375, 1189, 1094, 781 cm-1. 
EI-MS: m/z = 267 (100), 239 (40), 174 (39), 156 (24), 123 (24), 66 (22). 
Elemental Analysis for C21H18Cl4N2 (440.19): 
 
 
Calcd.: C 57.30; H 4.12; N 6.36. 
Found: C 57.26; H 3.91; N 6.35. 
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7 Abbreviations 
 
 
[α]rtD  specific rotation 
Å  angstrom(s) 
Ac  acetyl 
aq.  aqueous 
Ar  aryl 
atm  atmosphere(s) 
Bn  benzyl 
Boc  tert-butoxycarbonyl 
Box  bisoxazoline 
br  broad (spectral) 
Bu  butyl 
i-Bu  iso-butyl 
t-Bu  tert-butyl 
c  concentration 
°C  degrees Celsius 
calcd  calculated 
cat.  catalyst 
Cbz  benzyloxycarbonyl 
cm−1  wavenumber(s) 
δ  chemical shift in parts per million downfield from tetramethylsilane 
d  day(s) 
d  doublet (spectral) 
DABCO 1,4-diazabicyclo[2.2.2]octane 
dd  doublet of doublets (spectral) 
DMF  N,N-dimethylformamide 
DMSO  dimethyl sulfoxide 
dr  diastereomeric ratio 
de  diastereomeric excess 
ee  enantiomeric excess 
EI  electronic impact (in mass spectrometry) 
eq.  equivalent(s) 
Et  ethyl 
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FAB  fast atom bombardament (in mass spectrometry) 
g  gram 
GC  gas chromatography 
h  hour(s) 
HPLC  high-performance liquid chromatography 
HRMS  high-resolution mass spectrometry 
Hz  hertz 
IR  infrared 
J  coupling constant in NMR spectrometry 
L  ligand 
LDA  lithium diisopropylamide 
LUMO  lowest unoccupied molecular orbital 
m  multiplet (spectral) 
M  molar (moles per liter) 
M+  parent molecular ion (in mass spectrometry) 
Me  methyl 
MHz  megahertz 
mL  milliliter(s) 
Mp  melting point 
MS  mass spectrometry 
m/z  mass-to-charge ratio (in mass spectrometry) 
NMR  nuclear magnetic resonance 
Nu  nucleophile 
PG  protecting group 
Ph  phenyl 
ppm  part(s) per million 
i-Pr  isopropyl 
q  quartet (spectral) 
rac  racemic 
r.t.  room temperature 
s  singlet (spectral) 
t  triplet (spectral) 
TADDOL α, α, α’, α’-tetraaryl-2,2-dimethyl-1,3-dioxolan-4,5-dimethanol 
Tf  trifluoromethanesulfonyl 
THF  tetrahydrofuran 
t.l.c.  thin-layer chromatography 
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TMS  trimethylsilyl 
TMS  tetramethylsilane 
tR  retention time 
Ts  p-toluenesulfonyl (tosyl) 
TS  transition state 
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